UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________________________________
Form 10-K
_________________________________
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the fiscal year ended September 30, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
For the transition period from to
Commission file number 001-11593
______________________________________________________________
The Scotts Miracle-Gro Co mpany
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
(937 ) 644-0011
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered |
Securities registered pursuant to Section 12(g) of the Act:
None
______________________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
☑ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company | |||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No þ
The aggregate market value of Common Shares (the only common equity of the registrant) held by non-affiliates (for this purpose, executive officers and directors of the registrant are considered affiliates) as of March 29, 2019 (the last business day of the most recently completed second quarter) was approximately $3,085,305,949 .
There were 55,819,060 Common Shares of the registrant outstanding as of November 22, 2019.
______________________________________________________________
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of the definitive Proxy Statement for the registrant’s 2020 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended September 30, 2019.
The Scotts Miracle-Gro Company
Annual Report on Form 10-K
For the Fiscal Year Ended September 30, 2019
Table of Contents
Page | |||
PART I
ITEM 1. | BUSINESS |
Company Description and Development of the Business
The discussion below describes the business conducted by The Scotts Miracle-Gro Company, an Ohio corporation (“Scotts Miracle-Gro” and, together with its subsidiaries, the “Company,” “we” or “us”), including general developments in the Company’s business during the fiscal year ended September 30, 2019 (“fiscal 2019”). For additional information on recent business developments, see “ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS” of this Annual Report on Form 10-K.
We are the leading manufacturer and marketer of branded consumer lawn and garden products in North America. Our products are marketed under some of the most recognized brand names in the industry. Our key consumer lawn and garden brands include Scotts® and Turf Builder® lawn and grass seed products; Miracle-Gro®, Nature’s Care®, Scotts®, LiquaFeed® and Osmocote®1 gardening and landscape products; and Ortho®, Roundup®2, Home Defense® and Tomcat® branded insect control, weed control and rodent control products. We are the exclusive agent of the Monsanto Company, a subsidiary of Bayer AG since June 2018 (“Monsanto”), for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products within the United States and certain other specified countries. We have a presence in similar branded consumer products in China and Latin America.
Through our Hawthorne segment, we are a leading manufacturer, marketer and distributor of nutrients, growing media, advanced indoor garden, lighting and ventilation systems and accessories for hydroponic gardening. Our key hydroponic gardening brands include General Hydroponics®, Gavita®, Botanicare®, Vermicrop®, Agrolux®, Can-Filters® and AeroGardenTM. On June 4, 2018, our Hawthorne segment acquired substantially all of the assets and certain liabilities of Sunlight Supply, Inc., Sunlight Garden Supply, Inc., Sunlight Garden Supply, ULC, and IP Holdings, LLC, and all of the issued and outstanding equity interests of Columbia River Industrial Holdings, LLC (collectively “Sunlight Supply”). Prior to the transaction, Sunlight Supply was the largest distributor of hydroponic products in the United States, and was engaged in the business of developing, manufacturing, marketing and distributing horticultural, organics, lighting and hydroponics products (including lighting fixtures, nutrients, seeds and growing media, systems, trays, fans, filters, humidifiers and dehumidifiers, timers, instruments, water pumps, irrigation supplies and hand tools) under key brands including Sun System®, Gro Pro®, Mother Earth®, Hurricane® and Grower’s Edge®. See “Acquisitions” for further discussion.
Scotts Miracle-Gro traces its heritage to a company founded by O.M. Scott in Marysville, Ohio in 1868. In the mid-1900s, we became widely known for the development of quality lawn fertilizers and grass seeds that led to the creation of a new industry - consumer lawn care. In the 1990s, we significantly expanded our product offering with three powerful leading brands in the U.S. home lawn and garden industry. In fiscal 1995, through a merger with Stern’s Miracle-Gro Products, Inc., which was founded by Horace Hagedorn and Otto Stern in Long Island, New York in 1951, we acquired the Miracle-Gro® brand, the industry leader in water-soluble garden plant foods. In fiscal 1999, we acquired the Ortho® brand in the United States and obtained exclusive rights to market Monsanto’s consumer Roundup® brand within the United States and other contractually specified countries, thereby adding industry-leading weed, pest and disease control products to our portfolio. Today, Scotts®, Turf Builder®, Miracle-Gro®, Ortho® and Roundup® brands make us one of the most widely recognized companies in the consumer lawn and garden industry in the United States.
Business Segments
We divide our business into the following reportable segments:
• | U.S. Consumer |
• | Hawthorne |
• | Other |
U.S. Consumer consists of our consumer lawn and garden business located in the geographic United States. Hawthorne consists of our indoor, urban and hydroponic gardening business. Other consists of our consumer lawn and garden business in geographies other than the United States and our product sales to commercial nurseries, greenhouses and other professional customers. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the business segments. This division of reportable segments is consistent with how the segments report to and
________________________ | ||
1 Osmocote® is a registered trademark of Everris International B.V., a subsidiary of Israel Chemicals Ltd. | ||
2 Roundup® is a registered trademark of Monsanto Technology LLC, a company affiliated with Monsanto Company. | ||
2
are managed by our Chief Executive Officer (the chief operating decision maker of the Company). Financial information about these segments for each of the three fiscal years ended September 30, 2019, 2018 and 2017 is presented in “NOTE 21. SEGMENT INFORMATION” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
Principal Products and Services
In our reportable segments, we manufacture, market and sell lawn and garden products in the following categories:
Lawn Care: The lawn care category is designed to help users obtain and enjoy the lawn they want. Products within this category include lawn fertilizer products under the Scotts® and Turf Builder® brand names; grass seed products under the Scotts®, Turf Builder®, EZ Seed®, PatchMaster® and Thick’R Lawn® brand and sub-brand names; and lawn-related weed, pest and disease control products primarily under the Scotts® brand name, including sub-brands such as GrubEx®. The lawn care category also includes spreaders and other durables under the Scotts® brand name, including Turf Builder® EdgeGuard® spreaders and Handy Green® II handheld spreaders. In addition, we market outdoor cleaners under the Scotts® OxiCleanTM3 brand name.
Gardening and Landscape: The gardening and landscape category is designed to help consumers grow and enjoy flower and vegetable gardens and beautify landscaped areas. Products within this category include a complete line of water-soluble plant foods under the Miracle-Gro® brand and sub-brands such as LiquaFeed®, continuous-release plant foods under the Miracle-Gro®, Scotts® and Osmocote® brands and sub-brands of Miracle-Gro® such as Shake ‘N Feed®; potting mixes and garden soils under the Miracle-Gro®, Scotts®, Hyponex®, Earthgro®, SuperSoil® and Fafard® brand names; mulch and decorative groundcover products under the Scotts® brand, including the sub-brands Nature Scapes®, Earthgro® and Hyponex®; plant-related pest and disease control products under the Ortho® brand; organic garden products under the Miracle-Gro® Performance Organics®, Miracle-Gro® Organic Choice®, Nature’s Care®, Scotts®, Whitney Farms® and EcoScraps® brand names; and live goods and seeding solutions under the Miracle-Gro® brand. In the second quarter of fiscal 2016, we entered into a Marketing, R&D and Ancillary Services Agreement (the “Services Agreement”) and a Term Loan Agreement (the “Term Loan Agreement”) with Bonnie Plants, Inc. (“Bonnie”) and its sole shareholder, Alabama Farmers Cooperative, Inc. (“AFC”), pursuant to which we provide financing and certain services to Bonnie’s business of planting, growing, developing, manufacturing, distributing, marketing, and selling to retail stores throughout the United States live plants, plant food, fertilizer and potting soil (the “Bonnie Business”). See “Acquisitions” for further discussion.
Hydroponics: The hydroponic category is designed to help customers grow plants, flowers and vegetables in an indoor or urban environment using little or no soil. Products within this category include horticultural, organic, lighting and hydroponics products, including lighting fixtures, nutrients, seeds and growing media, systems, trays, fans, filters, humidifiers and dehumidifiers, timers, instruments, water pumps, irrigation supplies and hand tools, and are marketed under the General Hydroponics®, Gavita®, Botanicare®, Vermicrop®, Agrolux®, Can-Filters®, Sun System®, Gro Pro®, Mother Earth®, Hurricane®, Grower’s Edge® and AeroGardenTM brand names.
Controls: The controls category is designed to help consumers protect their homes from pests and maintain external home areas. Insect control products are marketed under the Ortho® brand name, including Ortho Max®, Home Defense Max® and Bug B Gon Max® sub-brands; rodent control products are marketed under the Tomcat® and Ortho® brands; selective weed control products are marketed under the Ortho® Weed B Gon® sub-brand; and non-selective weed killer products are marketed under the Groundclear® brand name.
Marketing Agreement: We are Monsanto’s exclusive agent for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries. On May 15, 2015, we entered into an amendment (the “Marketing Agreement Amendment”) to the Amended and Restated Exclusive Agency and Marketing Agreement (as amended, the “Original Marketing Agreement”) with Monsanto and also entered into a lawn and garden brand extension agreement (the “Brand Extension Agreement”) and a commercialization and technology agreement (the “Commercialization and Technology Agreement”) with Monsanto. On August 31, 2017, in connection with the sale of our consumer lawn and garden businesses located in Australia, Austria, Belgium, Luxembourg, Czech Republic, France, Germany, Poland and the United Kingdom (the “International Business”), we entered into the Second Amended and Restated Agency and Marketing Agreement (the “Restated Marketing Agreement”) and the Amended and Restated Lawn and Garden Brand Extension Agreement - Americas (the “Restated Brand Extension Agreement”) to reflect the Company’s transfer and assignment to Exponent Private Equity LLP (“Exponent”) of the Company’s rights and responsibilities under the Original Marketing Agreement, as amended, and the Brand Extension Agreement relating to those countries and territories subject to the sale.
________________________ |
3 OxiCleanTM is a registered trademark of Church & Dwight Co., Inc. |
3
Effective August 1, 2019, we entered into (i) the Third Amended and Restated Exclusive Agency and Marketing Agreement (the “Third Restated Agreement”) which amends and restates the Restated Marketing Agreement, (ii) a Brand Extension Agreement Asset Purchase Agreement (the “BEA Purchase Agreement”) under which we sold certain assets to Monsanto related to the development, manufacture, production, advertising, marketing, promotion, distribution, importation, exportation, offer for sale and sale of specified Roundup® branded products sold outside the non-selective weedkiller category within the residential lawn and garden market and (iii) agreements terminating both the Restated Brand Extension Agreement and the Commercialization and Technology Agreement.
Under the terms of the Third Restated Agreement, we provide certain consumer and trade marketing program services, sales, merchandising, warehousing and other selling and marketing support for these products. Among other things, the Third Restated Agreement amends the provisions of the Restated Marketing Agreement relating to commissions, contributions, noncompetition, and termination. The Company also performs other services on behalf of Monsanto, including manufacturing conversion services, pursuant to ancillary agreements. For additional details regarding the Third Restated Agreement, see “ITEM 1A. RISK FACTORS — In the event the Third Restated Agreement for Monsanto’s consumer Roundup® products terminates or Monsanto’s consumer Roundup® business materially declines, we would lose a substantial source of future earnings and overhead expense absorption” of this Annual Report on Form 10-K and “NOTE 7. MARKETING AGREEMENT” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
Acquisitions
2018
On October 2, 2017, our Hawthorne segment acquired the remaining 25% noncontrolling interest in Gavita Holdings B.V., and its subsidiaries (collectively, “Gavita”), including Agrolux Holding B.V. (now known as Hawthorne Lighting B.V.), and its subsidiaries (collectively, “Agrolux”), for $69.2 million, plus payment of contingent consideration of $3.0 million.
On October 11, 2017, our Hawthorne segment completed the acquisition of substantially all of the U.S. and Canadian assets of Can-Filters Group Inc. (“Can-Filters”) for $74.1 million. Based in British Columbia, Can-Filters is a wholesaler of ventilation products for indoor and hydroponic gardening and industrial market customers.
On June 4, 2018, our Hawthorne segment acquired Sunlight Supply for $459.1 million. Sunlight Supply, based in Vancouver, Washington, is a leading developer, manufacturer, marketer and distributer of horticultural, organics, lighting, and hydroponics products. Prior to the transaction, Sunlight Supply served as a non-exclusive distributor of our products.
2017
On October 3, 2016, our Hawthorne segment completed the acquisition of American Agritech, L.L.C., d/b/a Botanicare (“Botanicare”), an Arizona-based leading producer of plant nutrients, plant supplements and growing systems used for hydroponic gardening, for $92.6 million.
On November 29, 2016, our wholly-owned subsidiary SMG Growing Media, Inc. fully exercised its outstanding warrants to acquire additional shares of common stock of AeroGrow International, Inc. (“AeroGrow”) for $8.1 million, which increased our percentage ownership of AeroGrow’s outstanding shares of common stock (on a fully diluted basis) from 45% to 80%. AeroGrow is a developer, marketer, direct-seller, and wholesaler of advanced indoor garden systems designed for consumer use in gardening, and home and office décor markets. AeroGrow operates primarily in the United States, Canada, Australia and select countries in Europe and Asia.
During the first quarter of fiscal 2017, our U.S. Consumer segment also completed two acquisitions of companies whose products support water positive landscapes and internet-enabled technology for an aggregate purchase price of $3.2 million.
On May 26, 2017, our majority-owned subsidiary Gavita completed the acquisition of Agrolux for $21.8 million. Agrolux, based in the Netherlands, is a worldwide supplier of horticultural lighting.
During the third quarter of fiscal 2017, our Hawthorne segment also completed the acquisition of a company focused on the technology supporting hydroponic growing systems for $3.5 million.
On August 11, 2017, our Hawthorne segment completed the acquisition of substantially all of the assets of the exclusive manufacturer and formulator of branded Botanicare products for $32.0 million.
During the fourth quarter of fiscal 2017, we also made a $29.4 million investment in an unconsolidated subsidiary whose products support the professional U.S. industrial, turf and ornamental market (the “IT&O Joint Venture”).
2016
In the second quarter of fiscal 2016, we entered into the Services Agreement and the Term Loan Agreement with Bonnie and AFC providing for our participation in the Bonnie Business. The Term Loan Agreement provides a loan from us to AFC, with Bonnie as guarantor, in the amount of $72.0 million with a fixed coupon rate of 6.95% (the “Term Loan”). Under the Services
4
Agreement, we provide marketing, research and development and certain ancillary services to the Bonnie Business for a commission fee based on the profits of the Bonnie Business and the reimbursement of certain costs.
On May 26, 2016, our Hawthorne segment acquired majority control and a 75% economic interest in Gavita, a Netherlands-based leading producer and marketer of indoor lighting used in the greenhouse and hydroponic markets, predominately in the United States and Europe, for $136.2 million. Gavita’s former ownership group initially retained a 25% noncontrolling interest in Gavita consisting of ownership of 5% of the outstanding shares of Gavita and a loan with interest payable based on distributions by Gavita.
In the third quarter of fiscal 2016, our Other segment completed an acquisition to expand our Canadian growing media operations for an estimated purchase price of $33.9 million, which was adjusted down by $4.3 million during fiscal 2017 based on the resolution of contingent consideration.
2015
On March 30, 2015, our Hawthorne segment acquired the assets of General Hydroponics, Inc. (“General Hydroponics”) and Bio-Organic Solutions, Inc. (“Vermicrop”), leading producers of liquid plant food products, growing media and accessories for hydroponic gardening, for $120.0 million and $15.0 million, respectively. The Vermicrop purchase price was paid in common shares of Scotts Miracle-Gro (“Common Shares”) based on the average share price at the time of payment.
On May 15, 2015, we amended our Original Marketing Agreement with Monsanto and entered into a lawn and garden brand extension agreement, and a commercialization and technology agreement with Monsanto gaining certain rights and protections pursuant to the agreements. We paid Monsanto $300.0 million in consideration for these agreements on August 14, 2015.
Divestitures
On March 19, 2019, we sold all of our approximately 30% equity interest in Outdoor Home Services Holdings LLC, a lawn services joint venture between the Company and TruGreen Holding Corporation (the “TruGreen Joint Venture”) to TruGreen Companies L.L.C., a subsidiary of TruGreen Holding Corporation. Prior to this transaction, our net investment and advances with respect to the TruGreen Joint Venture had been reduced to a liability which resulted in an amount recorded in the “Distributions in excess of investment in unconsolidated affiliate” line in the Consolidated Balance Sheets of $21.9 million at September 30, 2018. In connection with this transaction, we received cash proceeds of $234.2 million related to the sale of our equity interest in the TruGreen Joint Venture and $18.4 million related to the payoff of second lien term loan financing.
On April 1, 2019, we sold all of our noncontrolling equity interest in the IT&O Joint Venture for cash proceeds of $36.6 million.
On April 29, 2017, we received a binding and irrevocable offer (the “Offer”) from Exponent to purchase the International Business for approximately $250.0 million (subject to potential adjustment following closing in respect of the actual financial position at closing) and a deferred payment amount of up to $23.8 million. On July 5, 2017, we accepted the Offer and entered into the Share and Business Sale Agreement contemplated by the Offer. On August 31, 2017, we completed the sale of the International Business for cash proceeds of $150.6 million at closing, which was net of a closing statement adjustment for expected financial position at closing and net of seller financing provided by us of $29.7 million.
On April 13, 2016, we contributed the Scotts LawnService® business (the “SLS Business”) to the TruGreen Joint Venture in exchange for a minority equity interest of approximately 30% in the TruGreen Joint Venture, which had an initial fair value of $294.0 million, and received a tax-deferred cash distribution of $196.2 million, partially offset by an investment of $18.0 million in second lien term loan financing provided by us to the TruGreen Joint Venture.
Where required, we have classified our results of operations for all periods presented in this Annual Report on Form 10-K to reflect these businesses as discontinued operations during the applicable periods. See “NOTE 3. DISCONTINUED OPERATIONS” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K for additional information.
Principal Markets and Methods of Distribution
We sell our products primarily to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers through both a direct sales force and our network of brokers and distributors. In addition, during fiscal 2019, we employed approximately 2,100 full-time and seasonal in-store associates within the United States to help our retail partners merchandise their lawn and garden departments directly to consumers of our products.
5
The majority of our shipments to customers are made via common carriers or through distributors in the United States. We primarily utilize third parties to manage the key distribution centers for our consumer business in North America, which are strategically located across the United States and Canada. Growing media products are generally shipped direct-to-store without passing through a distribution center.
Raw Materials
We purchase raw materials for our products from various sources. We are subject to market risk as a result of the fluctuating prices of raw materials, including urea and other fertilizer inputs, resins, diesel, gasoline, natural gas, sphagnum peat, bark and grass seed. Our objectives surrounding the procurement of these materials are to ensure continuous supply, minimize costs and improve predictability. We seek to achieve these objectives through negotiation of contracts with favorable terms directly with vendors. When appropriate, we commit to purchase a certain percentage of our needs in advance of the lawn and garden season to secure pre-determined prices. We also hedge certain commodities, particularly diesel, resin and urea, to improve cost predictability and control. Sufficient raw materials were available during fiscal 2019.
Trademarks, Patents and Licenses
We consider our trademarks, patents and licenses to be key competitive advantages. We pursue a vigorous trademark protection strategy consisting of registration, renewal and maintenance of key trademarks and proactive monitoring and enforcement activities to protect against infringement. The Scotts®, Miracle-Gro®, Ortho®, Tomcat®, Hyponex®, Earthgro®, General Hydroponics®, Vermicrop®, Gavita®, Botanicare®, Agrolux®, Sun System®, Mother Earth® and Can-Filters® brand names and logos, as well as a number of product trademarks, including Turf Builder®, EZ Seed®, Organic Choice®, Nature’s Care®, Home Defense Max®, Nature Scapes®, Weed B Gon® and Roundup® for Lawns are registered in the United States and/or internationally and are considered material to our business.
In addition, we actively develop and maintain an extensive portfolio of utility and design patents covering subject matters such as fertilizer, weed killer, chemical and growing media compositions and processes; grass seed varieties; and mechanical dispensing devices such as applicators, spreaders and sprayers. Our utility patents provide protection generally extending to 20 years from the date of filing, and many of our patents will continue well into the next decade. We also hold exclusive and non-exclusive patent licenses and supply arrangements, permitting the use and sale of additional patented fertilizers, pesticides and mechanical devices. Although our portfolio of patents and patent licenses is important to our success, no single patent or group of related patents is considered significant to any of our business segments or the business as a whole.
Seasonality and Backlog
Our business is highly seasonal, with approximately 75% of our annual net sales occurring in our second and third fiscal quarters combined. Our annual sales are further concentrated in our second and third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products, thereby reducing retailers’ pre-season inventories.
We anticipate significant orders for the upcoming spring season will start to be received late in the winter and continue through the spring season. Historically, substantially all orders have been received and shipped within the same fiscal year with minimal carryover of open orders at the end of the fiscal year.
Significant Customers
Our three largest customers are Home Depot, Lowe’s and Walmart. Home Depot and Lowe’s are the only customers that individually represent more than 10% of reported consolidated net sales during any of the three most recent fiscal years. For additional details regarding significant customers, see “ITEM 1A. RISK FACTORS — Because of the concentration of our sales to a small number of retail customers, the loss of one or more of, or a significant reduction in orders from, our top customers could adversely affect our financial results” of this Annual Report on Form 10-K and “NOTE 21. SEGMENT INFORMATION” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
Competitive Marketplace
The markets in which we sell our products are highly competitive. We compete primarily on the basis of product innovation, product quality, product performance, value, brand strength, supply chain competency, field sales support, in-store sales support, the strength of our relationships with major retailers, distributors and advertising.
In the lawn and garden, pest control and indoor gardening and hydroponic markets, our products compete against private-label as well as branded products. Primary competitors include Spectrum Brands Holdings, Inc., Central Garden & Pet Company, Enforcer Products, Inc., Kellogg Garden Products, Oldcastle Retail, Inc., Lebanon Seaboard Corporation, Reckitt Benckiser Group plc, FoxFarm Soil & Fertilizer Company, Nanolux Technology, Inc., Sun Gro Horticulture, Inc., Advanced Nutrients, Ltd. and
6
Hydrofarm, LLC. In addition, we face competition from smaller regional competitors who operate in many of the areas where we compete.
In Canada, we face competition in the lawn and garden market from Premier Tech Ltd. and a variety of local companies including private label brands.
Research and Development
We continually invest in research and development, both in the laboratory and at the consumer level, to improve our products, manufacturing processes, packaging and delivery systems. Spending on research and development was $39.6 million, $42.5 million and $39.9 million in fiscal 2019, fiscal 2018 and fiscal 2017, respectively, including product registration costs of $11.0 million, $11.4 million and $10.6 million, respectively. In addition to the benefits of our own research and development, we actively seek ways to leverage the research and development activities of our suppliers and other business partners.
Regulatory Considerations
Local, state, federal and foreign laws and regulations affect the manufacture, sale, distribution and application of our products in several ways. For example, in the United States, all pesticide products must comply with the Federal Insecticide, Fungicide, and Rodenticide Act (“FIFRA”), and most require registration with the U.S. Environmental Protection Agency (the “U.S. EPA”) and similar state agencies before they can be sold or distributed. Fertilizer and growing media products are subject to state and foreign labeling regulations. In addition to the regulations already described, federal, state and foreign agencies regulate the disposal, transport, handling and storage of waste, remediation of contaminated sites, air and water discharges from our facilities, and workplace health and safety. Our grass seed products are regulated by the Federal Seed Act and various state regulations.
In addition, the use of certain pesticide and fertilizer products is regulated by various local, state, federal and foreign environmental and public health agencies. These regulations may include requirements that only certified or professional users apply the product or that certain products be used only on certain types of locations (such as “not for use on sod farms or golf courses”), may require users to post notices on properties to which products have been or will be applied, may require notification to individuals in the vicinity that products will be applied in the future or may ban the use of certain ingredients or categories of products altogether.
State, federal and foreign authorities generally require growing media facilities to obtain permits (sometimes on an annual basis) in order to harvest peat and to discharge storm water run-off or water pumped from peat deposits. The permits typically specify the condition in which the property must be left after the peat is fully harvested, with the residual use typically being natural wetland habitats combined with open water areas. We are generally required by these permits to limit our harvesting and to restore the property consistent with the intended residual use. In some locations, these facilities have been required to create water retention ponds to control the sediment content of discharged water.
For more information regarding how compliance with local, state, federal and foreign laws and regulations may affect us, see “ITEM 1A. RISK FACTORS — Compliance with environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase our costs of doing business or limit our ability to market all of our products” of this Annual Report on Form 10-K.
Regulatory Matters
We are subject to various environmental proceedings, the majority of which are for site remediation. At September 30, 2019, $3.9 million was accrued for such environmental matters. During fiscal 2019, fiscal 2018 and fiscal 2017, we expensed $1.4 million, $1.6 million and $1.1 million, respectively, for such environmental matters. We had no material capital expenditures during the last three fiscal years related to environmental or regulatory matters.
Employees
As of September 30, 2019, we employed approximately 5,600 employees. During peak sales and production periods, we employed approximately 6,100 employees, including seasonal and temporary labor.
General Information
We maintain a website at http://investor.scotts.com (this uniform resource locator, or URL, is an inactive textual reference only and is not intended to incorporate our website into this Annual Report on Form 10-K). We file reports with the Securities and Exchange Commission (the “SEC”) and make available, free of charge, on or through our website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as well as our proxy and information statements, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.
7
ITEM 1A. | RISK FACTORS |
Cautionary Note Regarding Forward-Looking Statements
This Annual Report on Form 10-K, including the exhibits hereto and the information incorporated by reference herein, as well as our 2019 Annual Report to Shareholders (our “2019 Annual Report”), contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to risks and uncertainties. Information regarding activities, events and developments that we expect or anticipate will or may occur in the future, including, but not limited to, information relating to our future growth and profitability targets and strategies designed to increase total shareholder value, are forward-looking statements based on management’s estimates, assumptions and projections. Forward-looking statements also include, but are not limited to, statements regarding our future economic and financial condition and results of operations, the plans and objectives of management and our assumptions regarding our performance and such plans and objectives, as well as the amount and timing of repurchases of our Common Shares or other uses of cash flows. Forward-looking statements generally can be identified through the use of words such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” and other similar words and variations.
Forward-looking statements contained in this Annual Report on Form 10-K and our 2019 Annual Report are predictions only and actual results could differ materially from management’s expectations due to a variety of factors, including those described below. All forward-looking statements attributable to us or persons working on our behalf are expressly qualified in their entirety by such risk factors.
The forward-looking statements that we make in this Annual Report on Form 10-K and our 2019 Annual Report are based on management’s current views and assumptions regarding future events and speak only as of their dates. We disclaim any obligation to update developments of these risk factors or to announce publicly any revisions to any of the forward-looking statements that we make, or to make corrections to reflect future events or developments, except as required by the federal securities laws.
Compliance with environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase our costs of doing business or limit our ability to market all of our products.
Local, state, federal and foreign laws and regulations relating to environmental matters affect us in several ways. In the United States, all pesticide products must comply with FIFRA and most must be registered with the U.S. EPA and similar state agencies before they can be sold or distributed. Our inability to obtain or maintain such registrations, or the cancellation of any such registration of our products, could have an adverse effect on our business, the severity of which would depend on a variety of factors including the product(s) involved, whether another product could be substituted and whether our competitors were similarly affected. We attempt to anticipate regulatory developments and maintain registrations of, and access to, substitute active ingredients, but there can be no assurance that we will be able to avoid or reduce these risks. In addition, in Canada, regulations have been adopted by several provinces that substantially restrict our ability to market and sell certain of our consumer pesticide products.
Under the Food Quality Protection Act, enacted by the U.S. Congress in 1996, food-use pesticides are evaluated to determine whether there is reasonable certainty that no harm will result from the cumulative effects of pesticide exposures. Under this Act, the U.S. EPA is evaluating the cumulative and aggregate risks from dietary and non-dietary exposures to pesticides. The pesticides in our products, certain of which may be also used on crops processed into various food products, are manufactured by independent third parties and continue to be evaluated by the U.S. EPA as part of this exposure risk assessment. The U.S. EPA or the third-party registrant may decide that a pesticide we use in our products will be limited or made unavailable to us. We cannot predict the outcome or the severity of the effect of these continuing evaluations.
In addition, the use of certain pesticide and fertilizer products (including pesticide products that contain glyphosate) is regulated by various local, state, federal and foreign environmental and public health agencies. These regulations may, among other things, ban the use of certain ingredients contained in such products or require (i) that only certified or professional users apply the product, (ii) that certain products be used only on certain types of locations, (iii) users to post notices on properties to which products have been or will be applied, and (iv) notification to individuals in the vicinity that products will be applied in the future. Even if we are able to comply with all such regulations and obtain all necessary registrations and licenses, we cannot provide assurance that our products, particularly pesticide products, will not cause or be alleged to cause injury to the environment or to people under all circumstances, particularly when used improperly or contrary to instructions. The costs of compliance, remediation or products liability have adversely affected operating results in the past and could materially adversely affect future quarterly or annual operating results.
8
Our products and operations may be subject to increased regulatory and environmental scrutiny in jurisdictions in which we do business. For example, we are subject to regulations relating to our harvesting of peat for our growing media business which has come under increasing regulatory and environmental scrutiny. In the United States, state regulations frequently require us to limit our harvesting and to restore the property to an agreed-upon condition. In some locations, we have been required to create water retention ponds to control the sediment content of discharged water. In Canada, our peat extraction efforts are also the subject of regulation.
In addition to the regulations already described, local, state, federal and foreign agencies regulate the disposal, transport, handling and storage of waste, remediation of contaminated sites, air and water discharges from our facilities, and workplace health and safety.
Under certain environmental laws, we may be liable for the costs of investigation and remediation of the presence of certain regulated materials, as well as related costs of investigation and remediation of damage to natural resources, at various properties, including our current and former properties as well as offsite waste handling or disposal sites that we have used. Liability may be imposed upon us without regard to whether we knew of or caused the presence of such materials and, under certain circumstances, on a joint and several basis. There can be no assurances that the presence of such regulated materials at any such locations, or locations that we may acquire in the future, will not result in liability to us under such laws or expose us to third-party actions such as tort suits based on alleged conduct or environmental conditions.
The adequacy of our current non-FIFRA compliance-related environmental accruals and future provisions depends upon our operating in substantial compliance with applicable environmental and public health laws and regulations, as well as the assumptions that we have both identified all of the significant sites that must be remediated and that there are no significant conditions of potential contamination that are unknown to us. A significant change in the facts and circumstances surrounding these assumptions or in current enforcement policies or requirements, or a finding that we are not in substantial compliance with applicable environmental and public health laws and regulations, could have a material adverse effect on future environmental capital expenditures and other environmental expenses, as well as our financial condition, results of operations and cash flows.
Damage to our reputation or the reputation of our products or products we market on behalf of third parties could have an adverse effect on our business.
Maintaining our strong reputation and a strong reputation of our products and products we market on behalf of third parties with both consumers and our retail customers is a key component in our success. Product recalls, our inability to ship, sell or transport affected products, governmental actions, investigations or other legal proceedings, and adverse media commentary may harm our reputation and hinder the acceptance by consumers of our products or products we market on behalf of third parties (including certain of Monsanto’s consumer Roundup® branded products). In addition to effects on consumer behavior, retailers could decide to stop carrying those products which may materially and adversely affect our business operations, reduce sales and increase costs.
In addition, notwithstanding the weight of scientific evidence supporting the safety of these products, claims or allegations that our products or products we market on behalf of third parties are not safe could adversely affect us and contribute to the risk we will be subjected to legal action. We manufacture a variety of products, such as fertilizers, growing media, pesticides, and herbicides, and also serve as marketer for certain of Monsanto’s consumer Roundup® branded products. On occasion, allegations are made that some of these products have failed to perform up to expectations, are inappropriately labeled, contain insufficient instructions or have caused damage or injury to individuals or property. Public commentary by media agencies or non-governmental organizations and/or litigation-related assertions, even when such commentary or assertions may be inaccurate, may lead consumers or our retail customers to believe that certain of our products or products we market on behalf of third parties may be unsafe. For example, notwithstanding the weight of scientific evidence and regulatory determinations supporting the safety of glyphosate, recent litigation involving Monsanto’s consumer Roundup® non-selective glyphosate-containing weedkiller products has led to negative publicity and consumer sentiment with respect to these products and Monsanto’s Roundup® brand. As another example, based on reports of contamination at a third-party supplier’s vermiculite mine, the public may perceive that some of our products manufactured in the past using vermiculite are or may be contaminated in a way that makes them unsafe.
Even when inaccurate or not supported by the scientific evidence, claims and allegations that our products or products we market on behalf of third parties are not safe could impair our reputation, the reputation of our products or the reputation of products we market on behalf of third parties, involve us in litigation, damage our brand names and have a material adverse effect on our business.
9
Our business could be negatively impacted by corporate citizenship and sustainability matters and/or our reporting of such matters.
There is an increasing focus from certain investors, customers, consumers, employees, and other stakeholders concerning corporate citizenship and sustainability matters. From time to time, we communicate certain initiatives, including goals, regarding environmental matters, responsible sourcing and social investments. We could fail, or be perceived to fail, in our achievement of such initiatives or goals, or we could fail in fully and accurately reporting our progress on such initiatives and goals. In addition, we could be criticized for the scope of such initiatives or goals or perceived as not acting responsibly in connection with these matters. Our business could be negatively impacted by such matters. Any such matters, or related corporate citizenship and sustainability matters, could have a material adverse effect on our business.
Certain of our products may be purchased for use in new and emerging industries or segments and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, and consumer perceptions.
We sell products, including hydroponic gardening products, that end users may purchase for use in new and emerging industries or segments, including the growing of cannabis, that may not grow or achieve market acceptance in a manner that we can predict. The demand for these products depends on the uncertain growth of these industries or segments.
In addition, we sell products that end users may purchase for use in industries or segments, including the growing of cannabis, that are subject to varying, inconsistent, and rapidly changing laws, regulations, administrative practices, enforcement approaches, judicial interpretations, and consumer perceptions. For example, certain countries and 33 U.S. states have adopted frameworks that authorize, regulate, and tax the cultivation, processing, sale, and use of cannabis for medicinal and/or non-medicinal use, while the U.S. Controlled Substances Act and the laws of other U.S. states prohibit growing cannabis.
Our gardening products, including our hydroponic gardening products, are multi-purpose products designed and intended for growing a wide range of plants and are generally purchased from retailers by end users who may grow any variety of plants, including cannabis. Although the demand for our products may be negatively impacted depending on how laws, regulations, administrative practices, enforcement approaches, judicial interpretations, and consumer perceptions develop, we cannot reasonably predict the nature of such developments or the effect, if any, that such developments could have on our business.
Our marketing activities may not be successful.
We invest substantial resources in advertising, consumer promotions and other marketing activities to maintain, extend and expand our brand image. There can be no assurances that our marketing strategies will be effective or that the amount we invest in advertising activities will result in a corresponding increase in sales of our products. If our marketing initiatives are not successful, we will have incurred significant expenses without the benefit of higher revenues.
Our success depends upon the retention and availability of key personnel and the effective succession of senior management.
Our success largely depends on the performance of our management team and other key personnel. Our future operations could be harmed if we are unable to attract and retain talented, highly qualified senior executives and other key personnel. In addition, if we are unable to effectively provide for the succession of senior management, including our chief executive officer, our business, prospects, results of operations, financial condition and cash flows may be materially adversely affected.
Disruptions in availability or increases in the prices of raw materials or fuel could adversely affect our results of operations.
We source many of our commodities and other raw materials on a global basis. The general availability and price of those raw materials can be affected by numerous forces beyond our control, including political instability, trade restrictions and other government regulations, duties and tariffs, price controls, changes in currency exchange rates and weather.
A significant disruption in the availability of any of our key raw materials could negatively impact our business. In addition, increases in the prices of key commodities and other raw materials could adversely affect our ability to manage our cost structure. Market conditions may limit our ability to raise selling prices to offset increases in our raw material costs. Our proprietary technologies can limit our ability to locate or utilize alternative inputs for certain products. For certain inputs, new sources of supply may have to be qualified under regulatory standards, which can require additional investment and delay bringing a product to market.
We utilize hedge agreements periodically to fix the prices of a portion of our urea, resin and fuel needs. The hedge agreements are designed to mitigate the earnings and cash flow fluctuations associated with the costs of urea, resin and fuel. In periods of declining prices, utilizing these hedge agreements may effectively increase our expenditures for these raw materials.
10
Our business is subject to risks associated with sourcing and manufacturing outside of the U.S. and risks from tariffs and/or international trade wars.
The Company imports many of its raw materials and finished goods from countries outside of the United States, including but not limited to China. Our import operations are subject to complex customs laws, regulations, tax requirements, and trade regulations, such as tariffs set by governments, either through mutual agreements or bilateral actions. Recent changes in U.S. tariffs on goods imported into the U.S., particularly goods from China, have increased the cost of goods purchased by the Company. Additional tariffs could be imposed by the U.S. with relatively short notice to the Company. These governmental actions could have, and any similar future actions may have, a material adverse effect on our business, financial condition and results of operations. The overall effect of these risks is that our costs may increase, which in turn may result in lower profitability if we are unable to offset such increases through higher prices, and/or that we may suffer a decline in sales if our customers do not accept price increases.
Our hedging arrangements expose us to certain counterparty risks.
In addition to commodity hedge agreements, we utilize interest rate swap agreements to manage the net interest rate risk inherent in our sources of borrowing as well as foreign currency forward contracts to manage the exchange rate risk associated with certain intercompany loans with foreign subsidiaries and other approved transactional currency exposures. Utilizing these hedge agreements exposes us to certain counterparty risks. The failure of one or more of the counterparties to fulfill their obligations under the hedge agreements, whether as a result of weakening financial stability or otherwise, could adversely affect our financial condition, results of operations or cash flows.
Economic conditions could adversely affect our business.
Uncertain global economic conditions could adversely affect our business. Negative global economic trends, such as decreased consumer and business spending, high unemployment levels, reduced rates of home ownership and housing starts, high foreclosure rates and declining consumer and business confidence, pose challenges to our business and could result in declining revenues, profitability and cash flow. Although we continue to devote significant resources to support our brands, unfavorable economic conditions may negatively affect consumer demand for our products. Consumers may reduce discretionary spending during periods of economic uncertainty, which could reduce sales volumes of our products or result in a shift in our product mix from higher margin to lower margin products.
The highly competitive nature of our markets could adversely affect our ability to maintain or grow revenues.
Each of our operating segments participates in markets that are highly competitive. Our products compete against national and regional products and private label products produced by various suppliers. Many of our competitors sell their products at prices lower than ours. Our most price sensitive customers may trade down to lower priced products during challenging economic times or if current economic conditions worsen. We compete primarily on the basis of product innovation, product quality, product performance, value, brand strength, supply chain competency, field sales support, in-store sales support, the strength of our relationships with major retailers and advertising. Some of our competitors have significant financial resources. The strong competition that we face in all of our markets may prevent us from achieving our revenue goals, which may have a material adverse effect on our financial condition, results of operations and cash flows. Our inability to continue to develop and grow brands with leading market positions, maintain our relationships with key retailers and deliver high quality products on a reliable basis at competitive prices could have a material adverse effect on our business.
We may not successfully develop new product lines and products or improve existing product lines and products or maintain our effectiveness in reaching consumers through rapidly evolving communication vehicles, platforms and technologies.
Our future success depends on creating and successfully competing in markets for our products including our ability to improve our existing product lines and products and to develop, manufacture and market new product lines and products to meet evolving consumer needs, as well as our ability to leverage new media such as digital media and social networks to reach existing and potential consumers. We cannot be certain that we will be successful in developing, manufacturing and marketing new product lines and products or product innovations which satisfy consumer needs or achieve market acceptance, or that we will develop, manufacture and market new product lines and products or product innovations in a timely manner. If we fail to successfully develop, manufacture and market new product lines and products or product innovations, or if we fail to reach existing and potential consumers, our ability to maintain or grow our market share may be adversely affected, which in turn could materially adversely affect our business, financial condition and results of operations. In addition, the development and introduction of new product lines and products and product innovations require substantial research, development and marketing expenditures, which we may be unable to recoup if such new product lines, products or innovations do not achieve market acceptance.
11
Many of the products we manufacture and market contain active ingredients that are subject to regulatory approval. The need to obtain such approval could delay the launch of new products or product innovations that contain active ingredients or otherwise prevent us from developing and manufacturing certain products and product innovations.
Our ongoing investment in new product lines and products and technologies is inherently risky and could disrupt our ongoing businesses.
We have invested and expect to continue to invest in new product lines, products, and technologies. Such endeavors may involve significant risks and uncertainties, including distraction of management from current operations, insufficient revenues to offset liabilities assumed and expenses associated with these new investments, inadequate return of capital on our investments, and unidentified issues not discovered in our due diligence of such strategies and offerings. Because these new ventures are inherently risky, no assurance can be given that such strategies and offerings will be successful and will not adversely affect our reputation, financial condition, and operating results.
If we are unable to effectively execute our e-commerce business, our reputation and operating results may be harmed.
We sell certain of our products over the Internet through our online store, which represents a small but growing percentage of our overall net sales concentrated mostly in our Hawthorne segment. The success of our e-commerce business depends on our investment in this platform, consumer preferences and buying trends relating to e-commerce, and our ability to both maintain the continuous operation of our online store and our fulfillment operations and provide a shopping experience that will generate orders and return visits to our online store.
We are also vulnerable to certain additional risks and uncertainties associated with our e-commerce business, including: changes in required technology interfaces; website downtime and other technical failures; costs and technical issues associated with website software, systems and technology investments and upgrades; data and system security; system failures, disruptions and breaches and the costs to address and remedy such failures, disruptions or breaches; computer viruses; and changes in and compliance with applicable federal and state regulations. In addition, our efforts to remain competitive with technology trends, including the use of new or improved technology, creative user interfaces and other e-commerce marketing tools such as paid search and mobile applications, among others, may increase our costs and may not increase sales or attract consumers. Our failure to successfully respond to these risks and uncertainties might adversely affect the sales of our e-commerce business, as well as damage our reputation and brands.
Additionally, the success of our e-commerce business and the satisfaction of our consumers depend on their timely receipt of our products. The efficient delivery of our products to our consumers requires that our distribution centers have adequate capacity to support the current level of e-commerce operations and any anticipated increased levels that may occur as a result of the growth of our e-commerce business. If we encounter difficulties with our distribution centers, or if any distribution centers shut down for any reason, including as a result of fire or other natural disaster, we could face shortages of inventory, resulting in out of stock conditions in our online store, and we could incur significantly higher costs and longer lead times associated with distributing our products to our consumers and experience dissatisfaction from our consumers. Any of these issues could have a material adverse effect on our business and harm our reputation.
Because of the concentration of our sales to a small number of retail customers, the loss of one or more of, or a significant reduction in orders from, our top customers could adversely affect our financial results.
Our top three retail customers together accounted for 57% of our fiscal 2019 net sales and 61% of our outstanding accounts receivable as of September 30, 2019. The loss of, or reduction in orders from, our top three retail customers, Home Depot, Lowe’s, and Walmart, or any other major customer for any reason (including, for example, changes in a retailer’s strategy, claims or allegations that our products or products we market on behalf of third parties are unsafe, a decline in consumer demand, regulatory, legal or other external pressures or a change in marketing strategy) could have a material adverse effect on our business, financial condition, results of operations and cash flows, as could customer disputes regarding shipments, fees, merchandise condition or related matters. Our inability to collect accounts receivable from one of our major customers, or a significant deterioration in the financial condition of one of these customers, including a bankruptcy filing or a liquidation, could also have a material adverse effect on our financial condition, results of operations and cash flows.
We do not have long-term sales agreements with, or other contractual assurances as to future sales to, any of our major retail customers. In addition, continued consolidation in the retail industry has resulted in an increasingly concentrated retail base, and as a result, we are significantly dependent upon sales to key retailers who have significant bargaining strength. To the extent such concentration continues to occur, our net sales and income from operations may be increasingly sensitive to deterioration in the financial condition of, or other adverse developments involving our relationship with, one or more of our key customers. In addition, our business may be negatively affected by changes in the policies of our retailers, such as inventory destocking, limitations on access to shelf space, price demands and other conditions.
12
Our reliance on third-party manufacturers could harm our business.
We rely on third parties to manufacture certain of our products. This reliance generates a number of risks, including decreased control over the production process, which could lead to production delays or interruptions and inferior product quality control. In addition, performance problems at these third-party manufacturers could lead to cost overruns, shortages or other problems, which could increase our costs of production or result in delivery delays to our customers.
In addition, if one or more of our third-party manufacturers becomes insolvent or unwilling to continue to manufacture products of acceptable quality, at acceptable costs and in a timely manner, our ability to deliver products to our retail customers could be significantly impaired. Substitute manufacturers might not be available or, if available, might be unwilling or unable to manufacture the products we need on acceptable terms. Moreover, if customer demand for our products increases, we may be unable to secure sufficient additional capacity from our current third-party manufacturers, or others, on commercially reasonable terms, or at all.
Our reliance on a limited base of suppliers may result in disruptions to our business and adversely affect our financial results.
Although we continue to implement risk-mitigation strategies for single-source suppliers, we also rely on a limited number of suppliers for certain of our raw materials, product components and other necessary supplies, including certain active ingredients used in our products. If we are unable to maintain supplier arrangements and relationships, if we are unable to contract with suppliers at the quantity and quality levels needed for our business, or if any of our key suppliers becomes insolvent or experience other financial distress, we could experience disruptions in production, which could have a material adverse effect on our financial condition, results of operations and cash flows.
A significant interruption in the operation of our or our suppliers’ facilities could impact our capacity to produce products and service our customers, which could adversely affect revenues and earnings.
Operations at our and our suppliers’ facilities are subject to disruption for a variety of reasons, including fire, flooding or other natural disasters, disease outbreaks or pandemics, acts of war, terrorism, government shut-downs and work stoppages. A significant interruption in the operation of our or our suppliers’ facilities could significantly impact our capacity to produce products and service our customers in a timely manner, which could have a material adverse effect on our revenues, earnings and financial position. This is especially true for those products that we manufacture at a limited number of facilities, such as our fertilizer and liquid products.
Climate change and unfavorable weather conditions could adversely impact financial results.
The issue of climate change is receiving ever increasing worldwide attention. The possible effects, as described in various public accounts, could include changes in rainfall patterns, water shortages, changing storm patterns and intensities, and changing temperature levels that could adversely impact our costs and business operations and the supply and demand for our fertilizer, garden soils and pesticide products. In addition, fluctuating climatic conditions may result in unpredictable modifications in the manner in which consumers garden or their attitudes towards gardening, making it more difficult for us to provide appropriate products to appropriate markets in time to meet consumer demand.
Because of the uncertainty of weather volatility related to climate change and any resulting unfavorable weather conditions, we cannot predict its potential impact on our financial condition, results of operations and cash flows.
Our indebtedness could limit our flexibility and adversely affect our financial condition.
As of September 30, 2019, we had $1,659.3 million of debt and $1,326.2 million was available to be borrowed under our credit agreement. Our inability to meet restrictive financial and non-financial covenants associated with that debt, or to generate sufficient cash flow to repay maturing debt, could adversely affect our financial condition. For example, our debt level could:
• | make it more difficult for us to satisfy our obligations with respect to our indebtedness; |
• | make us more vulnerable to general adverse economic and industry conditions; |
• | require us to dedicate a substantial portion of cash flows from operating activities to payments on our indebtedness, which would reduce the cash flows available to fund working capital, capital expenditures, advertising, research and development efforts and other general corporate requirements; |
• | limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate; |
• | limit our ability to borrow additional funds; |
13
• | expose us to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which could result in higher interest expense in the event of increases in interest rates; and |
• | place us at a competitive disadvantage compared to our competitors that have less debt. |
Our ability to make payments on or to refinance our indebtedness, fund planned capital expenditures and acquisitions, pay dividends and make repurchases of our Common Shares will depend on our ability to generate cash in the future. This, to some extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. We cannot provide any assurance that our business will generate sufficient cash flow from operating activities or that future borrowings will be available to us under our credit facility in amounts sufficient to enable us to pay our indebtedness or to fund our other liquidity needs.
In addition, our credit facility and the indentures governing our 5.250% Senior Notes due 2026 (the “5.250% Senior Notes”) and our 4.500% Senior Notes due 2029 (the “4.500% Senior Notes”) contain restrictive covenants and cross-default provisions. Our credit facility also requires us to maintain specified financial ratios. Our ability to comply with those covenants and satisfy those financial ratios can be affected by events beyond our control including prevailing economic, financial and industry conditions. A breach of any of those financial ratio covenants or other covenants could result in a default. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, and could cease making further loans and institute foreclosure proceedings against our assets. We cannot provide any assurance that the holders of such indebtedness would waive a default or that we could pay the indebtedness in full if it were accelerated.
Subject to compliance with certain covenants under our credit facility and the indentures governing the 5.250% Senior Notes and the 4.500% Senior Notes, we may incur additional debt in the future. If we incur additional debt, the risks described above could intensify.
Our lending activities may adversely impact our business and results of operations.
As part of our strategic initiatives, we have provided financing to buyers of certain business assets we have sold and to certain strategic partners. Our exposure to credit losses on these financing balances will depend on the financial condition of these counterparties and macroeconomic factors beyond our control, such as deteriorating conditions in the world economy or in the industries served by the borrowers. While we monitor our exposure, there can be no guarantee we will be able to successfully mitigate all of these risks. Credit losses, if significant, could have a material adverse effect on our business, financial condition, results of operations and cash flows.
Changes in credit ratings issued by nationally recognized statistical rating organizations (NRSROs) could adversely affect our cost of financing and the market price of our 5.250% Senior Notes and 4.500% Senior Notes.
NRSROs rate the 5.250% Senior Notes, the 4.500% Senior Notes and the Company based on factors that include our operating results, actions that we take, their view of the general outlook for our industry and their view of the general outlook for the economy. Actions taken by the NRSROs can include maintaining, upgrading or downgrading the current rating or placing us on a watch list for possible future downgrading. Downgrading the credit rating of the 5.250% Senior Notes or the 4.500% Senior Notes or placing us on a watch list for possible future downgrading could increase our cost of financing, limit our access to the capital markets and have an adverse effect on the market price of the 5.250% Senior Notes and the 4.500% Senior Notes.
Our postretirement-related costs and funding requirements could increase as a result of volatility in the financial markets, changes in interest rates and actuarial assumptions.
We sponsor a number of defined benefit pension plans associated with our U.S. and former international businesses, as well as a postretirement medical plan in the United States for certain retired associates and their dependents. The performance of the financial markets and changes in interest rates impact the funded status of these plans and cause volatility in our postretirement-related costs and future funding requirements. If the financial markets do not provide the expected long-term returns on invested assets, we could be required to make significant pension contributions. Additionally, changes in interest rates and legislation enacted by governmental authorities can impact the timing and amounts of contribution requirements.
We utilize third-party actuaries to evaluate assumptions used in determining projected benefit obligations and the fair value of plan assets for our pension and other postretirement benefit plans. In the event we determine that our assumptions should be revised, such as the discount rate or expected return on assets, our future pension and postretirement benefit expenses could increase or decrease. The assumptions we use may differ from actual results, which could have a significant impact on our pension and postretirement liabilities and related costs and funding requirements.
14
Our international operations make us susceptible to the costs and risks associated with operating internationally.
We operate manufacturing, sales and service facilities outside of the United States, particularly in Canada, China and the Netherlands. Accordingly, we are subject to risks associated with operating in foreign countries, including:
• | fluctuations in currency exchange rates; |
• | limitations on the remittance of dividends and other payments by foreign subsidiaries; |
• | additional costs of compliance with local regulations; |
• | historically, in certain countries, higher rates of inflation than in the United States; |
• | changes in the economic conditions or consumer preferences or demand for our products in these markets; |
• | restrictive actions by multi-national governing bodies, foreign governments or subdivisions thereof; |
• | changes in foreign labor laws and regulations affecting our ability to hire and retain employees; |
• | changes in U.S. and foreign laws regarding trade and investment; |
• | less robust protection of our intellectual property under foreign laws; and |
• | difficulty in obtaining distribution and support for our products. |
In addition, our operations outside the United States are subject to the risk of new and different legal and regulatory requirements in local jurisdictions, potential difficulties in staffing and managing local operations and potentially adverse tax consequences. The costs associated with operating our continuing international business could adversely affect our results of operations, financial condition and cash flows in the future.
Unanticipated changes in our tax provisions, the adoption of new tax legislation or exposure to additional tax liabilities could affect our profitability and cash flows.
We are subject to income and other taxes in the United States federal jurisdiction and various local, state and foreign jurisdictions. Our effective tax rate in the future could be adversely affected by changes to our operating structure, changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets (such as net operating losses and tax credits) and liabilities, changes in tax laws and the discovery of new information in the course of our tax return preparation process. In particular, the carrying value of deferred tax assets, which are predominantly related to our operations in the United States, is dependent on our ability to generate future taxable income of the appropriate character in the relevant jurisdiction.
From time to time, tax proposals are introduced or considered by the U.S. Congress or the legislative bodies in local, state and foreign jurisdictions that could also affect our tax rate, the carrying value of our deferred tax assets, or our tax liabilities. Our tax liabilities are also affected by the amounts we charge for inventory, services, licenses, funding and other items in intercompany transactions. We are subject to ongoing tax audits in various jurisdictions. In connection with these audits (or future audits), tax authorities may disagree with our intercompany charges, cross-jurisdictional transfer pricing or other matters and assess additional taxes. We regularly assess the likely outcomes of our audits in order to determine the appropriateness of our tax provision. As a result, the ultimate resolution of our tax audits, changes in tax laws or tax rates, and the ability to utilize our deferred tax assets could materially affect our tax provision, net income and cash flows in future periods.
Our operations may be impaired if our information technology systems fail to perform adequately or if we are the subject of a data breach or cyber attack.
We rely on information technology systems in order to conduct business, including communicating with employees and our key retail customers, ordering and managing materials from suppliers, shipping products to retail customers and analyzing and reporting results of operations. While we have taken steps to ensure the security of our information technology systems, our systems may nevertheless be vulnerable to computer viruses, security breaches and other disruptions from unauthorized users. If our information technology systems are damaged or cease to function properly for an extended period of time, whether as a result of a significant cyber incident or otherwise, our ability to communicate internally as well as with our retail customers could be significantly impaired, which may adversely impact our business.
Additionally, in the normal course of our business, we collect, store and transmit proprietary and confidential information regarding our customers, employees, suppliers and others, including personally identifiable information. An operational failure
15
or breach of security from increasingly sophisticated cyber threats could lead to loss, misuse or unauthorized disclosure of this information about our employees or customers, which may result in regulatory or other legal proceedings, and have a material adverse effect on our business and reputation. We also may not have the resources or technical sophistication to anticipate or prevent rapidly-evolving types of cyber attacks. Any such attacks or precautionary measures taken to prevent anticipated attacks may result in increasing costs, including costs for additional technologies, training and third party consultants. The losses incurred from a breach of data security and operational failures as well as the precautionary measures required to address this evolving risk may adversely impact our financial condition, results of operations and cash flows.
We may not be able to adequately protect our intellectual property and other proprietary rights that are material to our business.
Our ability to compete effectively depends in part on our rights to service marks, trademarks, tradenames and other intellectual property rights we own or license, particularly our registered brand names and issued patents. We have not sought to register every one of our marks either in the United States or in every country in which such mark is used. Furthermore, because of the differences in foreign trademark, patent and other intellectual property or proprietary rights laws, we may not receive the same protection in other countries as we would in the United States with respect to the registered brand names and issued patents we hold. If we are unable to protect our intellectual property, proprietary information and/or brand names, we could suffer a material adverse effect on our business, financial condition and results of operations.
Litigation may be necessary to enforce our intellectual property rights and protect our proprietary information, or to defend against claims by third parties that our products or services infringe their intellectual property rights. Any litigation or claims brought by or against us could result in substantial costs and diversion of our resources. A successful claim of trademark, patent or other intellectual property infringement against us, or any other successful challenge to the use of our intellectual property, could subject us to damages or prevent us from providing certain products or services, or using certain of our recognized brand names, which could have a material adverse effect on our business, financial condition and results of operations.
In the event the Third Restated Agreement for Monsanto’s consumer Roundup® products terminates or Monsanto’s consumer Roundup® business materially declines, we would lose a substantial source of future earnings and overhead expense absorption.
If we (i) become insolvent, (ii) commit a material breach, material fraud or material willful misconduct under the Third Restated Agreement, (iii) experience a change of control of the Company (subject to certain exceptions), or (iv) impermissibly assign our rights or delegate our obligations under the Third Restated Agreement, Monsanto may terminate the Third Restated Agreement without paying a termination fee to the Company, subject to certain terms and conditions as set forth in the applicable agreements. In addition, if, after January 16, 2021, Program EBIT (as defined in the Third Restated Agreement) falls below $50 million in any program year, Monsanto may terminate the Third Restated Agreement without paying a termination fee to the Company, subject to certain terms and conditions as set forth in the applicable agreements.
Monsanto may also terminate the Third Restated Agreement in the event of (a) a change of control of Monsanto or a sale of the Roundup® business effective at the end of the fifth full year after providing notice of termination, subject to certain terms and conditions as set forth in the applicable agreements, (b) Monsanto’s decision to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Event”), but, in each case, Monsanto would have to pay a termination fee to the Company.
If circumstances exist or otherwise develop that result in a material decline in Monsanto’s consumer Roundup® business, or in the event of Monsanto’s insolvency or bankruptcy, we would seek to mitigate the impact on us by exercising various rights and remedies under the Third Restated Agreement and applicable law. We cannot, however, provide any assurance that our exercise of such rights or remedies would produce the desired outcomes or that a material decline in Monsanto’s consumer Roundup® business would not have a material adverse effect on our business, financial condition or results of operations.
In the event that the Third Restated Agreement terminates or Monsanto’s consumer Roundup® business materially declines, we would lose all, or a substantial portion, of the significant source of earnings and overhead expense absorption the Third Restated Agreement provides.
For additional information regarding the Third Restated Agreement including certain of our rights and remedies under the Third Restated Agreement, see “NOTE 7. MARKETING AGREEMENT” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
16
Hagedorn Partnership, L.P. beneficially owns approximately 26% of our Common Shares and can significantly influence decisions that require the approval of shareholders.
Hagedorn Partnership, L.P. beneficially owned approximately 26% of our outstanding Common Shares on a fully diluted basis as of November 22, 2019. As a result, it has sufficient voting power to significantly influence the election of directors and the approval of other actions requiring the approval of our shareholders, including the entering into of certain business combination transactions. In addition, because of the percentage of ownership and voting concentration in Hagedorn Partnership, L.P., elections of our board of directors will generally be within the control of Hagedorn Partnership, L.P. While all of our shareholders are entitled to vote on matters submitted to our shareholders for approval, the concentration of our Common Shares and voting control presently lies with Hagedorn Partnership, L.P. As such, it would be difficult for shareholders to propose and have approved proposals not supported by Hagedorn Partnership, L.P. Hagedorn Partnership, L.P.’s interests could differ from, or be in conflict with, the interests of other shareholders.
While we have, over the past few years, increased the rate of cash dividends on, and engaged in repurchases of, our Common Shares, any future decisions to reduce or discontinue paying cash dividends to our shareholders or repurchasing our Common Shares pursuant to our previously announced repurchase program could cause the market price for our Common Shares to decline.
Our payment of quarterly cash dividends on and repurchase of our Common Shares pursuant to our stock repurchase program are subject to, among other things, our financial position and results of operations, available cash and cash flow, capital requirements, and other factors. We have, over the past few years, increased the rate of cash dividends on, and repurchases of, our Common Shares. In the fourth quarter of fiscal 2019, we increased the amount of our quarterly cash dividend by 5% to $0.58 per Common Share. The total remaining share repurchase authorization as of September 30, 2019 is $285.4 million.
We may further increase or decrease the rate of cash dividends on, and the amount of repurchases of, our Common Shares in the future. Any reduction or discontinuance by us of the payment of quarterly cash dividends or repurchases of our Common Shares pursuant to our current share repurchase authorization program could cause the market price of our Common Shares to decline. Moreover, in the event our payment of quarterly cash dividends on or repurchases of our Common Shares are reduced or discontinued, our failure or inability to resume paying cash dividends or repurchasing Common Shares at historical levels could result in a lower market valuation of our Common Shares.
Acquisitions, other strategic alliances and investments could result in operating difficulties, dilution, and other harmful consequences that may adversely impact our business and results of operations.
Acquisitions are an important element of our overall corporate strategy and use of capital, and these transactions could be material to our financial condition and results of operations. We expect to continue to evaluate and enter into discussions regarding a wide array of potential strategic transactions. The process of integrating an acquired company, business, or product has created, and will continue to create, unforeseen operating difficulties and expenditures. The areas where we face risks include:
• | Diversion of management time and focus from operating our business to acquisition integration challenges. |
• | Failure to successfully further develop the acquired business or product lines. |
• | Implementation or remediation of controls, procedures and policies at the acquired company. |
• | Integration of the acquired company’s accounting, human resources and other administrative systems, and coordination of product, engineering and sales and marketing functions. |
• | Transition of operations, users and customers onto our existing platforms. |
• | Reliance on the expertise of our strategic partners with respect to market development, sales, local regulatory compliance and other operational matters. |
• | Failure to obtain required approvals on a timely basis, if at all, from governmental authorities, or conditions placed upon approval, under competition and antitrust laws which could, among other things, delay or prevent us from completing a transaction, or otherwise restrict our ability to realize the expected financial or strategic goals of an acquisition. |
• | In the case of foreign acquisitions, the need to integrate operations across different cultures and languages and to address the particular economic, currency, political and regulatory risks associated with specific countries. |
17
• | Cultural challenges associated with integrating employees from the acquired company into our organization, and retention of employees from the businesses we acquire. |
• | Liability for or reputational harm from activities of the acquired company before the acquisition or from our strategic partners, including patent and trademark infringement claims, violations of laws, commercial disputes, tax liabilities and other known and unknown liabilities. |
• | Litigation or other claims in connection with the acquired company, including claims from terminated employees, customers, former shareholders or other third parties. |
Our failure to address these risks or other problems encountered in connection with our past or future acquisitions and investments or strategic alliances could cause us to fail to realize the anticipated benefits of such acquisitions, investments or alliances, incur unanticipated liabilities, and harm our business generally.
Our acquisitions could also result in dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities or amortization expenses, or impairment of goodwill and purchased long-lived assets, and restructuring charges, any of which could harm our financial condition or results of operations and cash flows. Also, the anticipated benefits of many of our acquisitions may not materialize.
A failure to dispose of assets or businesses in a timely manner may cause the results of the Company to suffer.
We evaluate as necessary the potential disposition of assets and businesses that may no longer help meet our objectives. When we decide to sell assets or a business, we may encounter difficulty in finding buyers or alternative exit strategies on acceptable terms in a timely manner, which could delay the accomplishment of our strategic objectives. Alternatively, we may dispose of a business at a price or on terms that are less than we had anticipated. After reaching an agreement with a buyer for the disposition of a business, we are subject to the satisfaction of pre-closing conditions, which may prevent us from completing the transaction. Dispositions may also involve continued financial involvement in the divested business, such as through continuing equity ownership, guarantees, indemnities or other financial obligations. Under these arrangements, performance by the divested businesses or other conditions outside our control could affect future financial results.
We are involved in a number of legal proceedings and, while we cannot predict the outcomes of such proceedings and other contingencies with certainty, some of these outcomes could adversely affect our business, financial condition, results of operations and cash flows.
We are involved in legal proceedings and are subject to investigations, inspections, audits, inquiries and similar actions by governmental authorities, arising in the course of our business (see the discussion in “ITEM 3. LEGAL PROCEEDINGS” of this Annual Report on Form 10-K). Legal proceedings, in general, can be expensive and disruptive. Some of these suits may purport or may be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts of damages, including punitive or exemplary damages, and may remain unresolved for several years. For example, product liability claims challenging the safety of our products or products we market on behalf of third parties may also result in a decline in sales for a particular product and could damage the reputation or the value of related brands, involve us in litigation and have a material adverse effect on our business.
From time to time, we are also involved in legal proceedings as a plaintiff involving contract, intellectual property and other matters. We cannot predict with certainty the outcomes of these legal proceedings and other contingencies, and the costs incurred in litigation can be substantial, regardless of the outcome. Substantial unanticipated verdicts, fines and rulings do sometimes occur. As a result, we could from time to time incur judgments, enter into settlements or revise our expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on our results of operations in the period in which the amounts are accrued and/or our cash flows in the period in which the amounts are paid. The outcome of some of these legal proceedings and other contingencies could require us to take, or refrain from taking, actions which could negatively affect our operations and, depending on the nature of the allegations, could negatively impact our reputation or the reputation of products we market on behalf of third parties. Additionally, defending against these legal proceedings may involve significant expense and diversion of management’s attention and resources.
ITEM 1B. | UNRESOLVED STAFF COMMENTS |
None.
18
ITEM 2. | PROPERTIES |
Our corporate headquarters is located in Marysville, Ohio, where we own approximately 705 acres of land and lease approximately 24 acres of land. In addition, we own and lease numerous industrial, commercial and office properties located in North America, Europe and Asia that support the management, manufacturing, distribution and research and development of our products and services. We believe our properties are suitable and adequate to serve the needs of our business and that our leased properties are subject to appropriate lease agreements.
The following is a summary of owned and leased properties by country:
Location | Owned | Leased | ||
United States | 35 | 72 | ||
Canada | 9 | 13 | ||
China | — | 5 | ||
The Netherlands | — | 3 | ||
Total | 44 | 93 | ||
We own or lease 73 manufacturing properties, 14 distribution properties and three research and development properties in the United States. We own or lease 19 manufacturing and one distribution property in Canada, one manufacturing and two distribution properties in the Netherlands and two manufacturing properties in China. Most of the manufacturing properties, which include growing media properties and peat harvesting properties, have production lines, warehouses, offices and field processing areas.
ITEM 3. | LEGAL PROCEEDINGS |
As noted in the discussion in “ITEM 1. BUSINESS — Regulatory Considerations — Regulatory Matters” of this Annual Report on Form 10-K, we are involved in several pending environmental and regulatory matters. We believe that our assessment of contingencies is reasonable and that the related accruals, in the aggregate, are adequate; however, there can be no assurance that the final resolution of these matters will not have a material effect on our financial condition, results of operations or cash flows.
The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.
We are involved in other lawsuits and claims which arise in the normal course of our business including the initiation and defense of proceedings to protect intellectual property rights, advertising claims and employment disputes. In our opinion, these claims individually and in the aggregate are not expected to have a material adverse effect on our financial condition, results of operations or cash flows.
ITEM 4. | MINE SAFETY DISCLOSURE |
Not Applicable.
19
SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE REGISTRANT
The executive officers of Scotts Miracle-Gro, their positions and, as of November 22, 2019, their ages and years with Scotts Miracle-Gro (and its predecessors) are set forth below.
Name | Age | Position(s) Held | Years with Company | |||||
James Hagedorn | 64 | Chief Executive Officer and Chairman of the Board | 32 | |||||
Michael C. Lukemire | 61 | President and Chief Operating Officer | 23 | |||||
Thomas R. Coleman | 50 | Executive Vice President and Chief Financial Officer | 20 | |||||
James D. King | 56 | Executive Vice President, Chief Communications Officer | 18 | |||||
Ivan C. Smith | 50 | Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer | 16 | |||||
Denise S. Stump | 65 | Executive Vice President, Global Human Resources and Chief Ethics Officer | 19 | |||||
Executive officers serve at the discretion of the Board of Directors of Scotts Miracle-Gro and pursuant to executive severance agreements or other arrangements. The business experience of each of the individuals listed above during at least the past five years is as follows:
Mr. Hagedorn was named Chairman of the Board of Scotts Miracle-Gro’s predecessor in January 2003 and Chief Executive Officer of Scotts Miracle-Gro’s predecessor in May 2001. He also served as President of Scotts Miracle-Gro (or its predecessor) from October 2015 until February 2016. Mr. Hagedorn serves on Scotts Miracle-Gro’s Board of Directors, a position he has held with Scotts Miracle-Gro (or its predecessor) since 1995. Mr. Hagedorn is the brother of Katherine Hagedorn Littlefield, a director of Scotts Miracle-Gro.
Mr. Lukemire was named President and Chief Operating Officer of Scotts Miracle-Gro in February 2016. He served as Executive Vice President and Chief Operating Officer of Scotts Miracle-Gro from December 2014 until February 2016. Prior to this appointment, Mr. Lukemire had served as Executive Vice President, North American Operations of Scotts Miracle-Gro from April 2014 until December 2014 and as Executive Vice President, Business Execution of Scotts Miracle-Gro from May 2013 until April 2014.
Mr. Coleman was named Executive Vice President and Chief Financial Officer of Scotts Miracle-Gro in April 2014. Prior to this appointment, Mr. Coleman had served as Senior Vice President, Global Finance Operations and Enterprise Performance Management Analytics for The Scotts Company LLC, a wholly-owned subsidiary of Scotts Miracle-Gro, since January 2011.
Mr. King was named Executive Vice President, Chief Communications Officer of Scotts Miracle-Gro in April 2019. Prior to this appointment, Mr. King had served as Senior Vice President, Chief Communications Officer from June 2008 to April 2019.
Mr. Smith was named Executive Vice President, General Counsel and Corporate Secretary of Scotts Miracle-Gro in July 2013 and Chief Compliance Officer of Scotts Miracle-Gro in October 2013.
Ms. Stump was named Executive Vice President, Global Human Resources of Scotts Miracle-Gro (or its predecessor) in February 2003 and Chief Ethics Officer of Scotts Miracle-Gro in October 2013.
20
PART II
ITEM 5. | MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES |
The Common Shares trade on the New York Stock Exchange under the symbol “SMG.” The payment of future dividends, if any, on the Common Shares will be determined by the Board of Directors in light of conditions then existing, including the Company’s earnings, financial condition and capital requirements, restrictions in financing agreements, business conditions and other factors. On July 5, 2018, the Company entered into a fifth amended and restated credit agreement (the “Fifth A&R Credit Agreement”), which allows the Company to make unlimited restricted payments (as defined in the Fifth A&R Credit Agreement), including dividend payments and Common Share repurchases, as long as the leverage ratio resulting from the making of such restricted payments is 4.00 or less. Otherwise, the Company may make further restricted payments in an aggregate amount for each fiscal year not to exceed the amount set forth in the Fifth A&R Credit Agreement for such fiscal year ($200.0 million for fiscal 2019 and $225.0 million for fiscal 2020 and thereafter). The Company’s leverage ratio was 3.67 at September 30, 2019 and restricted payments for fiscal 2019 were within the amounts allowed by the Fifth A&R Credit Agreement. See “NOTE 12. DEBT” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K for further discussion regarding the restrictions on dividend payments.
As of November 22, 2019, there were approximately 149,000 shareholders, including holders of record and our estimate of beneficial holders.
The following table shows the purchases of Common Shares made by or on behalf of Scotts Miracle-Gro or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of Scotts Miracle-Gro for each of the three fiscal months in the quarter ended September 30, 2019:
Period | Total Number of Common Shares Purchased(1) | Average Price Paid per Common Share(2) | Total Number of Common Shares Purchased as Part of Publicly Announced Plans or Programs(3) | Approximate Dollar Value of Common Shares That May Yet be Purchased Under the Plans or Programs(3) | ||||||||||
June 30 through July 27, 2019 | 959 | $ | 103.78 | — | $ | 285,432,143 | ||||||||
July 28 through August 24, 2019 | 11 | $ | 106.34 | — | $ | 285,432,143 | ||||||||
August 25 through September 30, 2019 | 2,788 | $ | 104.34 | — | $ | 285,432,143 | ||||||||
Total | 3,758 | $ | 104.20 | — | ||||||||||
(1) | All of the Common Shares purchased during the fourth quarter of fiscal 2019 were purchased in open market transactions. The total number of Common Shares purchased during the quarter includes 3,758 Common Shares purchased by the trustee of the rabbi trust established by the Company as permitted pursuant to the terms of The Scotts Company LLC Executive Retirement Plan (the “ERP”). |
(2) | The average price paid per Common Share is calculated on a settlement basis and includes commissions. |
(3) | On August 11, 2014, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $500.0 million of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 million increase to the share repurchase authorization ending on September 30, 2019. On August 2, 2019, the Scotts Miracle-Gro Board of Directors authorized an extension of the current share repurchase authorization through March 28, 2020. The amended authorization allows for repurchases of Common Shares of up to an aggregate amount of $1.0 billion through March 28, 2020. The dollar amounts indicated reflect the remaining amounts that were available for repurchase under the authorized repurchase program. |
21
Comparison of Cumulative Five-Year Total Return*
The following graph compares the yearly change in the cumulative total stockholder return on our Common Stock for the past five fiscal years with the cumulative total return of the Russell 2000 Index and the S&P 500 Household Products Index.
ITEM 6. | SELECTED FINANCIAL DATA |
The following table sets forth selected consolidated financial data for the periods indicated. You should read the following summary consolidated financial data in conjunction with our consolidated financial statements and the notes thereto and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in this Annual Report on Form 10-K. The summary consolidated financial data presented below as of and for the fiscal years ended September 30, 2019, 2018, 2017, 2016 and 2015 has been derived from our consolidated financial statements.
22
Five-Year Summary(1)
Year Ended September 30, | |||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||||||
(In millions, except per share amounts) | |||||||||||||||||||
GAAP OPERATING RESULTS: | |||||||||||||||||||
Net sales | $ | 3,156.0 | $ | 2,663.4 | $ | 2,642.1 | $ | 2,506.2 | $ | 2,371.1 | |||||||||
Gross profit | 1,019.6 | 864.6 | 972.6 | 900.3 | 810.8 | ||||||||||||||
Income from operations | 409.6 | 198.9 | 433.4 | 447.6 | 253.8 | ||||||||||||||
Income from continuing operations | 436.7 | 127.6 | 198.3 | 246.1 | 128.7 | ||||||||||||||
Income (loss) from discontinued operations, net of tax | 23.5 | (63.9 | ) | 20.5 | 68.7 | 30.0 | |||||||||||||
Net income | 460.2 | 63.7 | 218.8 | 314.8 | 158.7 | ||||||||||||||
Net income attributable to controlling interest | 460.7 | 63.7 | 218.3 | 315.3 | 159.8 | ||||||||||||||
NON-GAAP ADJUSTED OPERATING RESULTS(2): | |||||||||||||||||||
Adjusted income from operations | $ | 422.9 | $ | 351.7 | $ | 438.3 | $ | 402.1 | $ | 334.0 | |||||||||
Adjusted income from continuing operations | 251.3 | 211.6 | 237.4 | 230.2 | 180.4 | ||||||||||||||
Adjusted net income attributable to controlling interest from continuing operations | 251.8 | 211.6 | 236.9 | 230.7 | 181.5 | ||||||||||||||
SLS Divestiture adjusted income | 251.8 | 211.6 | 236.9 | 221.7 | 203.4 | ||||||||||||||
FINANCIAL POSITION: | |||||||||||||||||||
Working capital(3) | $ | 421.2 | $ | 273.0 | $ | 337.2 | $ | 325.8 | $ | 382.8 | |||||||||
Current ratio(3) | 1.7 | 1.4 | 1.6 | 1.5 | 1.8 | ||||||||||||||
Property, plant and equipment, net | 546.0 | 530.8 | 467.7 | 444.9 | 413.4 | ||||||||||||||
Total assets | 3,028.7 | 3,054.5 | 2,747.0 | 2,755.8 | 2,458.3 | ||||||||||||||
Total debt to total book capitalization(4) | 69.7 | % | 85.0 | % | 68.3 | % | 63.0 | % | 63.1 | % | |||||||||
Total debt | 1,651.6 | 2,016.4 | 1,401.1 | 1,215.9 | 1,061.1 | ||||||||||||||
Total equity—controlling interest | 718.7 | 354.6 | 648.8 | 715.2 | 620.7 | ||||||||||||||
GAAP CASH FLOWS: | |||||||||||||||||||
Cash flows provided by operating activities | $ | 226.8 | $ | 342.5 | $ | 363.2 | $ | 244.0 | $ | 250.1 | |||||||||
Investments in property, plant and equipment | 42.4 | 68.2 | 69.6 | 58.3 | 61.7 | ||||||||||||||
Investments in acquired businesses and payments on seller notes, net of cash acquired | 7.4 | 501.8 | 150.4 | 161.2 | 181.7 | ||||||||||||||
Dividends paid(5) | 124.5 | 120.0 | 120.3 | 116.6 | 111.3 | ||||||||||||||
Purchases of Common Shares | 3.1 | 327.7 | 255.2 | 137.4 | 18.0 | ||||||||||||||
NON-GAAP CASH FLOWS(2): | |||||||||||||||||||
Free cash flow | 184.4 | 274.3 | 293.6 | 185.7 | 188.4 | ||||||||||||||
Free cash flow productivity | 40.1 | % | 430.6 | % | 134.2 | % | 59.0 | % | 118.7 | % | |||||||||
PER SHARE DATA: | |||||||||||||||||||
GAAP earnings per common share from continuing operations: | |||||||||||||||||||
Basic | $ | 7.88 | $ | 2.27 | $ | 3.33 | $ | 4.04 | $ | 2.12 | |||||||||
Diluted | 7.77 | 2.23 | 3.29 | 3.98 | 2.09 | ||||||||||||||
Non-GAAP adjusted earnings per common share from continuing operations: | |||||||||||||||||||
Adjusted diluted(2) | 4.47 | 3.71 | 3.94 | 3.72 | 2.92 | ||||||||||||||
SLS Divestiture adjusted income(2) | 4.47 | 3.71 | 3.94 | 3.58 | 3.27 | ||||||||||||||
Dividends per common share(5) | 2.230 | 2.140 | 2.030 | 1.910 | 1.820 | ||||||||||||||
OTHER: | |||||||||||||||||||
Adjusted EBITDA(2)(6) | $ | 558.2 | $ | 482.0 | $ | 560.5 | $ | 517.4 | $ | 471.8 | |||||||||
Leverage ratio(6) | 3.67 | 4.23 | 3.04 | 3.10 | 2.63 | ||||||||||||||
Interest coverage ratio(6) | 5.78 | 5.55 | 7.54 | 7.88 | 9.34 | ||||||||||||||
Weighted average Common Shares outstanding | 55.5 | 56.2 | 59.4 | 61.1 | 61.1 | ||||||||||||||
Common shares and dilutive potential common shares used in diluted EPS calculation | 56.3 | 57.1 | 60.2 | 62.0 | 62.2 | ||||||||||||||
23
(1) | The Selected Financial Data has been retrospectively updated to recast activity for the following: |
Discontinued Operations
On April 13, 2016, we completed the contribution of the SLS Business to the TruGreen Joint Venture in exchange for a minority equity interest of approximately 30% in the TruGreen Joint Venture. As a result, effective in our second quarter of fiscal 2016, we classified the SLS Business as a discontinued operation in accordance with GAAP.
On August 31, 2017, we completed the sale of the International Business. As a result, effective in our fourth quarter of fiscal 2017, we classified the International Business as a discontinued operation in accordance with GAAP.
Recent Accounting Pronouncements
In April 2015, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update that requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the corresponding debt liability rather than as an asset; however debt issuance costs relating to revolving credit facilities will remain in other assets. We adopted this guidance on a retrospective basis effective October 1, 2016. As a result, debt issuance costs have been presented as a component of the carrying amount of long-term debt in the Consolidated Balance Sheets. These amounts were previously reported within other assets.
In November 2015, the FASB issued an accounting standard update to simplify the presentation of deferred income taxes by requiring that deferred income tax liabilities and assets be classified as noncurrent in a classified statement of financial position. We adopted this guidance on a retrospective basis during the fourth quarter of fiscal 2017. As a result, deferred tax assets have been presented net within other liabilities in the Consolidated Balance Sheets. These amounts were previously reported within prepaid and other current assets.
In March 2016, the FASB issued an accounting standard update that simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The amended accounting guidance requires cash paid to a tax authority when shares are withheld to satisfy statutory income tax withholding obligations to be classified as a financing activity in the statement of cash flows. These amounts were previously classified as an operating activity in the statement of cash flows.
(2) | Reconciliation of Non-GAAP Measures |
Use of Non-GAAP Measures
To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), we use non-GAAP financial measures. The reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. These non-GAAP financial measures should not be considered in isolation from, or as a substitute for or superior to, financial measures reported in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of the business as determined in accordance with GAAP. Other companies may calculate similarly titled non-GAAP financial measures differently than us, limiting the usefulness of those measures for comparative purposes.
In addition to GAAP measures, we use these non-GAAP financial measures to evaluate our performance, engage in financial and operational planning and determine incentive compensation because we believe that these measures provide additional perspective on and, in some circumstances are more closely correlated to, the performance of our underlying, ongoing business.
We believe that these non-GAAP financial measures are useful to investors in their assessment of operating performance and the valuation of the Company. In addition, these non-GAAP financial measures address questions routinely received from analysts and investors and, in order to ensure that all investors have access to the same data, we have determined that it is appropriate to make this data available to all investors. Non-GAAP financial measures exclude the impact of certain items (as further described below) and provide supplemental information regarding operating performance. By disclosing these non-GAAP financial measures, we intend to provide investors with a supplemental comparison of operating results and trends for the periods presented. We believe these measures are also useful to investors as such measures allow investors to evaluate performance using the same metrics that we use to evaluate past performance and
24
prospects for future performance. We view free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends and discretionary investment. We view free cash flow productivity as a useful measure to help investors understand the Company’s ability to generate cash.
Exclusions from Non-GAAP Financial Measures
Non-GAAP financial measures reflect adjustments based on the following items:
• | Impairments, which are excluded because they do not occur in or reflect the ordinary course of our ongoing business operations and their exclusion results in a metric that provides supplemental information about the sustainability of operating performance. |
• | Restructuring and employee severance costs, which include charges for discrete projects or transactions that fundamentally change our operations and are excluded because they are not part of the ongoing operations of our underlying business, which includes normal levels of reinvestment in the business. |
• | Costs related to refinancing, which are excluded because they do not typically occur in the normal course of business and may obscure analysis of trends and financial performance. Additionally, the amount and frequency of these types of charges is not consistent and is significantly impacted by the timing and size of debt financing transactions. |
• | Charges or credits incurred by the TruGreen Joint Venture that are apart from and not indicative of the results of its ongoing operations, including transaction related costs, refinancing costs, restructurings and other discrete projects or transactions including a non-cash purchase accounting fair value write-down adjustment related to deferred revenue and advertising (“TruGreen Joint Venture non-GAAP adjustments”). We held a noncontrolling equity interest of approximately 30% in the TruGreen Joint Venture until March 2019. We did not control, nor did we have any legal claim to, the revenues and expenses of the TruGreen Joint Venture or its other unconsolidated affiliates. The use of non-GAAP measures that are subject to TruGreen Joint Venture non-GAAP adjustments is not intended to imply that we had control over the operations and resulting revenue and expenses of the TruGreen Joint Venture or its other unconsolidated affiliates. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all revenue and expenses of the unconsolidated affiliates. |
• | Discontinued operations and other unusual items, which include costs or gains related to discrete projects or transactions and are excluded because they are not comparable from one period to the next and are not part of the ongoing operations of our underlying business. |
The tax effect for each of the items listed above is determined using the tax rate and other tax attributes applicable to the item and the jurisdiction(s) in which the item is recorded.
Definitions of Non-GAAP Financial Measures
The reconciliations of non-GAAP disclosure items include the following financial measures that are not calculated in accordance with GAAP and are utilized by us in evaluating the performance of the business, engaging in financial and operational planning, the determination of incentive compensation, and by investors and analysts in evaluating performance of the business:
Adjusted income (loss) from operations: Income (loss) from operations excluding impairment, restructuring and other charges / recoveries.
Adjusted income (loss) from continuing operations: Income (loss) from continuing operations excluding impairment, restructuring and other charges / recoveries, costs related to refinancing and TruGreen Joint Venture non-GAAP adjustments, each net of tax.
Adjusted net income (loss) attributable to controlling interest from continuing operations: Net income (loss) attributable to controlling interest excluding impairment, restructuring and other charges / recoveries, costs related to refinancing, TruGreen Joint Venture non-GAAP adjustments and discontinued operations, each net of tax.
Adjusted diluted income (loss) per common share from continuing operations: Diluted net income (loss) per common share from continuing operations excluding impairment, restructuring and other charges / recoveries, costs related to refinancing and TruGreen Joint Venture non-GAAP adjustments, each net of tax.
SLS Divestiture adjusted income (loss): Net income (loss) from continuing operations excluding impairment, restructuring and other charges / recoveries, costs related to refinancing and TruGreen Joint Venture non-GAAP adjustments, each net of tax. This measure also includes income (loss) from discontinued operations related to the SLS Business; however, excludes the gain on the contribution of the SLS Business to the TruGreen Joint Venture, each net of tax.
25
SLS Divestiture adjusted income (loss) per common share: Diluted net income (loss) per common share excluding impairment, restructuring and other charges / recoveries, costs related to refinancing and TruGreen Joint Venture non-GAAP adjustments, each net of tax. This measure also includes income (loss) from discontinued operations related to the SLS Business; however, excludes the gain on the contribution of the SLS Business to the TruGreen Joint Venture, each net of tax.
Free cash flow: Net cash provided by (used in) operating activities reduced by investments in property, plant and equipment.
Free cash flow productivity: Ratio of free cash flow to net income (loss).
Adjusted EBITDA: Net income (loss) before interest, taxes, depreciation and amortization as well as certain other items such as the impact of the cumulative effect of changes in accounting, costs associated with debt refinancing and other non-recurring or non-cash items affecting net income (loss). The presentation of adjusted EBITDA is intended to be consistent with the calculation of that measure as required by our borrowing arrangements, and used to calculate a leverage ratio (maximum of 5.00 at September 30, 2019) and an interest coverage ratio (minimum of 3.00 for the twelve months ended September 30, 2019).
26
A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is presented in the following table:
Year Ended September 30, | |||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||||||
(In millions, except per share data) | |||||||||||||||||||
Income from operations (GAAP) | $ | 409.6 | $ | 198.9 | $ | 433.4 | $ | 447.6 | $ | 253.8 | |||||||||
Impairment, restructuring and other charges (recoveries) | 13.3 | 152.8 | 4.9 | (45.5 | ) | 80.2 | |||||||||||||
Adjusted income from operations (Non-GAAP) | $ | 422.9 | $ | 351.7 | $ | 438.3 | $ | 402.1 | $ | 334.0 | |||||||||
Income from continuing operations (GAAP) | $ | 436.7 | $ | 127.6 | $ | 198.3 | $ | 246.1 | $ | 128.7 | |||||||||
Impairment, restructuring and other charges (recoveries) | 13.3 | 152.8 | 30.1 | (33.8 | ) | 80.2 | |||||||||||||
Costs related to refinancing | — | — | — | 8.8 | — | ||||||||||||||
Other non-operating (income) expense, net | (260.2 | ) | 11.7 | 13.4 | — | — | |||||||||||||
Adjustment to income tax expense (benefit) from continuing operations | 61.5 | (80.5 | ) | (4.4 | ) | 9.1 | (28.5 | ) | |||||||||||
Adjusted income from continuing operations (Non-GAAP) | $ | 251.3 | $ | 211.6 | $ | 237.4 | $ | 230.2 | $ | 180.4 | |||||||||
Net income attributable to controlling interest (GAAP) | $ | 460.7 | $ | 63.7 | $ | 218.3 | $ | 315.3 | $ | 159.8 | |||||||||
Income (loss) from discontinued operations, net of tax | 23.5 | (63.9 | ) | 20.5 | 68.7 | 30.0 | |||||||||||||
Impairment, restructuring and other charges (recoveries) | 13.3 | 152.8 | 30.1 | (33.8 | ) | 80.2 | |||||||||||||
Costs related to refinancing | — | — | — | 8.8 | — | ||||||||||||||
Other non-operating (income) expense, net | (260.2 | ) | 11.7 | 13.4 | — | — | |||||||||||||
Adjustment to income tax expense (benefit) from continuing operations | 61.5 | (80.5 | ) | (4.4 | ) | 9.1 | (28.5 | ) | |||||||||||
Adjusted net income attributable to controlling interest from continuing operations (Non-GAAP) | $ | 251.8 | $ | 211.6 | $ | 236.9 | $ | 230.7 | $ | 181.5 | |||||||||
Income from continuing operations (GAAP) | $ | 436.7 | $ | 127.6 | $ | 198.3 | $ | 246.1 | $ | 128.7 | |||||||||
Net (income) loss attributable to noncontrolling interest | 0.5 | — | (0.5 | ) | 0.5 | 1.1 | |||||||||||||
Net income attributable to controlling interest from continuing operations | 437.2 | 127.6 | 197.8 | 246.6 | 129.8 | ||||||||||||||
Impairment, restructuring and other charges (recoveries) | 13.3 | 152.8 | 30.1 | (33.8 | ) | 80.2 | |||||||||||||
Costs related to refinancing | — | — | — | 8.8 | — | ||||||||||||||
Other non-operating (income) expense, net | (260.2 | ) | 11.7 | 13.4 | — | — | |||||||||||||
Adjustment to income tax expense (benefit) from continuing operations | 61.5 | (80.5 | ) | (4.4 | ) | 9.1 | (28.5 | ) | |||||||||||
Adjusted income attributable to controlling interest from continuing operations (Non-GAAP) | $ | 251.8 | $ | 211.6 | $ | 236.9 | $ | 230.7 | $ | 181.5 | |||||||||
Income (loss) from discontinued operations from SLS Business | — | — | (1.8 | ) | 102.9 | 32.5 | |||||||||||||
Gain on contribution of SLS Business | — | — | — | (131.2 | ) | — | |||||||||||||
Adjustment to gain on contribution on SLS Business | — | — | 1.0 | — | — | ||||||||||||||
Impairment, restructuring and other from SLS Business in discontinued operations | — | — | 0.8 | 13.6 | 1.5 | ||||||||||||||
Adjustment to income tax expense (benefit) from SLS Business in discontinued operations | — | — | — | 5.7 | (12.1 | ) | |||||||||||||
Adjusted income (loss) from SLS Business in discontinued operations, net of tax | — | — | — | (9.0 | ) | 21.9 | |||||||||||||
SLS Divestiture adjusted income (Non-GAAP) | $ | 251.8 | $ | 211.6 | $ | 236.9 | $ | 221.7 | $ | 203.4 | |||||||||
Diluted income per share from continuing operations (GAAP) | $ | 7.77 | $ | 2.23 | $ | 3.29 | $ | 3.98 | $ | 2.09 | |||||||||
Impairment, restructuring and other charges (recoveries) | 0.24 | 2.68 | 0.50 | (0.55 | ) | 1.29 | |||||||||||||
Costs related to refinancing | — | — | — | 0.14 | — | ||||||||||||||
Other non-operating (income) expense, net | (4.62 | ) | 0.20 | 0.22 | — | — | |||||||||||||
Adjustment to income tax expense (benefit) from continuing operations | 1.09 | (1.41 | ) | (0.07 | ) | 0.15 | (0.46 | ) | |||||||||||
Adjusted diluted income per common share from continuing operations (Non-GAAP) | $ | 4.47 | $ | 3.71 | $ | 3.94 | $ | 3.72 | $ | 2.92 | |||||||||
Income (loss) from discontinued operations from SLS Business | $ | — | $ | — | $ | (0.03 | ) | $ | 1.66 | $ | 0.52 | ||||||||
Gain on contribution of SLS Business | — | — | — | (2.12 | ) | — | |||||||||||||
Adjustment to gain on contribution of SLS Business | — | — | 0.02 | — | — | ||||||||||||||
Impairment, restructuring and other from SLS Business in discontinued operations | — | — | 0.01 | 0.22 | 0.02 | ||||||||||||||
Adjustment to income tax expense (benefit) from SLS Business in discontinued operations | — | — | — | 0.09 | (0.19 | ) | |||||||||||||
Adjusted diluted income (loss) from SLS Business in discontinued operations, net of tax | — | — | — | (0.15 | ) | 0.35 | |||||||||||||
SLS Divestiture adjusted income per common share (Non-GAAP) | $ | 4.47 | $ | 3.71 | $ | 3.94 | $ | 3.58 | $ | 3.27 | |||||||||
The sum of the components may not equal the total due to rounding.
27
Year Ended September 30, | |||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||||||
(In millions, except per share data) | |||||||||||||||||||
Net cash provided by operating activities (GAAP) | $ | 226.8 | $ | 342.5 | $ | 363.2 | $ | 244.0 | $ | 250.1 | |||||||||
Investments in property, plant and equipment | (42.4 | ) | (68.2 | ) | (69.6 | ) | (58.3 | ) | (61.7 | ) | |||||||||
Free cash flow (Non-GAAP) | $ | 184.4 | $ | 274.3 | $ | 293.6 | $ | 185.7 | $ | 188.4 | |||||||||
Free cash flow (Non-GAAP) | $ | 184.4 | $ | 274.3 | $ | 293.6 | $ | 185.7 | $ | 188.4 | |||||||||
Net income (GAAP) | 460.2 | 63.7 | 218.8 | 314.8 | 158.7 | ||||||||||||||
Free cash flow productivity (Non-GAAP) | 40.1 | % | 430.6 | % | 134.2 | % | 59.0 | % | 118.7 | % | |||||||||
The sum of the components may not equal the total due to rounding.
(3) | Working capital is calculated as current assets minus current liabilities. Current ratio is calculated as current assets divided by current liabilities. |
(4) | The total debt to total book capitalization percentage is calculated by dividing total debt by total debt plus total equity—controlling interest. |
(5) | Scotts Miracle-Gro pays a quarterly dividend to the holders of its Common Shares. On August 3, 2015, Scotts Miracle-Gro announced that its Board of Directors had increased our quarterly cash dividend from $0.45 to $0.47 per Common Share, which was first paid in the fourth quarter of fiscal 2015. On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors had further increased our quarterly cash dividend from $0.47 to $0.50 per Common Share, which was first paid in the fourth quarter of fiscal 2016. On August 1, 2017, Scotts Miracle-Gro announced that its Board of Directors had further increased our quarterly cash dividend from $0.50 to $0.53 per Common Share, which was first paid in the fourth quarter of fiscal 2017. On August 6, 2018, Scotts Miracle-Gro announced that its Board of Directors had further increased our quarterly cash dividend from $0.53 to $0.55 per Common Share, which was first paid in the fourth quarter of fiscal 2018. On July 30, 2019, the Scotts Miracle-Gro Board of Directors approved an increase in our quarterly cash dividend from $0.55 to $0.58 per Common Share, which was first paid in the fourth quarter of fiscal 2019. The payment of future dividends, if any, on the Common Shares will be determined by the Board of Directors in light of conditions then existing, including the Company’s earnings, financial condition and capital requirements, restrictions in financing agreements, business conditions and other factors. |
(6) | We view our credit facility as material to our ability to fund operations, particularly in light of our seasonality. Please refer to “ITEM 1A. RISK FACTORS — Our indebtedness could limit our flexibility and adversely affect our financial condition” of this Annual Report on Form 10-K for a more complete discussion of the risks associated with our debt and our credit facility and the restrictive covenants therein. Our ability to generate cash flows sufficient to cover our debt service costs is essential to our ability to maintain our borrowing capacity. We believe that Adjusted EBITDA provides additional information for determining our ability to meet debt service requirements. The presentation of Adjusted EBITDA herein is intended to be consistent with the calculation of that measure as required by our borrowing arrangements, and used to calculate a leverage ratio (maximum of 5.00 at September 30, 2019) and an interest coverage ratio (minimum of 3.00 for the twelve months ended September 30, 2019). Leverage ratio is calculated as average total indebtedness divided by Adjusted EBITDA. Interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the Fifth A&R Credit Agreement, and excludes costs related to refinancings. Our leverage ratio was 3.67 at September 30, 2019 and our interest coverage ratio was 5.78 for the twelve months ended September 30, 2019. Please refer to “ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS — Liquidity and Capital Resources — Borrowing Agreements” of this Annual Report on Form 10-K for a discussion of our credit facility. |
Our calculation of Adjusted EBITDA does not represent and should not be considered as an alternative to net income or cash flows from operating activities as determined by GAAP. We make no representation or assertion that Adjusted EBITDA is indicative of our cash flows from operating activities or results of operations. We have provided a reconciliation of Adjusted EBITDA to net income from solely for the purpose of complying with SEC regulations and not as an indication that Adjusted EBITDA is a substitute measure for net income.
28
A numeric reconciliation of net income to Adjusted EBITDA is as follows:
Year Ended September 30, | |||||||||||||||||||
2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||||||
(In millions) | |||||||||||||||||||
Net income (GAAP) | $ | 460.2 | $ | 63.7 | $ | 218.8 | $ | 314.8 | $ | 158.7 | |||||||||
Income tax expense (benefit) from continuing operations | 144.9 | (11.9 | ) | 116.6 | 137.6 | 76.3 | |||||||||||||
Income tax expense (benefit) from discontinued operations | 11.7 | (25.5 | ) | 11.9 | 43.2 | 9.1 | |||||||||||||
(Gain) loss on sale / contribution of business | — | 0.7 | (31.7 | ) | (131.2 | ) | — | ||||||||||||
Costs related to refinancings | — | — | — | 8.8 | — | ||||||||||||||
Interest expense | 101.8 | 86.4 | 76.6 | 65.6 | 50.5 | ||||||||||||||
Depreciation | 55.9 | 53.4 | 55.1 | 53.8 | 51.4 | ||||||||||||||
Amortization | 33.4 | 30.0 | 25.0 | 19.7 | 17.6 | ||||||||||||||
Impairment, restructuring and other charges (recoveries) from continuing operations | 13.3 | 152.8 | 30.1 | (33.8 | ) | 80.2 | |||||||||||||
Impairment, restructuring and other charges (recoveries) from discontinued operations | (35.8 | ) | 86.8 | 15.9 | 19.7 | 11.3 | |||||||||||||
Other non-operating (income) expense, net | (260.2 | ) | 11.7 | 13.4 | — | — | |||||||||||||
Interest income | (8.6 | ) | (10.0 | ) | — | — | — | ||||||||||||
Expense on certain leases | 3.2 | 3.5 | 3.6 | 3.6 | 3.5 | ||||||||||||||
Share-based compensation expense | 38.4 | 40.4 | 25.2 | 15.6 | 13.2 | ||||||||||||||
Adjusted EBITDA (Non-GAAP) | $ | 558.2 | $ | 482.0 | $ | 560.5 | $ | 517.4 | $ | 471.8 | |||||||||
29
ITEM 7. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
The purpose of this Management’s Discussion and Analysis (“MD&A”) is to provide an understanding of our financial condition and results of operations by focusing on changes in certain key measures from year-to-year. This MD&A is divided into the following sections:
• | Executive summary |
• | Results of operations |
• | Segment results |
• | Liquidity and capital resources |
• | Regulatory matters |
• | Critical accounting policies and estimates |
Executive Summary
We are a leading manufacturer and marketer of branded consumer lawn and garden products. We are the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products within the United States and certain other specified countries. Through our Hawthorne segment, we are a leading manufacturer, marketer and distributor of nutrients, growing media, advanced indoor garden, lighting and ventilation systems and accessories for indoor, urban and hydroponic gardening.
Beginning in fiscal 2015, our Hawthorne segment made a series of key acquisitions, including General Hydroponics, Gavita, Botanicare, Vermicrop, Agrolux, Can-Filters and AeroGrow. On June 4, 2018, our Hawthorne segment acquired substantially all of the assets of Sunlight Supply. Prior to the acquisition, Sunlight Supply was the largest distributor of hydroponic products in the United States, and engaged in the business of developing, manufacturing, marketing and distributing horticultural, organics, lighting and hydroponics products, including lighting fixtures, nutrients, seeds and growing media, systems, trays, fans, filters, humidifiers and dehumidifiers, timers, instruments, water pumps, irrigation supplies and hand tools. In connection with our acquisition of Sunlight Supply, we announced the launch of an initiative called Project Catalyst. Project Catalyst is a company-wide restructuring effort to reduce operating costs throughout our U.S. Consumer, Hawthorne and Other segments and drive synergies from acquisitions within our Hawthorne segment.
Our operations are divided into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of our consumer lawn and garden business located in the geographic United States. Hawthorne consists of our indoor, urban and hydroponic gardening business. Other consists of our consumer lawn and garden business in geographies other than the U.S. and our product sales to commercial nurseries, greenhouses and other professional customers. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the business segments. This division of reportable segments is consistent with how the segments report to and are managed by our chief operating decision maker. See “SEGMENT RESULTS” below for additional information regarding our evaluation of segment performance.
As a leading consumer branded lawn and garden company, our product development and marketing efforts are largely focused on providing innovative and differentiated products and continually increasing brand and product awareness to inspire consumers to create retail demand. We have implemented this model for a number of years by focusing on research and development and investing approximately 4-5% of our annual net sales in advertising to support and promote our consumer lawn and garden products and brands. We continually explore new and innovative ways to communicate with consumers. We believe that we receive a significant benefit from these expenditures and anticipate a similar commitment to research and development, advertising and marketing investments in the future, with the continuing objective of driving category growth and profitably increasing market share.
Our net sales in any one year are susceptible to weather conditions in the markets in which our products are sold and our services are offered. For instance, periods of abnormally wet or dry weather can adversely impact the sale of certain products, while increasing demand for other products, or delay the timing of the provision of certain services. We believe that our diversified product line and our geographic diversification reduce this risk, although to a lesser extent in a year in which unfavorable weather is geographically widespread and extends across a significant portion of the lawn and garden season. We also believe that weather conditions in any one year, positive or negative, do not materially impact longer-term category growth trends.
30
Due to the seasonal nature of the lawn and garden business, significant portions of our products ship to our retail customers during our second and third fiscal quarters, as noted in the chart below. Our annual net sales are further concentrated in the second and third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products, thereby reducing retailers’ pre-season inventories.
Percent of Net Sales from Continuing Operations by Quarter | ||||||||
2019 | 2018 | 2017 | ||||||
First Quarter | 9.4 | % | 8.3 | % | 7.8 | % | ||
Second Quarter | 37.7 | % | 38.0 | % | 41.1 | % | ||
Third Quarter | 37.1 | % | 37.3 | % | 36.8 | % | ||
Fourth Quarter | 15.8 | % | 16.3 | % | 14.3 | % | ||
We follow a 13-week quarterly accounting cycle pursuant to which the first three fiscal quarters end on a Saturday and the fiscal year always ends on September 30. This fiscal calendar convention requires us to cycle forward the first three fiscal quarter ends every six years.
Management focuses on a variety of key indicators and operating metrics to monitor the financial condition and performance of the continuing operations of our business. These metrics include consumer purchases (point-of-sale data), market share, category growth, net sales (including unit volume, pricing and foreign exchange movements), gross profit margins, advertising to net sales ratios, income from operations, income from continuing operations, net income and earnings per share. To the extent applicable, these metrics are evaluated with and without impairment, restructuring and other charges that do not occur in or reflect the ordinary course of our ongoing business operations. Metrics that exclude impairment, restructuring and other charges are used by management to evaluate our performance, engage in financial and operational planning and determine incentive compensation because we believe that these measures provide additional perspective on the performance of our underlying, ongoing business. Refer to “ITEM 6. SELECTED FINANCIAL DATA” for further discussion of non-GAAP measures. We also focus on measures to optimize cash flow and return on invested capital, including the management of working capital and capital expenditures.
On August 11, 2014, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $500.0 million of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 million increase to the share repurchase authorization ending on September 30, 2019. On August 2, 2019, the Scotts Miracle-Gro Board of Directors authorized an extension of the current share repurchase authorization through March 28, 2020. The amended authorization allows for repurchases of Common Shares of up to an aggregate of $1.0 billion through March 28, 2020. There were no share repurchases under the program during fiscal 2019. From the inception of this share repurchase program in the fourth quarter of fiscal 2014 through September 30, 2019, Scotts Miracle-Gro repurchased approximately 8.3 million Common Shares for $714.6 million.
On August 6, 2018, Scotts Miracle-Gro announced that its Board of Directors approved an increase in our quarterly cash dividend from $0.53 to $0.55 per Common Share, which was first paid in the fourth quarter of fiscal 2018. On July 30, 2019, the Scotts Miracle-Gro Board of Directors approved an increase in our quarterly cash dividend from $0.55 to $0.58 per Common Share, which was first paid in the fourth quarter of fiscal 2019.
31
Results of Operations
Effective in our fourth quarter of fiscal 2017, we classified our results of operations for all periods presented to reflect the International Business as a discontinued operation. As a result, unless otherwise specifically stated, all discussions regarding results for the fiscal years ended September 30, 2019, 2018 and 2017 reflect results from our continuing operations.
The following table sets forth the components of income and expense as a percentage of net sales:
Year Ended September 30, | |||||||||||||||||
2019 | % of Net Sales | 2018 | % of Net Sales | 2017 | % of Net Sales | ||||||||||||
Net sales | $ | 3,156.0 | 100.0 | % | $ | 2,663.4 | 100.0 | % | $ | 2,642.1 | 100.0 | % | |||||
Cost of sales | 2,130.5 | 67.5 | 1,778.3 | 66.8 | 1,669.5 | 63.2 | |||||||||||
Cost of sales—impairment, restructuring and other | 5.9 | 0.2 | 20.5 | 0.8 | — | — | |||||||||||
Gross profit | 1,019.6 | 32.3 | 864.6 | 32.5 | 972.6 | 36.8 | |||||||||||
Operating expenses: | |||||||||||||||||
Selling, general and administrative | 601.3 | 19.1 | 540.1 | 20.3 | 550.9 | 20.9 | |||||||||||
Impairment, restructuring and other | 7.4 | 0.2 | 132.3 | 5.0 | 4.9 | 0.2 | |||||||||||
Other (income) expense, net | 1.3 | — | (6.7 | ) | (0.3 | ) | (16.6 | ) | (0.6 | ) | |||||||
Income from operations | 409.6 | 13.0 | 198.9 | 7.5 | 433.4 | 16.4 | |||||||||||
Equity in income of unconsolidated affiliates | (3.3 | ) | (0.1 | ) | (4.9 | ) | (0.2 | ) | 29.0 | 1.1 | |||||||
Interest expense | 101.8 | 3.2 | 86.4 | 3.2 | 76.1 | 2.9 | |||||||||||
Other non-operating (income) expense, net | (270.5 | ) | (8.6 | ) | 1.7 | 0.1 | 13.4 | 0.5 | |||||||||
Income from continuing operations before income taxes | 581.6 | 18.4 | 115.7 | 4.3 | 314.9 | 11.9 | |||||||||||
Income tax expense (benefit) from continuing operations | 144.9 | 4.6 | (11.9 | ) | (0.4 | ) | 116.6 | 4.4 | |||||||||
Income from continuing operations | 436.7 | 13.8 | 127.6 | 4.8 | 198.3 | 7.5 | |||||||||||
Income (loss) from discontinued operations, net of tax | 23.5 | 0.7 | (63.9 | ) | (2.4 | ) | 20.5 | 0.8 | |||||||||
Net income | $ | 460.2 | 14.6 | % | $ | 63.7 | 2.4 | % | $ | 218.8 | 8.3 | % | |||||
The sum of the components may not equal due to rounding.
Net Sales
Net sales for fiscal 2019 were $3,156.0 million, an increase of 18.5% from net sales of $2,663.4 million for fiscal 2018. Net sales for fiscal 2018 increased 0.8% from net sales of $2,642.1 million for fiscal 2017. These changes in net sales were attributable to the following:
Year Ended September 30, | |||||
2019 | 2018 | ||||
Volume | 9.0 | % | (3.6 | )% | |
Acquisitions | 8.7 | 5.2 | |||
Pricing | 1.3 | (1.1 | ) | ||
Foreign exchange rates | (0.5 | ) | 0.3 | ||
Change in net sales | 18.5 | % | 0.8 | % | |
The increase in net sales for fiscal 2019 as compared to fiscal 2018 was primarily driven by:
• | increased sales volume driven by increased sales of soils, mulch, grass seed and fertilizer products in our U.S. Consumer segment and hydroponic gardening products in our Hawthorne segment excluding the impact of acquisitions, partially offset by decreased sales in our Other segment as a result of the closure of our business in Mexico; |
• | the addition of net sales from the Sunlight Supply acquisition of $231.4 million in our Hawthorne segment; and |
• | increased pricing in our U.S. Consumer and Other segments, partially offset by higher volume-based customer rebates in our U.S. Consumer segment and decreased pricing in our Hawthorne segment primarily driven by increased promotional activities; |
32
• | partially offset by decreased net sales associated with the Roundup® marketing agreement; and |
• | the unfavorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to the euro and the Canadian dollar. |
The increase in net sales for fiscal 2018 as compared to fiscal 2017 was primarily driven by:
• | the addition of net sales from acquisitions of $136.3 million in our Hawthorne segment, primarily from Sunlight Supply, Agrolux, and Can-Filters; and |
• | the favorable impact of foreign exchange rates as a result of the weakening of the U.S. dollar relative to the euro and the Canadian dollar; |
• | partially offset by decreased sales volume driven by decreased sales of fertilizer, controls and plant food products in our U.S. Consumer segment and hydroponic gardening products in our Hawthorne segment excluding the impact of acquisitions, partially offset by increased sales of soils and grass seed products in our U.S. Consumer segment and increased sales in our Other segment from our business in Canada; |
• | decreased pricing in our U.S. Consumer segment driven by higher customer rebates and sales mix; and |
• | decreased net sales associated with the Roundup® marketing agreement. |
Cost of Sales
The following table shows the major components of cost of sales:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Materials | $ | 1,196.4 | $ | 994.2 | $ | 966.9 | |||||
Manufacturing labor and overhead | 485.8 | 401.3 | 356.7 | ||||||||
Distribution and warehousing | 394.9 | 328.3 | 289.8 | ||||||||
Costs associated with Roundup® marketing agreement | 53.4 | 54.5 | 56.1 | ||||||||
Cost of sales | 2,130.5 | 1,778.3 | 1,669.5 | ||||||||
Cost of sales—impairment, restructuring and other | 5.9 | 20.5 | — | ||||||||
$ | 2,136.4 | $ | 1,798.8 | $ | 1,669.5 | ||||||
Factors contributing to the change in cost of sales are outlined in the following table:
Year Ended September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
Volume, product mix and other | $ | 358.2 | $ | 104.2 | |||
Material costs | 5.6 | (0.7 | ) | ||||
Costs associated with Roundup® marketing agreement | (1.1 | ) | (1.6 | ) | |||
Foreign exchange rates | (10.5 | ) | 6.9 | ||||
352.2 | 108.8 | ||||||
Impairment, restructuring and other | (14.6 | ) | 20.5 | ||||
Change in cost of sales | $ | 337.6 | $ | 129.3 | |||
The increase in cost of sales for fiscal 2019 as compared to fiscal 2018 was primarily driven by:
• | costs of $199.6 million included within “volume, product mix and other” related to sales from the Sunlight Supply acquisition in our Hawthorne segment; |
• | higher sales volume in our U.S. Consumer and Hawthorne segments excluding the impact of acquisitions, partially offset by decreased sales in our Other segment; |
• | higher transportation costs included within “volume, product mix and other” associated with our U.S. Consumer segment; and |
• | higher material costs in our U.S. Consumer and Other segments; |
33
• | partially offset by a decrease in costs associated with the Roundup® marketing agreement; |
• | the favorable impact of foreign exchange rates as a result of the strengthening of the U.S. dollar relative to the euro and the Canadian dollar; and |
• | a decrease in impairment, restructuring and other charges of $14.6 million as a result of lower costs associated with Project Catalyst. |
The increase in cost of sales for fiscal 2018 as compared to fiscal 2017 was primarily driven by:
• | costs of $125.2 million included within “volume, product mix and other” related to sales from acquisitions in our Hawthorne segment, primarily from Sunlight Supply, Agrolux and Can-Filters, and including $12.2 million related to acquisition date inventory fair value adjustments; |
• | higher transportation costs included within “volume, product mix and other” associated with our U.S. Consumer, Hawthorne and Other segments; |
• | the unfavorable impact of foreign exchange rates as a result of the weakening of the U.S. dollar relative to the euro and the Canadian dollar; and |
• | an increase in impairment, restructuring and other charges of $20.5 million related to facility closures, impairment of property, plant and equipment and employee termination benefits associated with Project Catalyst; |
• | partially offset by decreased sales volume in our U.S. Consumer and Hawthorne segments excluding the impact of acquisitions, partially offset by increased sales volume in our Other segment; and |
• | a decrease in net sales attributable to reimbursements under the Roundup® marketing agreement. |
Gross Profit
As a percentage of net sales, our gross profit rate was 32.3%, 32.5% and 36.8% for fiscal 2019, fiscal 2018 and fiscal 2017, respectively. Factors contributing to the change in gross profit rate are outlined in the following table:
Year Ended September 30, | |||||
2019 | 2018 | ||||
Acquisitions | (1.5 | )% | (1.4 | )% | |
Material costs | (0.2 | ) | — | ||
Roundup® commissions and reimbursements | (0.1 | ) | (0.1 | ) | |
Volume, product mix and other | 0.3 | (1.3 | ) | ||
Pricing | 0.8 | (0.8 | ) | ||
(0.7 | ) | (3.6 | ) | ||
Impairment, restructuring and other | 0.5 | (0.7 | ) | ||
Change in gross profit rate | (0.2 | )% | (4.3 | )% | |
The decrease in gross profit rate for fiscal 2019 as compared to fiscal 2018 was primarily driven by:
• | an unfavorable impact from acquisitions in our Hawthorne segment related to Sunlight Supply; |
• | higher material costs in our U.S. Consumer and Other segments; and |
• | higher transportation costs included within “volume, product mix and other” associated with our U.S. Consumer segment; |
• | partially offset by the favorable impact within “volume, product mix and other” of Sunlight Supply acquisition date inventory fair value adjustments of $12.2 million incurred during fiscal 2018; |
• | increased pricing in our U.S. Consumer and Other segments, net of higher volume-based customer rebates in our U.S. Consumer segment and decreased pricing in our Hawthorne segment primarily driven by increased promotional activities; |
• | favorable leverage of fixed costs such as warehousing driven by higher sales volume in our U.S. Consumer and Hawthorne segments; and |
• | a decrease in impairment, restructuring and other charges as a result of lower costs associated with Project Catalyst. |
34
The decrease in gross profit rate for fiscal 2018 as compared to fiscal 2017 was primarily driven by:
• | an unfavorable net impact from acquisitions in our Hawthorne segment, primarily from Sunlight Supply, Agrolux and Can-Filters; |
• | higher transportation costs included within “volume, product mix and other” associated with our U.S. Consumer, Hawthorne and Other segments; |
• | unfavorable leverage of fixed costs such as warehousing driven by lower sales volumes in our U.S. Consumer and Hawthorne segments excluding the impact of acquisitions; |
• | unfavorable product mix in our U.S. Consumer segment due to decreased sales of fertilizer and plant food products; |
• | decreased pricing in our U.S. Consumer segment driven by higher customer rebates and sales mix; |
• | a decrease in net sales associated with the Roundup® marketing agreement; and |
• | an increase in impairment, restructuring and other charges related to facility closures, impairment of property, plant and equipment and employee termination benefits associated with Project Catalyst. |
Selling, General and Administrative Expenses
The following table sets forth the components of selling, general and administrative expenses (“SG&A”):
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions, except percentage figures) | |||||||||||
Advertising | $ | 120.3 | $ | 104.2 | $ | 123.0 | |||||
Advertising as a percentage of net sales | 3.8 | % | 3.9 | % | 4.7 | % | |||||
Research and development | 39.6 | 42.5 | 39.9 | ||||||||
Share-based compensation | 38.4 | 40.4 | 25.2 | ||||||||
Amortization of intangibles | 32.9 | 28.9 | 21.9 | ||||||||
Other selling, general and administrative | 370.1 | 324.1 | 340.9 | ||||||||
$ | 601.3 | $ | 540.1 | $ | 550.9 | ||||||
SG&A increased $61.2 million, or 11.3%, during fiscal 2019 compared to fiscal 2018. Advertising expense increased $16.1 million, or 15.5%, during fiscal 2019 driven by increased media spending in our U.S. Consumer segment. Share-based compensation expense decreased $2.0 million, or 5.0%, in fiscal 2019 due to a more significant increase in the expected payout percentage on long-term performance-based awards during fiscal 2018 as compared to fiscal 2019. Amortization expense increased $4.0 million, or 13.8%, in fiscal 2019 due to the impact of recent acquisitions. Other SG&A increased $46.0 million, or 14.2%, in fiscal 2019 driven by higher short-term variable cash incentive compensation expense of $33.3 million and the impact of recent acquisitions of $11.8 million.
SG&A decreased $10.8 million, or 2.0%, during fiscal 2018 compared to fiscal 2017. Advertising expense decreased $18.8 million, or 15.3%, during fiscal 2018 as our U.S. Consumer segment increased customer promotional spending with certain retailers, which is recorded as a reduction of net sales, and decreased SG&A media spending. Share-based compensation expense increased $15.2 million, or 60.3%, in fiscal 2018 due to an increase in the expected payout percentage on long-term performance-based awards as a result of strong cash flow performance. Amortization expense increased $7.0 million, or 32.0%, in fiscal 2018 due to the impact of recent acquisitions. Other SG&A decreased $16.8 million, or 4.9%, in fiscal 2018 due to lower short-term variable cash incentive compensation expense of $19.3 million as a result of decreased operating income in fiscal 2018 and lower selling, marketing and fringe benefit expenses of $12.3 million, partially offset by the impact of recent acquisitions of $14.7 million and increased headcount and integration costs for our hydroponic business.
35
Impairment, Restructuring and Other
The following table sets forth the components of impairment, restructuring and other charges (recoveries) recorded in the “Cost of sales—impairment, restructuring and other,” “Impairment, restructuring and other” and “Income (loss) from discontinued operations, net of tax” lines in the Consolidated Statements of Operations:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Cost of sales—impairment, restructuring and other: | |||||||||||
Restructuring and other charges | $ | 5.1 | $ | 12.3 | $ | — | |||||
Property, plant and equipment impairments | 0.8 | 8.2 | — | ||||||||
Operating expenses: | |||||||||||
Restructuring and other charges, net | 7.4 | 20.2 | 3.9 | ||||||||
Goodwill and intangible asset impairments | — | 112.1 | 1.0 | ||||||||
Impairment, restructuring and other charges from continuing operations | $ | 13.3 | $ | 152.8 | $ | 4.9 | |||||
Restructuring and other charges (recoveries) from discontinued operations | (35.8 | ) | 86.8 | 15.9 | |||||||
Total impairment, restructuring and other charges (recoveries) | $ | (22.5 | ) | $ | 239.6 | $ | 20.8 | ||||
Project Catalyst
In connection with the acquisition of Sunlight Supply during the third quarter of fiscal 2018, we announced the launch of an initiative called Project Catalyst, which is a company-wide restructuring effort to reduce operating costs throughout our U.S. Consumer, Hawthorne and Other segments and drive synergies from acquisitions within our Hawthorne segment. During fiscal 2019, we incurred charges of $13.7 million related to Project Catalyst. We incurred charges of $1.1 million in our U.S. Consumer segment, $4.2 million in our Hawthorne segment and $0.6 million in our Other segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2019 related to employee termination benefits, facility closure costs and impairment of property, plant and equipment. We incurred charges of $0.5 million in our U.S. Consumer segment, $3.9 million in our Hawthorne segment, $0.6 million in our Other segment and $2.8 million at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2019 related to employee termination benefits and facility closure costs.
During fiscal 2018, we incurred charges of $29.4 million related to Project Catalyst. We incurred charges of $8.2 million in our U.S. Consumer segment and $12.4 million in our Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2018 related to employee termination benefits, facility closure costs and impairment of property, plant and equipment. We incurred charges of $3.4 million in our U.S. Consumer segment and $5.4 million in our Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2018 related to employee termination benefits.
Project Focus
In the first quarter of fiscal 2016, we announced a series of initiatives called Project Focus designed to maximize the value of our non-core assets and focus on emerging categories of the lawn and garden industry in our core U.S. business. During fiscal 2018, our U.S. Consumer segment recognized adjustments of $0.1 million related to previously recognized termination benefits associated with Project Focus in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. During fiscal 2017, we recognized restructuring costs related to termination benefits and facility closure costs of $8.3 million in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, including $6.7 million for our U.S. Consumer segment, $0.9 million for our Hawthorne segment and $0.7 million for our Other segment.
On August 31, 2017, we completed the sale of the International Business. Refer to “NOTE 3. DISCONTINUED OPERATIONS” for more information. During fiscal 2018 and fiscal 2017, we recognized $1.8 million and $15.5 million, respectively, in transaction related costs associated with the sale of the International Business as well as termination benefits and facility closure costs of zero and $(0.4) million, respectively, in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations.
Other
During fiscal 2019, we recognized a favorable adjustment of $22.5 million as a result of the final resolution of the previously disclosed settlement agreement related to the In re Morning Song Bird Food Litigation legal matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations. In addition, during fiscal 2019, we recognized insurance recoveries of $13.4 million related to this matter in the “Income (loss) from discontinued operations, net of tax” line in
36
the Consolidated Statements of Operations. During fiscal 2018, we recognized a pre-tax charge of $85.0 million for a probable loss related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations. Refer to “NOTE 20. CONTINGENCIES” for more information.
During fiscal 2019, we recognized a favorable adjustment of $0.4 million related to the previously disclosed legal matter In re Scotts EZ Seed Litigation in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. During fiscal 2018, we recognized a charge of $11.7 million for a probable loss related to this matter in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. Refer to “NOTE 20. CONTINGENCIES” for more information.
During fiscal 2018, we recognized a non-cash impairment charge of $94.6 million related to a goodwill impairment in our Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations as a result of the Company’s annual fourth quarter quantitative goodwill impairment test. Refer to “NOTE 5. GOODWILL AND INTANGIBLE ASSETS, NET” for more information.
During fiscal 2018, we recognized a non-cash impairment charge of $17.5 million related to the settlement of a portion of certain previously acquired customer relationships due to the acquisition of Sunlight Supply in the “Impairment, restructuring and other” line in the Consolidated Statement of Operations. Refer to “NOTE 8. ACQUISITIONS AND INVESTMENTS” for more information.
During fiscal 2017, we recognized a recovery of $4.4 million related to the reduction of a contingent consideration liability associated with a historical acquisition and recorded a $1.0 million impairment charge on the write-off of a trademark asset due to recent performance and future growth expectations within the “Impairment, restructuring and other” line in the Consolidated Statements of Operations.
Other (Income) Expense, net
Other (income) expense, net is comprised of activities outside our normal business operations, such as royalty income from the licensing of certain of our brand names, foreign exchange transaction gains and losses and gains and losses from the disposition of non-inventory assets. Other (income) expense, net was $1.3 million, $(6.7) million and $(16.6) million in fiscal 2019, fiscal 2018 and fiscal 2017, respectively. The decrease for fiscal 2019 was primarily due to foreign currency transactional losses, a decrease in royalty income earned from Exponent related to its use of our brand names following the divestiture of the International Business due to the adoption of the amended revenue recognition accounting guidance and losses on long-lived assets. The decrease for fiscal 2018 was due to interest income of $10.0 million on loans receivable that was classified in the “Other (income) expense, net” line in the Consolidated Statements of Operations in fiscal 2017 but was classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations in fiscal 2018, as well as a decrease in royalty income earned from the TruGreen Joint Venture related to its use of our brand names following the divestiture of the SLS Business, partially offset by an increase in royalty income earned from Exponent related to its use of our brand names following the divestiture of the International Business.
Income from Operations
Income from operations was $409.6 million in fiscal 2019, an increase of 105.9% from fiscal 2018 income from operations of $198.9 million. The increase was driven by higher net sales and lower impairment, restructuring and other charges, partially offset by a decrease in gross profit rate, higher SG&A and a decrease in other income.
Income from operations was $198.9 million in fiscal 2018, a decrease of 54.1% from fiscal 2017 income from operations of $433.4 million. The decrease was driven by higher impairment, restructuring and other charges, a decrease in gross profit and a decrease in other income, partially offset by lower SG&A.
Equity in (Income) Loss of Unconsolidated Affiliates
Equity in (income) loss of unconsolidated affiliates was $(3.3) million, $(4.9) million and $29.0 million in fiscal 2019, fiscal 2018 and fiscal 2017, respectively. The decrease for fiscal 2019 was attributable to the sale of our noncontrolling equity interest in the IT&O Joint Venture on April 1, 2019.
Fiscal 2017 included our share of restructuring and other charges incurred by the TruGreen Joint Venture of $25.2 million. These charges included $1.3 million for transaction costs, $12.1 million for nonrecurring integration and separation costs, $7.2 million of costs associated with the TruGreen Joint Venture’s August 2017 debt refinancing and $4.6 million for a non-cash purchase accounting fair value write-down adjustment related to deferred revenue and advertising.
37
Interest Expense
Interest expense was $101.8 million in fiscal 2019, an increase of 17.8% from fiscal 2018 interest expense of $86.4 million. The increase was driven by an increase in average borrowings of $111.9 million and an increase in our weighted average interest rate of 50 basis points. The increase in average borrowings was driven by our acquisition activity and Common Share repurchase activity during fiscal 2018, partially offset by the application of the proceeds from the sale of our equity interests in the TruGreen Joint Venture and the IT&O Joint Venture to reduce our indebtedness. The increase in our weighted average interest rate was driven by higher borrowing rates.
Interest expense was $86.4 million in fiscal 2018, an increase of 13.5% from fiscal 2017 interest expense of $76.1 million. The increase was driven by an increase in average borrowings of $332.8 million, partially offset by a decrease in our weighted average interest rate of 24 basis points. The increase in average borrowings was driven by acquisition activity and an increase in repurchases of our Common Shares during fiscal 2018.
Other Non-Operating (Income) Expense, net
Other non-operating (income) expense, net was $(270.5) million, $1.7 million and $13.4 million in fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
On March 19, 2019, we entered into an agreement under which we sold all of our approximately 30% equity interest in the TruGreen Joint Venture. In connection with this transaction, we received cash proceeds of $234.2 million related to the sale of our equity interest in the TruGreen Joint Venture and $18.4 million related to the payoff of second lien term loan financing, which was previously recorded in the “Other assets” line in the Consolidated Balance Sheets. During fiscal 2019, we also received a distribution from the TruGreen Joint Venture intended to cover certain required tax payments of $3.5 million, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2019, we recognized a pre-tax gain of $259.8 million related to this sale. The cash proceeds were applied to reduce our indebtedness. During fiscal 2019, we made cash tax payments of $99.5 million associated with this disposition.
On April 1, 2019, we sold all of our noncontrolling equity interest in the IT&O Joint Venture for cash proceeds of $36.6 million. During fiscal 2019, we recognized a pre-tax gain of $2.9 million related to this sale. During fiscal 2019, we received a distribution of net earnings from the IT&O Joint Venture of $4.9 million, which was classified as an operating activity in the Consolidated Statements of Cash Flows.
During the second quarter of fiscal 2019, we recognized a charge of $2.5 million related to the write-off of accumulated foreign currency translation loss adjustments of a foreign subsidiary that was substantially liquidated as part of Project Catalyst.
As a result of the enactment of H.R.1 (the “Act,” formerly known as the “Tax Cuts and Jobs Act”) on December 22, 2017, we repatriated cash from a foreign subsidiary during the second quarter of fiscal 2018 resulting in the liquidation of substantially all of the assets of the subsidiary and the write-off of accumulated foreign currency translation loss adjustments of $11.7 million. This was partially offset by interest income on loans receivable of $10.0 million that was classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations in fiscal 2018, but was classified in the “Other income, net” line in the Consolidated Statements of Operations in fiscal 2017.
On October 2, 2017, we acquired the remaining 25% noncontrolling interest in Gavita and its subsidiaries, including Agrolux, for $72.2 million. We recorded a charge of $13.4 million during the fourth quarter of fiscal 2017 to write-up the fair value of the loan to the noncontrolling ownership group of Gavita to the agreed upon buyout value.
38
Income Tax Expense (Benefit) from Continuing Operations
A reconciliation of the federal corporate income tax rate and the effective tax rate on income from continuing operations before income taxes is summarized below:
Year Ended September 30, | ||||||||
2019 | 2018 | 2017 | ||||||
Statutory income tax rate | 21.0 | % | 24.5 | % | 35.0 | % | ||
Effect of foreign operations | 0.3 | 7.4 | 3.1 | |||||
State taxes, net of federal benefit | 1.8 | 6.5 | 2.9 | |||||
Domestic Production Activities Deduction permanent difference | — | (4.4 | ) | (3.1 | ) | |||
Effect of other permanent differences | (0.2 | ) | (3.0 | ) | 0.4 | |||
Research and Experimentation and other federal tax credits | (0.3 | ) | (1.7 | ) | (0.4 | ) | ||
Effect of tax contingencies | 1.9 | 1.3 | 0.9 | |||||
Effect of tax reform | — | (38.7 | ) | — | ||||
Other | 0.4 | (2.2 | ) | (1.8 | ) | |||
Effective income tax rate | 24.9 | % | (10.3 | )% | 37.0 | % | ||
On December 22, 2017, the Act was signed into law. The Act provides for significant changes to the U.S. Internal Revenue Code of 1986, as amended (the “Code”). Among other items, the Act implements a territorial tax system, imposed a one-time transition tax on deemed repatriated earnings of foreign subsidiaries, and reduces the federal corporate statutory tax rate to 21% effective January 1, 2018. As our fiscal year end falls on September 30, the federal corporate statutory tax rate for fiscal 2018 was prorated to 24.5%, with the statutory rate for fiscal 2019 and beyond at 21%. Included in the effective tax rate for fiscal 2018 are one-time impacts related to the tax law change of $42.8 million. These include a one-time $44.6 million net tax benefit adjustment reflecting the revaluation of our net deferred tax liability at the lower tax rate. In addition, we recognized a one-time tax expense on deemed repatriated earnings and cash of foreign subsidiaries as required by the Act of $21.2 million, partially offset by the recognition and application of foreign tax credits associated with these foreign subsidiaries of $18.2 million. We also reduced the value of deferred tax liabilities associated with the write-off of previously acquired customer relationship intangible assets by $7.3 million, which was recognized in the “Income tax expense (benefit) from continuing operations” line in the Consolidated Statement of Operations in fiscal 2018. During the fourth quarter of fiscal 2018, we recognized a non-cash goodwill impairment charge of $94.6 million, of which $20.0 million was not tax-deductible.
Income from Continuing Operations
Income from continuing operations was $436.7 million, or $7.77 per diluted share, in fiscal 2019 compared to $127.6 million, or $2.23 per diluted share, in fiscal 2018. The increase was driven by higher net sales, lower impairment, restructuring and other charges and an increase in other non-operating income, partially offset by a lower gross profit rate, higher SG&A, decreased other income and an increase in interest expense.
Diluted average common shares used in the diluted income per common share calculation were 56.3 million for fiscal 2019 compared to 57.1 million for fiscal 2018. The decrease was primarily the result of Common Share repurchase activity during fiscal 2018, partially offset by the exercise and issuance of share-based compensation awards and the payment of a portion of the purchase price of Sunlight Supply in Common Shares. Dilutive equivalent shares for fiscal 2019 and fiscal 2018 were 0.8 million and 0.9 million, respectively.
Income from continuing operations was $127.6 million, or $2.23 per diluted share, in fiscal 2018 compared to $198.3 million, or $3.29 per diluted share, in fiscal 2017. The decrease was driven by higher impairment, restructuring and other charges, a decrease in gross profit, a decrease in other income, an increase in interest expense and an increase in other non-operating expense, partially offset by the lower effective tax rate, an increase in equity in income of unconsolidated affiliates and a decrease in SG&A.
Diluted average common shares used in the diluted income per common share calculation were 57.1 million for fiscal 2018 compared to 60.2 million for fiscal 2017. The decrease was primarily the result of Common Share repurchase activity, partially offset by the exercise and issuance of share-based compensation awards and the payment of a portion of the purchase price of Sunlight Supply in Common Shares. Dilutive equivalent shares for fiscal 2018 and fiscal 2017 were 0.9 million and 0.8 million, respectively.
Income (Loss) from Discontinued Operations, net of tax
Income (loss) from discontinued operations, net of tax, was $23.5 million, $(63.9) million and $20.5 million for fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
39
During fiscal 2019, we recognized a favorable pre-tax adjustment of $22.5 million as a result of the final resolution of the previously disclosed settlement agreement related to the In re Morning Song Bird Food Litigation legal matter and recognized insurance recoveries of $13.4 million related to this matter. During fiscal 2018, we recognized a pre-tax charge of $85.0 million for a probable loss related to this matter. Refer to “NOTE 20. CONTINGENCIES” for more information.
During fiscal 2017, we recorded a gain on the sale of the International Business of $32.7 million, partially offset by the provision for income taxes of $12.0 million. During fiscal 2018, we recorded a reduction to the pre-tax gain of $0.7 million related to the resolution of post-closing working capital adjustments. During fiscal 2018 and fiscal 2017, we recognized $1.8 million and $15.5 million, respectively, in transaction related costs associated with the sale of the International Business. Refer to “NOTE 3. DISCONTINUED OPERATIONS” for more information.
Segment Results
We divide our business into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of our consumer lawn and garden business located in the geographic United States. Hawthorne consists of our indoor, urban and hydroponic gardening business. Other consists of our consumer lawn and garden business in geographies other than the U.S. and our product sales to commercial nurseries, greenhouses and other professional customers. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the business segments. This identification of reportable segments is consistent with how the segments report to and are managed by our chief operating decision maker.
Segment performance is evaluated based on several factors, including income (loss) from continuing operations before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”), which is a non-GAAP financial measure. Senior management uses this measure of profit (loss) to evaluate segment performance because they believe this measure is indicative of performance trends and the overall earnings potential of each segment.
The following table sets forth net sales by segment:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
U.S. Consumer | $ | 2,281.1 | $ | 2,109.6 | $ | 2,160.5 | |||||
Hawthorne | 671.2 | 344.9 | 287.2 | ||||||||
Other | 203.7 | 208.9 | 194.4 | ||||||||
Consolidated | $ | 3,156.0 | $ | 2,663.4 | $ | 2,642.1 | |||||
The following table sets forth Segment Profit as well as a reconciliation to income from continuing operations before income taxes, the most directly comparable GAAP measure:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
U.S. Consumer | $ | 527.8 | $ | 496.6 | $ | 521.5 | |||||
Hawthorne | 53.5 | (6.1 | ) | 35.5 | |||||||
Other | 10.3 | 11.2 | 13.4 | ||||||||
Total Segment Profit (Non-GAAP) | 591.6 | 501.7 | 570.4 | ||||||||
Corporate | (135.3 | ) | (120.8 | ) | (109.6 | ) | |||||
Intangible asset amortization | (33.4 | ) | (29.2 | ) | (22.5 | ) | |||||
Impairment, restructuring and other | (13.3 | ) | (152.8 | ) | (4.9 | ) | |||||
Equity in income (loss) of unconsolidated affiliates (a) | 3.3 | 4.9 | (29.0 | ) | |||||||
Interest expense | (101.8 | ) | (86.4 | ) | (76.1 | ) | |||||
Other non-operating income (expense), net | 270.5 | (1.7 | ) | (13.4 | ) | ||||||
Income from continuing operations before income taxes (GAAP) | $ | 581.6 | $ | 115.7 | $ | 314.9 | |||||
(a) | Included within equity in income (loss) of unconsolidated affiliates for fiscal 2017 are charges of $25.2 million, which represent our share of restructuring and other charges incurred by the TruGreen Joint Venture. |
40
U.S. Consumer
U.S. Consumer segment net sales were $2,281.1 million in fiscal 2019, an increase of 8.1% from fiscal 2018 net sales of $2,109.6 million. The increase was driven by the favorable impacts of volume and pricing of 6.3% and 1.8%, respectively. Increased sales volume for fiscal 2019 was driven by increased sales of soils, mulch, grass seed and fertilizer products.
U.S. Consumer Segment Profit was $527.8 million in fiscal 2019, an increase of 6.3% from fiscal 2018 Segment Profit of $496.6 million. The increase for fiscal 2019 was primarily due to higher net sales, partially offset by higher SG&A and lower other income.
U.S. Consumer segment net sales were $2,109.6 million in fiscal 2018, a decrease of 2.4% from fiscal 2017 net sales of $2,160.5 million. The decrease was driven by the unfavorable impacts of volume and pricing of 1.0% and 1.4%, respectively. Decreased sales volume for fiscal 2018 was driven by decreased sales of fertilizer, controls and plant food products, partially offset by increased sales of soils and grass seed products. Decreased pricing for fiscal 2018 was primarily driven by higher customer rebates and sales mix.
U.S. Consumer Segment Profit was $496.6 million in fiscal 2018, a decrease of 4.8% from fiscal 2017 Segment Profit of $521.5 million. The decrease for fiscal 2018 was primarily due to a decrease in net sales, gross profit rate and interest income that was classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations, partially offset by lower SG&A.
Hawthorne
Hawthorne segment net sales were $671.2 million in fiscal 2019, an increase of 94.6% from fiscal 2018 net sales of $344.9 million. The increase was driven by the favorable impacts of acquisitions and volume of 67.1% and 31.7%, respectively, partially offset by the unfavorable impacts of pricing and changes in foreign exchange rates of 2.2% and 2.0%, respectively.
Hawthorne Segment Profit was $53.5 million in fiscal 2019 as compared to fiscal 2018 Segment Loss of $6.1 million. The increase for fiscal 2019 was driven by higher net sales, gross profit rate, cost savings and other synergies as a result of Project Catalyst activities.
Hawthorne segment net sales were $344.9 million in fiscal 2018, an increase of 20.1% from fiscal 2017 net sales of $287.2 million. The increase was driven by the favorable impacts of acquisitions and changes in foreign exchange rates of 47.5% and 1.6%, respectively, partially offset by the unfavorable impact of volume of 28.8%. Decreased sales volume for fiscal 2018 was driven by declines in the North American hydroponic business partially offset by growth in the European professional greenhouse market and AeroGrow.
Hawthorne Segment Loss was $6.1 million in fiscal 2018 as compared to fiscal 2017 Segment Profit of $35.5 million. The decrease for fiscal 2018 was primarily due to a decrease in gross profit rate and higher SG&A, partially offset by increased net sales driven by acquisitions. Segment Loss for fiscal 2018 included increased cost of goods sold related to acquisition date inventory fair value adjustments and increased deal costs related to the acquisition of Sunlight Supply.
Other
Other segment net sales were $203.7 million in fiscal 2019, a decrease of 2.5% from fiscal 2018 net sales of $208.9 million. The decrease was driven by the unfavorable impacts of foreign exchange rates and volume of 2.9% and 1.8%, respectively, partially offset by the favorable impact of pricing of 2.2%. The decrease in sales volume for fiscal 2019 was driven by the closure of our business in Mexico.
Other Segment Profit was $10.3 million in fiscal 2019, a decrease of 8.0% from fiscal 2018 Segment Profit of $11.2 million. The decrease was due to lower net sales and lower other income, partially offset by a higher gross profit rate.
Other segment net sales were $208.9 million in fiscal 2018, an increase of 7.5% from fiscal 2017 net sales of $194.4 million. The increase was driven by the favorable impacts of volume and changes in foreign exchange rates of 5.0% and 2.3%, respectively.
Other Segment Profit was $11.2 million in fiscal 2018, a decrease of 16.4% from fiscal 2017 Segment Profit of $13.4 million. The decrease was due to a decrease in gross profit rate, partially offset by higher net sales and lower SG&A.
Corporate
Corporate expenses were $135.3 million in fiscal 2019, an increase of 12.0% from fiscal 2018 expenses of $120.8 million. The increase was primarily due to higher short-term variable cash incentive compensation expense and a decrease in royalty income earned from Exponent related to its use of our brand names following our divestiture of the International Business due to the adoption of the amended revenue recognition accounting guidance, partially offset by a decrease in expense related to long-term performance-based awards due to a more significant increase in the expected payout percentage during fiscal 2018 as compared to fiscal 2019.
41
Corporate expenses were $120.8 million in fiscal 2018, an increase of 10.2% from fiscal 2017 expenses of $109.6 million. The increase was primarily driven by higher share-based compensation expense due to an increase in the expected payout percentage on long-term performance-based awards, a decrease in royalty income earned from the TruGreen Joint Venture related to its use of our brand names following the divestiture of the SLS Business and interest income that was classified in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations for fiscal 2018, partially offset by lower variable incentive compensation expense and an increase in royalty income earned from Exponent related to its use of our brand names following our divestiture of the International Business.
Liquidity and Capital Resources
The following table summarizes cash activities for the years ended September 30:
2019 | 2018 | 2017 | |||||||||
Net cash provided by operating activities | $ | 226.8 | $ | 342.5 | $ | 363.2 | |||||
Net cash provided by (used in) investing activities | 255.2 | (580.7 | ) | 22.4 | |||||||
Net cash (used in) provided by financing activities | (496.5 | ) | 151.2 | (316.8 | ) | ||||||
Operating Activities
Cash provided by operating activities totaled $226.8 million for fiscal 2019, a decrease of $115.7 million as compared to cash provided by operating activities of $342.5 million for fiscal 2018. This decrease was driven by tax payments made in connection with the sale of our equity interest in the TruGreen Joint Venture of $99.5 million, payments made in connection with litigation settlements of $73.9 million partially offset by insurance reimbursements of $13.4 million, the timing of customer rebate payments, an increase in interest payments and higher SG&A, partially offset by increased net sales, lower short-term variable cash incentive payouts and a distribution of net earnings from the IT&O Joint Venture.
Cash provided by operating activities totaled $342.5 million for fiscal 2018, a decrease of $20.7 million as compared to cash provided by operating activities of $363.2 million for fiscal 2017. This decrease was driven by a decrease in gross profit and an increase in interest paid, partially offset by a decrease in income taxes paid, a decrease in payments related to restructuring activities, lower SG&A, the timing of customer rebate payments and cash used in operating activities associated with the International Business during fiscal 2017.
The seasonal nature of our operations generally requires cash to fund significant increases in inventories during the first half of the fiscal year. Receivables and payables also build substantially in our second quarter of the fiscal year in line with the timing of sales to support our retailers’ spring selling season. These balances liquidate during the June through September period as the lawn and garden season unwinds.
Investing Activities
Cash provided by investing activities totaled $255.2 million for fiscal 2019 as compared to cash used in investing activities of $580.7 million for fiscal 2018. During fiscal 2019, we sold our equity interest in the TruGreen Joint Venture for cash proceeds of $234.2 million related to the sale of the equity interest and $18.4 million related to the payoff of second lien term loan financing, and we sold our equity interest in the IT&O Joint Venture for cash proceeds of $36.6 million. Cash used for investments in property, plant and equipment during fiscal 2019 was $42.4 million. During fiscal 2019, we paid a post-closing net working capital adjustment obligation of $6.6 million related to the fiscal 2018 acquisition of Sunlight Supply and we received cash of $7.0 million associated with currency forward contracts.
Cash used in investing activities totaled $580.7 million for fiscal 2018 as compared to cash provided by investing activities of $22.4 million for fiscal 2017. Cash used for investments in property, plant and equipment during fiscal 2018 was $68.2 million. During fiscal 2018, we completed the acquisitions of Sunlight Supply and Can-Filters which included cash payments of $492.9 million, paid a post-closing working capital adjustment obligation of $35.3 million related to the sale of the International Business and received cash of $13.5 million associated with currency forward contracts.
For the three fiscal years ended September 30, 2019, our capital spending was allocated as follows: 68% for expansion and maintenance of existing productive assets; 9% for new productive assets; 11% to expand our information technology and transformation and integration capabilities; and 12% for corporate assets. We expect fiscal 2020 capital expenditures to be consistent with our recent capital spending amounts and allocations.
42
Financing Activities
Cash used in financing activities totaled $496.5 million in fiscal 2019 as compared to cash provided by financing activities of $151.2 million in fiscal 2018. This change was the result of net repayments under our Fifth A&R Credit Facilities of $389.3 million during fiscal 2019 driven by proceeds from the sale of our equity interests in the TruGreen Joint Venture and the IT&O Joint Venture that were used to reduce our indebtedness and an increase in cash received from the exercise of stock options of $10.9 million, as compared to net borrowings under our Fifth A&R Credit Facilities of $674.1 million during fiscal 2018 driven by the acquisitions of Sunlight Supply and Can-Filters, repurchases of our Common Shares of $327.7 million and a cash outflow of $70.7 million related to the acquisition of the remaining 25% noncontrolling interest in Gavita during fiscal 2018.
Financing activities provided cash of $151.2 million in fiscal 2018, a change of $468.0 million as compared to cash used in financing activities of $316.8 million in fiscal 2017. The change was the result of an increase in net borrowings under our credit facilities of $843.1 million, a decrease in payments on seller notes of $19.8 million and an $8.1 million distribution paid by AeroGrow to its noncontrolling interest holders during fiscal 2017, partially offset by an increase in repurchases of our Common Shares of $72.5 million, the issuance of $250.0 million of 5.250% Senior Notes during fiscal 2017, $70.7 million related to the acquisition of the remaining 25% noncontrolling interest in Gavita and the prospective adoption of a new accounting pronouncement that requires excess tax benefits to be classified as an operating activity.
Cash and Cash Equivalents
Our cash and cash equivalents were held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments having original maturities of three months or less. The cash and cash equivalents balances of $18.8 million and $33.9 million at September 30, 2019 and 2018, respectively, included $7.2 million and $17.7 million, respectively, held by controlled foreign corporations. As of September 30, 2019, we maintain our assertion of indefinite reinvestment of the earnings of all material foreign subsidiaries with the exception of the cumulative earnings of Scotts Luxembourg Sarl, which are generally taxed on a current basis under “Subpart F” of the Code which prevents deferral of recognition of U.S. taxable income through the use of foreign entities.
Borrowing Agreements
Credit Facilities
Our primary sources of liquidity are cash generated by operations and borrowings under our credit facilities, which are guaranteed by substantially all of Scotts Miracle-Gro’s domestic subsidiaries. We maintain a fifth amended and restated credit agreement (the “Fifth A&R Credit Agreement”) that provides senior secured loan facilities in the aggregate principal amount of $2.3 billion, comprised of a revolving credit facility of $1.5 billion and a term loan in the original principal amount of $800.0 million (the “Fifth A&R Credit Facilities”). The Fifth A&R Credit Agreement will terminate on July 5, 2023. The revolving credit facility is available for issuance of letters of credit up to $75.0 million.
At September 30, 2019, we had letters of credit outstanding in the aggregate principal amount of $26.7 million, and $1,326.2 million of borrowing availability under the Fifth A&R Credit Agreement. The weighted average interest rates on average borrowings under the Fifth A&R Credit Agreement and the former credit agreement were 4.6%, 4.0% and 3.9% for fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
The Fifth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding our leverage ratio on the last day of each quarter calculated as average total indebtedness, divided by our earnings before interest, taxes, depreciation and amortization (“EBITDA”), as adjusted pursuant to the terms of the Fifth A&R Credit Agreement (“Adjusted EBITDA”). The maximum leverage ratio is: (i) 5.00 for the third quarter of fiscal 2019 through the first quarter of fiscal 2020; (ii) 4.75 for the second quarter of fiscal 2020 through the fourth quarter of fiscal 2020; and (iii) 4.50 for the first quarter of fiscal 2021 and thereafter. Our leverage ratio was 3.67 at September 30, 2019. The Fifth A&R Credit Agreement also contains an affirmative covenant regarding our interest coverage ratio determined as of the end of each of its fiscal quarters. The interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the Fifth A&R Credit Agreement, and excludes costs related to refinancings. The minimum interest coverage ratio was 3.00 for the twelve months ended September 30, 2019. Our interest coverage ratio was 5.78 for the twelve months ended September 30, 2019. As of September 30, 2019, we were in compliance with these financial covenants.
The Fifth A&R Credit Agreement allows us to make unlimited restricted payments (as defined in the Fifth A&R Credit Agreement), including dividend payments and Common Share repurchases, as long as the leverage ratio resulting from the making of such restricted payments is 4.00 or less. Otherwise, we may make further restricted payments in an aggregate amount for each fiscal year not to exceed the amount set forth in the Fifth A&R Credit Agreement for such fiscal year ($200.0 million for fiscal 2019 and $225.0 million for fiscal 2020 and thereafter). We continue to monitor our compliance with the leverage ratio, interest coverage ratio and other covenants contained in the Fifth A&R Credit Agreement and, based upon our current operating assumptions, we expect to remain in compliance with the permissible leverage ratio and interest coverage ratio throughout fiscal 2020. However,
43
an unanticipated shortfall in earnings, an increase in net indebtedness or other factors could materially affect our ability to remain in compliance with the financial or other covenants of our credit agreement, potentially causing us to have to seek an amendment or waiver from our lending group which could result in repricing of our credit facilities. While we believe we have good relationships with our lending group, we can provide no assurance that such a request would result in a modified or replacement credit agreement on reasonable terms, if at all.
Senior Notes
At September 30, 2019, we had senior notes outstanding of $250.0 million aggregate principal amount of 5.250% Senior Notes due 2026 (the “5.250% Senior Notes”) and $400.0 million aggregate principal amount of 6.000% Senior Notes due 2023 (the “6.000% Senior Notes”). These senior notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. Substantially all of our domestic subsidiaries serve as guarantors of the 5.250% and 6.000% Senior Notes.
On October 22, 2019, we issued $450.0 million aggregate principal amount of 4.500% Senior Notes due 2029. The net proceeds of the offering were used to redeem all of our outstanding 6.000% Senior Notes and for general corporate purposes. The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with our existing and future unsecured senior debt. Substantially all of our domestic subsidiaries serve as guarantors of the 4.500% Senior Notes.
On October 23, 2019, we redeemed all of our outstanding 6.000% Senior Notes for a redemption price of $412.5 million, comprised of $0.5 million of accrued and unpaid interest, $12.0 million of redemption premium, and $400.0 million for outstanding principal amount. The $12.0 million redemption premium will be recognized in our first quarter of fiscal 2020. As of September 30, 2019, we classified the $400.0 million of 6.000% Senior Notes as long-term debt on the Consolidated Balance Sheet. Additionally, we had $3.1 million in unamortized bond issuance costs as of September 30, 2019, which are expected to be written-off in the first quarter of fiscal 2020.
Receivables Facility
We also maintain a master repurchase agreement that allows us to sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers and simultaneously agree to repurchase the receivables on a weekly basis. The eligible accounts receivable consist of accounts receivable generated by sales to three specified customers. The eligible amount of customer accounts receivables which may be sold under the Receivables Facility is $400.0 million and the commitment amount during the seasonal commitment period is $160.0 million. This agreement expires on August 21, 2020.
We account for the sale of receivables under the Receivables Facility as short-term debt and continue to carry the receivables on our Consolidated Balance Sheet, primarily as a result of our requirement to repurchase receivables sold. As of September 30, 2019 and 2018, there were $76.0 million in borrowings on receivables pledged as collateral under the Receivables Facility, and the carrying value of the receivables pledged as collateral was $84.5 million. As of September 30, 2019 and 2018, there was $0.1 million and $0.4 million, respectively, of availability under the Receivables Facility.
Interest Rate Swap Agreements
We enter into interest rate swap agreements with major financial institutions as a means to hedge our variable interest rate risk on our Fifth A&R Credit Agreement. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $850.0 million and $800.0 million at September 30, 2019 and 2018, respectively. Interest payments made between the effective date and expiration date are hedged by the swap agreements, except as noted below. The notional amount, effective date, expiration date and rate of each of these swap agreements outstanding at September 30, 2019 are shown in the table below:
Notional Amount (in millions) | Effective Date (a) | Expiration Date | Fixed Rate | |||||
250 | (b) | 1/8/2018 | 6/8/2020 | 2.09 | % | |||
100 | 6/20/2018 | 10/20/2020 | 2.15 | % | ||||
200 | (b) | 11/7/2018 | 6/7/2021 | 2.87 | % | |||
100 | 11/7/2018 | 7/7/2021 | 2.96 | % | ||||
200 | 11/7/2018 | 10/7/2021 | 2.98 | % | ||||
(a) | The effective date refers to the date on which interest payments were first hedged by the applicable swap agreement. |
(b) | Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time. |
44
We believe that our cash flows from operations and borrowings under our agreements described herein will be sufficient to meet debt service, capital expenditures and working capital needs for the foreseeable future. However, we cannot ensure that our business will generate sufficient cash flow from operations or that future borrowings will be available under our borrowing agreements in amounts sufficient to pay indebtedness or fund other liquidity needs. Actual results of operations will depend on numerous factors, many of which are beyond our control as further discussed in “Item 1A. RISK FACTORS — Our indebtedness could limit our flexibility and adversely affect our financial condition” of this Annual Report on Form 10-K.
Judicial and Administrative Proceedings
We are party to various pending judicial and administrative proceedings arising in the ordinary course of business, including, among others, proceedings based on accidents or product liability claims and alleged violations of environmental laws. We have reviewed these pending judicial and administrative proceedings, including the probable outcomes, reasonably anticipated costs and expenses, and the availability and limits of our insurance coverage, and have established what we believe to be appropriate accruals. We believe that our assessment of contingencies is reasonable and that the related accruals, in the aggregate, are adequate; however, there can be no assurance that future quarterly or annual operating results will not be materially affected by these proceedings, whether as a result of adverse outcomes or as a result of significant defense costs.
Contractual Obligations
The following table summarizes our future cash outflows for contractual obligations as of September 30, 2019:
Payments Due by Period | ||||||||||||||||||||
Contractual Cash Obligations | Total | Less Than 1 Year | 1-3 Years | 3-5 Years | More Than 5 Years | |||||||||||||||
(In millions) | ||||||||||||||||||||
Debt obligations | $ | 1,633.5 | $ | 126.0 | $ | 80.3 | $ | 1,177.2 | $ | 250.0 | ||||||||||
Interest expense on debt obligations | 344.6 | 74.9 | 147.5 | 89.3 | 32.9 | |||||||||||||||
Capital lease obligations | 32.6 | 3.0 | 7.0 | 7.2 | 15.4 | |||||||||||||||
Operating lease obligations | 157.1 | 52.8 | 68.4 | 23.3 | 12.6 | |||||||||||||||
Purchase obligations | 457.7 | 228.7 | 200.0 | 27.0 | 2.0 | |||||||||||||||
Other, primarily retirement plan obligations | 141.9 | 10.5 | 25.6 | 26.4 | 79.4 | |||||||||||||||
Total contractual cash obligations | $ | 2,767.4 | $ | 495.9 | $ | 528.8 | $ | 1,350.4 | $ | 392.3 | ||||||||||
We had long-term debt obligations and interest payments due primarily under the 5.250% Senior Notes, 6.000% Senior Notes and our credit facilities. Amounts in the table represent scheduled future maturities of long-term debt principal for the periods indicated. The impacts of the issuance of the 4.500% Senior Notes and the redemption of the 6.000% Senior Notes are not reflected in the table as these events took place subsequent to September 30, 2019.
The interest payments for our credit facilities are based on outstanding borrowings as of September 30, 2019. Actual interest expense will likely be higher due to the seasonality of our business and associated higher average borrowings.
Purchase obligations primarily represent commitments for materials used in our manufacturing processes, including urea and packaging, as well as commitments for warehouse services, grass seed and out-sourced information services which comprise the unconditional purchase obligations disclosed in “NOTE 19. COMMITMENTS” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K.
Other obligations include actuarially determined retiree benefit payments and pension funding to comply with local funding requirements. Pension funding requirements beyond fiscal 2019 are based on preliminary estimates using actuarial assumptions determined as of September 30, 2019. The above table excludes liabilities for unrecognized tax benefits and insurance accruals as we are unable to estimate the timing of payments for these items.
Off-Balance Sheet Arrangements
At September 30, 2019, we have letters of credit in the aggregate face amount of $26.7 million outstanding.
45
Regulatory Matters
We are subject to local, state, federal and foreign environmental protection laws and regulations with respect to our business operations and believe we are operating in substantial compliance with, or taking actions aimed at ensuring compliance with, such laws and regulations. We are involved in several legal actions with various governmental agencies related to environmental matters. While it is difficult to quantify the potential financial impact of actions involving these environmental matters, particularly remediation costs at waste disposal sites and future capital expenditures for environmental control equipment, in the opinion of management, the ultimate liability arising from such environmental matters, taking into account established accruals, should not have a material effect on our financial condition, results of operations or cash flows. However, there can be no assurance that the resolution of these matters will not materially affect our future quarterly or annual results of operations, financial condition or cash flows. Additional information on environmental matters affecting us is provided in “ITEM 1. BUSINESS — Regulatory Considerations” and “ITEM 3. LEGAL PROCEEDINGS” of this Annual Report on Form 10-K.
Critical Accounting Policies and Estimates
The preparation of financial statements requires management to use judgment and make estimates that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to customer programs and incentives, product returns, bad debts, inventories, intangible assets, income taxes, restructuring, environmental matters, contingencies and litigation. By their nature, these judgments are subject to uncertainty. We base our estimates on historical experience and on various other sources that we believe to be reasonable under the circumstances.
Certain accounting policies are particularly significant, including those related to revenue recognition, income taxes, inventories, goodwill and intangibles, certain associate benefits and contingencies. Our critical accounting policies are reviewed periodically with the Audit Committee of the Board of Directors of Scotts Miracle-Gro.
Revenue Recognition and Promotional Allowances
Our revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products. Product sales are recognized at a point in time when control of products transfers to customers and we have no further obligation to provide services related to such products. Sales are typically recognized when products are delivered to or picked up by the customer. We are generally the principal in a transaction, therefore revenue is primarily recorded on a gross basis. Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that we expect to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns.
Our promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotion costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. We exclude from revenue any amounts collected from customers for sales or other taxes.
Income Taxes
Our annual effective tax rate is established based on our pre-tax income (loss), statutory tax rates and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. We record income tax liabilities utilizing known obligations and estimates of potential obligations. A deferred tax asset or liability is recognized whenever there are future tax effects from existing temporary differences and operating loss and tax credit carryforwards. Valuation allowances are used to reduce deferred tax assets to the balances that are more likely than not to be realized. We must make estimates and judgments on future taxable income, considering feasible tax planning strategies and taking into account existing facts and circumstances, to determine the proper valuation allowances. When we determine that deferred tax assets could be realized in greater or lesser amounts than recorded, the asset balance and Consolidated Statements of Operations reflect the change in the period such determination is made. Due to changes in facts and circumstances and the estimates and judgments that are involved in determining the proper valuation allowances, differences between actual future events and prior estimates and judgments could result in adjustments to these valuation allowances. We use an estimate of our annual effective tax rate at each interim period based on the facts and circumstances available at that time, while the actual effective tax rate is calculated at year-end.
46
Inventories
Inventories are stated at the lower of cost or net realizable value, principally determined by the first in, first out method of accounting. Inventories acquired through the acquisition of or subsequently produced by Sunlight Supply, which represent approximately 22% of our consolidated inventories, were initially recorded at fair value at the date of the acquisition and subsequently were measured using the average costing method of inventory valuation. Inventories include the cost of raw materials, labor, manufacturing overhead and freight and in-bound handling costs incurred to pre-position goods in our warehouse network. We make provisions for obsolete or slow-moving inventories as necessary to properly reflect inventory at the lower of cost or net realizable value. Adjustments to net realizable value for excess and obsolete inventory are based on a variety of factors, including product changes and improvements, changes in active ingredient availability and regulatory acceptance, new product introductions and estimated future demand. The adequacy of our adjustments could be materially affected by changes in the demand for our products or regulatory actions. During fiscal 2018, we determined it was preferable to use the first in, first out inventory valuation method and adopted this method for the remaining U.S. Consumer segment inventories not subject to the first in, first out method. The impact on inventory value and cost of goods sold was immaterial.
Goodwill and Indefinite-lived Intangible Assets
We have significant investments in intangible assets and goodwill. Our annual goodwill and indefinite-lived intangible asset testing is performed as of the first day of our fiscal fourth quarter or more frequently if circumstances indicate potential impairment. In our evaluation of goodwill and indefinite-lived intangible assets impairment, we perform either an initial qualitative or quantitative evaluation for each of our reporting units and indefinite-lived intangible assets. Factors considered in the qualitative test include operating results as well as new events and circumstances impacting the operations or cash flows of the reporting unit and indefinite-lived intangible assets. For the quantitative test, the review for impairment of goodwill and indefinite-lived intangible assets is based on a combination of income-based and market-based approaches. If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value.
Under the income-based approach, we determine fair value using a discounted cash flow approach that requires significant judgment with respect to revenue and expense growth rates, based upon annual budgets and longer-range strategic plans, and the selection of an appropriate discount rate. These budgets and plans are used for internal purposes and are also the basis for communication with outside parties about future business trends. Under the market-based approach, we determine fair value by comparing our reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. We also use the guideline transaction method to determine fair value based on pricing multiples derived from the sale of companies that are similar to our reporting units.
Fair value estimates employed in our annual impairment review of indefinite-lived intangible assets and goodwill were determined using models involving several assumptions. Changes in our assumptions could materially impact our fair value estimates. Assumptions critical to our fair value estimates were: (i) discount rates used in determining the fair value of the reporting units and intangible assets; (ii) royalty rates used in our intangible asset valuations; (iii) projected future revenues and expenses used in the reporting unit and intangible asset models; and (iv) projected long-term growth rates used in the derivation of terminal year values. These and other assumptions are impacted by economic conditions and expectations of management and may change in the future based on period specific facts and circumstances. While we believe the assumptions we used to estimate future cash flows are reasonable, there can be no assurance that the expected future cash flows will be realized. As a result, impairment charges that possibly would have been recognized in earlier periods may not be recognized until later periods if actual results deviate unfavorably from earlier estimates. The use of different assumptions would increase or decrease discounted cash flows or earnings projections and, therefore, could change impairment determinations.
At September 30, 2019, goodwill totaled $538.7 million, with $228.1 million, $300.0 million and $10.6 million of goodwill for our U.S. Consumer, Hawthorne and Other segments, respectively. We performed annual impairment testing as of the first day of our fourth fiscal quarter in fiscal 2019, 2018 and 2017 and, with the exception of our Hawthorne reporting unit in fiscal 2018, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. Based on the results of the annual quantitative evaluation for fiscal 2019, the fair values of our U.S. Consumer, Hawthorne and Other segment reporting units exceeded their respective carrying values by 260%, 5% and 9%, respectively. A 100 basis point change in the discount rate would not have resulted in an impairment for our U.S. Consumer and Other segment reporting units, and would have resulted in a goodwill impairment charge of $11.7 million for our Hawthorne reporting unit. As discussed further in “NOTE 5. GOODWILL AND INTANGIBLE ASSETS, NET,” during the fourth quarter of fiscal 2018 we recognized a non-cash goodwill impairment charge of $94.6 million related to our Hawthorne reporting unit in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations.
47
At September 30, 2019, indefinite-lived intangible assets consisted of tradenames of $168.2 million and the Marketing Agreement Amendment of $155.7 million. Based on the results of the annual evaluation for fiscal 2019, the fair values of our indefinite-lived intangible assets exceeded their respective carrying values in a range of 17% to over 900%. All of our indefinite-lived intangible assets had an estimated fair value substantially in excess of carrying value as of the annual test date. A 100 basis point change in the discount rate would not have resulted in an impairment of any of our indefinite-lived intangible assets.
Associate Benefits
We sponsor various post-employment benefit plans, including pension plans, both defined contribution plans and defined benefit plans, and other post-employment benefit (“OPEB”) plans, consisting primarily of health care for retirees. For accounting purposes, the defined benefit pension and OPEB plans are dependent on a variety of assumptions to estimate the projected and accumulated benefit obligations and annual expense determined by actuarial valuations. These assumptions include the following: discount rate; expected salary increases; certain employee-related factors, such as turnover, retirement age and mortality; expected return on plan assets; and health care cost trend rates.
Assumptions are reviewed annually for appropriateness and updated as necessary. We base the discount rate assumption on investment yields available at fiscal year-end on high-quality corporate bonds that could be purchased to effectively settle the pension liabilities. The salary growth assumption reflects our long-term actual experience, the near-term outlook and assumed inflation. The expected return on plan assets assumption reflects asset allocation, investment strategy and the views of investment managers regarding the market. Retirement and mortality rates are based primarily on actual and expected plan experience. The effects of actual results that differ from our assumptions are accumulated and amortized over future periods.
Changes in the discount rate and investment returns can have a significant effect on the funded status of our pension plans and shareholders’ equity. We cannot predict discount rates or investment returns with certainty and, therefore, cannot determine whether adjustments to our shareholders’ equity for pension-related activity in subsequent years will be significant. We also cannot predict future investment returns, and therefore cannot determine whether future pension plan funding requirements could materially affect our financial condition, results of operations or cash flows. A 100 basis point change in the discount rate would have an immaterial effect on fiscal 2020 pension expense. A 100 basis point change in the discount rate would have a $34.5 million change in our projected benefit obligations as of September 30, 2019.
Contingencies
As described more fully in “NOTE 20. CONTINGENCIES” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K, we are involved in environmental and legal proceedings which have a high degree of uncertainty associated with them. We continually assess the likely outcome of these proceedings and the adequacy of accruals, if any, provided for their resolution. There can be no assurance that the ultimate outcomes of these proceedings will not differ materially from our current assessment of them, nor that all proceedings that may currently be brought against us are known by us at this time.
Other Significant Accounting Policies
Other significant accounting policies, primarily those with lower levels of uncertainty than those discussed above, are also critical to understanding the consolidated financial statements. The Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K contain additional information related to our accounting policies, including recent accounting pronouncements, and should be read in conjunction with this discussion.
48
ITEM 7A. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
As part of our ongoing business, we are exposed to certain market risks, including fluctuations in interest rates, foreign currency exchange rates and commodity prices. Financial derivatives and other instruments are used to manage these risks. These instruments are not used for speculative purposes.
Interest Rate Risk
The following table summarizes information about our debt instruments and derivative financial instruments that are sensitive to changes in interest rates as of September 30, 2019 and 2018. For debt instruments, the table presents principal cash flows and related weighted-average interest rates by expected maturity dates. For interest rate swap agreements, the table presents expected cash flows based on notional amounts and weighted-average interest rates by contractual maturity dates. We have outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $850.0 million and $800.0 million at September 30, 2019 and 2018, respectively. Weighted-average variable rates are based on rates in effect at September 30, 2019 and 2018. A change in our variable interest rate of 100 basis points for a full twelve-month period would have a $2.5 million impact on interest expense assuming approximately $250 million of our average fiscal 2019 variable-rate debt had not been hedged via an interest rate swap agreement.
Expected Maturity Date (in millions) | Total | Fair Value | ||||||||||||||||||||||||||||||
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | After | ||||||||||||||||||||||||||
Long-term debt: | ||||||||||||||||||||||||||||||||
Fixed rate debt | $ | — | $ | — | $ | — | $ | — | $ | 400.0 | $ | 250.0 | $ | 650.0 | $ | 675.9 | ||||||||||||||||
Average rate | — | — | — | — | 6.0 | % | 5.3 | % | 5.7 | % | — | |||||||||||||||||||||
Variable rate debt | $ | 116.0 | $ | 40.0 | $ | 40.0 | $ | 777.2 | $ | — | $ | — | $ | 973.2 | $ | 973.2 | ||||||||||||||||
Average rate | 3.1 | % | 3.8 | % | 3.8 | % | 3.7 | % | — | — | 3.6 | % | — | |||||||||||||||||||
Interest rate derivatives: | ||||||||||||||||||||||||||||||||
Interest rate swaps | $ | (0.4 | ) | $ | (4.3 | ) | $ | (6.1 | ) | $ | — | $ | — | $ | — | $ | (10.8 | ) | $ | (10.8 | ) | |||||||||||
Average rate | 2.1 | % | 2.7 | % | 3.0 | % | — | — | — | 2.8 | % | — | ||||||||||||||||||||
Expected Maturity Date (in millions) | Total | Fair Value | ||||||||||||||||||||||||||||||
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | After | ||||||||||||||||||||||||||
Long-term debt: | ||||||||||||||||||||||||||||||||
Fixed rate debt | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 650.0 | $ | 650.0 | $ | 650.4 | ||||||||||||||||
Average rate | — | — | — | — | — | 5.7 | % | 5.7 | % | — | ||||||||||||||||||||||
Variable rate debt | $ | 116.0 | $ | 40.0 | $ | 40.0 | $ | 40.0 | $ | 1,122.2 | $ | — | $ | 1,358.2 | $ | 1,358.2 | ||||||||||||||||
Average rate | 3.4 | % | 4.0 | % | 4.0 | % | 4.0 | % | 3.8 | % | — | 3.8 | % | — | ||||||||||||||||||
Interest rate derivatives: | ||||||||||||||||||||||||||||||||
Interest rate swaps | $ | 2.9 | $ | 0.9 | $ | — | $ | — | $ | — | $ | — | $ | 3.8 | $ | 3.8 | ||||||||||||||||
Average rate | 2.1 | % | 2.1 | % | — | — | — | — | 2.1 | % | — | |||||||||||||||||||||
Excluded from the information provided above are miscellaneous debt instruments of $10.3 million and $16.9 million and capital lease obligations of $25.8 million and $0.6 million at September 30, 2019 and 2018, respectively. Additionally, the impacts of the issuance of the 4.500% Senior Notes and the redemption of the 6.000% Senior Notes are not reflected in the table as these events took place subsequent to September 30, 2019.
Other Market Risks
We are subject to market risk from fluctuations in foreign currency exchange rates and fluctuating prices of certain raw materials, including urea and other fertilizer inputs, resins, diesel, gasoline, natural gas, sphagnum peat, bark and grass seed. Refer to “NOTE 16. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES” of the Notes to Consolidated Financial Statements included in this Annual Report on Form 10-K for discussion of these market risks and the derivatives used to manage these risks.
49
ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
The financial statements and other information required by this Item are contained in the Consolidated Financial Statements, Notes to Consolidated Financial Statements and Schedules Supporting the Consolidated Financial Statements listed in the “Index to Consolidated Financial Statements and Financial Statement Schedules” on page 57 of this Annual Report on Form 10-K.
ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE |
None.
ITEM 9A. | CONTROLS AND PROCEDURES |
Evaluation of Disclosure Controls and Procedures
With the participation of the principal executive officer and the principal financial officer of The Scotts Miracle-Gro Company (the “Registrant”), the Registrant’s management has evaluated the effectiveness of the Registrant’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934), as of the end of the fiscal year covered by this Annual Report on Form 10-K. Based upon that evaluation, the Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures were effective as of the end of the fiscal year covered by this Annual Report on Form 10-K.
Management’s Annual Report on Internal Control Over Financial Reporting
The “Annual Report of Management on Internal Control Over Financial Reporting” required by Item 308(a) of SEC Regulation S-K is included on page 58 of this Annual Report on Form 10-K.
Attestation Report of Independent Registered Public Accounting Firm
The “Report of Independent Registered Public Accounting Firm” required by Item 308(b) of SEC Regulation S-K is included on page 59 of this Annual Report on Form 10-K.
Changes in Internal Control Over Financial Reporting
No changes in the Registrant’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) occurred during the Registrant’s fiscal quarter ended September 30, 2019, that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.
ITEM 9B. | OTHER INFORMATION |
None.
50
PART III
ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE |
Directors, Executive Officers and Persons Nominated or Chosen to Become Directors or Executive Officers
The information required by Item 401 of SEC Regulation S-K concerning the directors of Scotts Miracle-Gro and the nominees for election or re-election as directors of Scotts Miracle-Gro at the Annual Meeting of Shareholders to be held on January 27, 2020 (the “2020 Annual Meeting”) is incorporated herein by reference from the disclosure which will be included under the caption “PROPOSAL NUMBER 1 — ELECTION OF DIRECTORS” in Scotts Miracle-Gro’s definitive Proxy Statement relating to the 2020 Annual Meeting (“Scotts Miracle-Gro’s Definitive Proxy Statement”), which will be filed pursuant to SEC Regulation 14A not later than 120 days after the end of Scotts Miracle-Gro’s fiscal year ended September 30, 2019.
The information required by Item 401 of SEC Regulation S-K concerning the executive officers of Scotts Miracle-Gro is incorporated herein by reference from the disclosure included under the caption “SUPPLEMENTAL ITEM. EXECUTIVE OFFICERS OF THE REGISTRANT” in Part I of this Annual Report on Form 10-K.
Compliance with Section 16(a) of the Securities Exchange Act of 1934
The information required by Item 405 of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE” in Scotts Miracle-Gro’s Definitive Proxy Statement.
Procedures for Recommending Director Nominees
Information concerning the procedures by which shareholders of Scotts Miracle-Gro may recommend nominees to Scotts Miracle-Gro’s Board of Directors is incorporated herein by reference from the disclosures which will be included under the captions “CORPORATE GOVERNANCE — Nominations of Directors” and “MEETINGS AND COMMITTEES OF THE BOARD — Committees of the Board — Nominating and Governance Committee” in Scotts Miracle-Gro’s Definitive Proxy Statement. These procedures have not materially changed from those described in Scotts Miracle-Gro’s definitive Proxy Statement for the 2019 Annual Meeting of Shareholders held on January 25, 2019.
Audit Committee
The information required by Items 407(d)(4) and 407(d)(5) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “MEETINGS AND COMMITTEES OF THE BOARD — Committees of the Board” in Scotts Miracle-Gro’s Definitive Proxy Statement.
Committee Charters; Code of Business Conduct & Ethics; Corporate Governance Guidelines
The Board of Directors of Scotts Miracle-Gro has adopted charters for each of the Audit Committee, the Nominating and Governance Committee, the Compensation and Organization Committee, the Innovation and Technology Committee and the Finance Committee, as well as Corporate Governance Guidelines, as contemplated by the applicable sections of the New York Stock Exchange Listed Company Manual.
In accordance with the requirements of Section 303A.10 of the New York Stock Exchange Listed Company Manual and Item 406 of SEC Regulation S-K, the Board of Directors of Scotts Miracle-Gro has adopted a Code of Business Conduct & Ethics covering the members of Scotts Miracle-Gro’s Board of Directors and associates (employees) of Scotts Miracle-Gro and its subsidiaries, including, without limitation, Scotts Miracle-Gro’s principal executive officer, principal financial officer and principal accounting officer. Scotts Miracle-Gro intends to disclose the following events, if they occur, on its Internet website located at http://investor.scotts.com within four business days following their occurrence: (A) the date and nature of any amendment to a provision of Scotts Miracle-Gro’s Code of Business Conduct & Ethics that (i) applies to Scotts Miracle-Gro’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, (ii) relates to any element of the code of ethics definition enumerated in Item 406(b) of SEC Regulation S-K, and (iii) is not a technical, administrative or other non-substantive amendment; and (B) a description of any waiver (including the nature of the waiver, the name of the person to whom the waiver was granted and the date of the waiver), including an implicit waiver, from a provision of the Code of Business Conduct & Ethics granted to Scotts Miracle-Gro’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, that relates to one or more of the elements of the code of ethics definition enumerated in Item 406(b) of SEC Regulation S-K. In addition, Scotts Miracle-Gro will disclose any waivers from the provisions of the Code of Business Conduct & Ethics granted to an executive officer or a director of Scotts
51
Miracle-Gro on Scotts Miracle-Gro’s Internet website located at http://investor.scotts.com within four business days of the determination to grant any such waiver.
The text of Scotts Miracle-Gro’s Code of Business Conduct & Ethics, Scotts Miracle-Gro’s Corporate Governance Guidelines, the Audit Committee charter, the Nominating and Governance Committee charter, the Compensation and Organization Committee charter, the Innovation and Technology Committee charter and the Finance Committee charter are posted under the “Corporate Governance” link on Scotts Miracle-Gro’s Internet website located at http://investor.scotts.com. Interested persons and shareholders of Scotts Miracle-Gro may also obtain copies of each of these documents without charge by writing to The Scotts Miracle-Gro Company, Attention: Corporate Secretary, 14111 Scottslawn Road, Marysville, Ohio 43041.
ITEM 11. | EXECUTIVE COMPENSATION |
The information required by Item 402 of SEC Regulation S-K is incorporated herein by reference from the disclosures which will be included under the captions “EXECUTIVE COMPENSATION,” “NON-EMPLOYEE DIRECTOR COMPENSATION,” “EXECUTIVE COMPENSATION TABLES,” “SEVERANCE AND CHANGE IN CONTROL (CIC) ARRANGEMENTS,” and “PAYMENTS ON TERMINATION OF EMPLOYMENT AND/OR CHANGE IN CONTROL” in Scotts Miracle-Gro’s Definitive Proxy Statement.
The information required by Item 407(e)(4) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “MEETINGS AND COMMITTEES OF THE BOARD — Compensation and Organization Committee Interlocks and Insider Participation” in Scotts Miracle-Gro’s Definitive Proxy Statement.
The information required by Item 407(e)(5) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “COMPENSATION COMMITTEE REPORT” in Scotts Miracle-Gro’s Definitive Proxy Statement.
ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS |
Ownership of Common Shares of Scotts Miracle-Gro
The information required by Item 403 of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT” in Scotts Miracle-Gro’s Definitive Proxy Statement.
Equity Compensation Plan Information
The information required by Item 201(d) of SEC Regulation S-K is incorporated herein by reference from the disclosure which will be included under the caption “EQUITY COMPENSATION PLAN INFORMATION” in Scotts Miracle-Gro’s Definitive Proxy Statement.
52
ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE |
Certain Relationships and Related Person Transactions
The information required by Item 404 of SEC Regulation S-K is incorporated herein by reference from the disclosures which will be included under the caption “CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS” in Scotts Miracle-Gro’s Definitive Proxy Statement.
Director Independence
The information required by Item 407(a) of SEC Regulation S-K is incorporated herein by reference from the disclosures which will be included under the captions “CORPORATE GOVERNANCE — Director Independence” and “MEETINGS AND COMMITTEES OF THE BOARD” in Scotts Miracle-Gro’s Definitive Proxy Statement.
ITEM 14. | PRINCIPAL ACCOUNTING FEES AND SERVICES |
The information required by this Item 14 is incorporated herein by reference from the disclosures which will be included under the captions “AUDIT COMMITTEE MATTERS — Fees of the Independent Registered Public Accounting Firm” and “AUDIT COMMITTEE MATTERS — Pre-Approval of Services Performed by the Independent Registered Public Accounting Firm” in Scotts Miracle-Gro’s Definitive Proxy Statement.
53
PART IV
ITEM 15. | EXHIBITS, FINANCIAL STATEMENT SCHEDULES |
(a) LIST OF DOCUMENTS FILED AS PART OF THIS REPORT
1 and 2. Financial Statements and Financial Statement Schedules:
The response to this portion of Item 15 is submitted as a separate section of this Annual Report on Form 10-K. Reference is made to the “Index to Consolidated Financial Statements and Financial Statement Schedules” on page 57 of this Annual Report on Form 10-K.
(b) EXHIBITS
The exhibits listed on the “Index to Exhibits” beginning on page 125 of this Annual Report on Form 10-K are filed or furnished with this Annual Report on Form 10-K or incorporated herein by reference as noted in the “Index to Exhibits.”
(c) FINANCIAL STATEMENT SCHEDULES
The financial statement schedule filed with this Annual Report on Form 10-K is submitted in a separate section hereof. For a description of such financial statement schedules, see “Index to Consolidated Financial Statements and Financial Statement Schedules” on page 57 of this Annual Report on Form 10-K.
ITEM 16. | FORM 10-K SUMMARY |
None.
54
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
THE SCOTTS MIRACLE-GRO COMPANY | |||
By: | /s/ JAMES HAGEDORN | ||
James Hagedorn, Chief Executive Officer and Chairman of the Board | |||
Dated: November 27, 2019
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature | Title | Date | ||
/s/ THOMAS RANDAL COLEMAN | Chief Financial Officer and Executive Vice President | November 27, 2019 | ||
Thomas Randal Coleman | (Principal Financial Officer and Principal Accounting Officer) | |||
/s/ JAMES HAGEDORN | Chief Executive Officer, Chairman of the Board and Director | November 27, 2019 | ||
James Hagedorn | (Principal Executive Officer) | |||
/s/ DAVID C. EVANS* | Director | November 27, 2019 | ||
David C. Evans | ||||
/s/ BRIAN D. FINN* | Director | November 27, 2019 | ||
Brian D. Finn | ||||
/s/ ADAM HANFT* | Director | November 27, 2019 | ||
Adam Hanft | ||||
/s/ STEPHEN L. JOHNSON* | Director | November 27, 2019 | ||
Stephen L. Johnson | ||||
/s/ THOMAS N. KELLY JR.* | Director | November 27, 2019 | ||
Thomas N. Kelly Jr. | ||||
/s/ KATHERINE HAGEDORN LITTLEFIELD* | Director | November 27, 2019 | ||
Katherine Hagedorn Littlefield | ||||
55
Signature | Title | Date | ||
/s/ NANCY G. MISTRETTA* | Director | November 27, 2019 | ||
Nancy G. Mistretta | ||||
/s/ PETER E. SHUMLIN* | Director | November 27, 2019 | ||
Peter E. Shumlin | ||||
/s/ JOHN R. VINES* | Director | November 27, 2019 | ||
John R. Vines | ||||
* | The undersigned, by signing his name hereto, does hereby sign this Report on behalf of each of the directors of the Registrant identified above pursuant to Powers of Attorney executed by the directors identified above, which Powers of Attorney are filed with this Report as exhibits. |
By: | /s/ THOMAS RANDAL COLEMAN | |
Thomas Randal Coleman, Attorney-in-Fact | ||
56
THE SCOTTS MIRACLE-GRO COMPANY
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
AND FINANCIAL STATEMENT SCHEDULES
Page | |
Consolidated Financial Statements of The Scotts Miracle-Gro Company and Subsidiaries: | |
Schedules Supporting the Consolidated Financial Statements: | |
All other financial statement schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are omitted because they are not required or are not applicable, or the required information has been presented in the Consolidated Financial Statements or Notes thereto.
57
ANNUAL REPORT OF MANAGEMENT ON INTERNAL
CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of The Scotts Miracle-Gro Company and our consolidated subsidiaries; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of The Scotts Miracle-Gro Company and our consolidated subsidiaries are being made only in accordance with authorizations of management and directors of The Scotts Miracle-Gro Company and our consolidated subsidiaries, as appropriate; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the assets of The Scotts Miracle-Gro Company and our consolidated subsidiaries that could have a material effect on our consolidated financial statements.
Management, with the participation of our principal executive officer and principal financial officer, assessed the effectiveness of our internal control over financial reporting as of September 30, 2019, the end of our fiscal year. Management based its assessment on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Management’s assessment included evaluation of such elements as the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies and our overall control environment. This assessment is supported by testing and monitoring performed under the direction of management.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluations of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Accordingly, even an effective system of internal control over financial reporting will provide only reasonable assurance with respect to financial statement preparation.
Based on our assessment, management has concluded that our internal control over financial reporting was effective as of September 30, 2019, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with accounting principles generally accepted in the United States of America. We reviewed the results of management’s assessment with the Audit Committee of the Board of Directors of The Scotts Miracle-Gro Company.
Our independent registered public accounting firm, Deloitte & Touche LLP, independently audited our internal control over financial reporting as of September 30, 2019 and has issued their attestation report which appears herein.
/s/ JAMES HAGEDORN | /s/ THOMAS RANDAL COLEMAN | |||
James Hagedorn | Thomas Randal Coleman | |||
Chief Executive Officer and Chairman of the Board | Executive Vice President and Chief Financial Officer | |||
Dated: | November 27, 2019 | Dated: | November 27, 2019 | |
58
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of
The Scotts Miracle-Gro Company
Marysville, Ohio
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of The Scotts Miracle-Gro Company and subsidiaries (the “Company”) as of September 30, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), shareholders’ equity, and cash flows, for each of the three years in the period ended September 30, 2019, and the related notes and the schedules (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of September 30, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2019, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of September 30, 2019, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated November 27, 2019, expressed an unqualified opinion on the Company’s internal control over financial reporting.
Changes in Accounting Principle
As discussed in Note 1 to the financial statements, on June 30, 2018, the Company prospectively adopted the new accounting guidance in ASU 2017-04 Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.
As discussed in Note 1 to the financial statements, on October 1, 2018, the Company adopted the new accounting guidance in ASU 2014-09 Revenue from Contracts with Customers (Topic 606) under the modified retrospective approach.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
59
Goodwill — Hawthorne Reporting Unit — Refer to Notes 1 and 5 to the financial statements.
Critical Audit Matter Description
When evaluating goodwill for impairment, the Company performs either an initial qualitative or quantitative evaluation for each of their reporting units. For the quantitative evaluation, the Company compares fair value of each reporting unit to its carrying value. The Company determines the fair value of its reporting units using a combination of income-based and market-based approaches and incorporates assumptions it believes market participants would utilize. Under the income-based approach, the Company determines fair value using a discounted cash flow approach that requires significant judgment with respect to revenue and expense growth rates based upon annual budgets and longer-range strategic plans and the selection of an appropriate discount rate. Under the market-based approach, the Company determines fair value by comparing its reporting units to similar businesses or guideline companies whose securities are actively traded in public markets. The use of different assumptions would increase or decrease discounted cash flows or earnings projections and could, therefore, change impairment determinations. The goodwill balance was $538.7 million as of September 30, 2019, of which $300 million was allocated to the Hawthorne reporting unit. The fair value of the Hawthorne reporting unit exceeded its carrying value as of the measurement date and, therefore, no impairment was recognized. Hawthorne’s operations are sensitive to changes in the U.S. retail hydroponic market as the demand for its products depends on the uncertain growth of the market.
Given the significant estimates and assumptions management makes to estimate the fair value of Hawthorne and the sensitivity of Hawthorne’s operations to changes in the U.S. retail hydroponic market, performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions with respect to revenue and expense growth rates, the selection of an appropriate discount rate, and pricing multiples for Hawthorne required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures with respect to revenue and expense growth rates, the selection of an appropriate discount rate, and pricing multiples for Hawthorne included the following, among others:
• | We tested the effectiveness of controls over management’s goodwill impairment evaluation, including those over the determination of the fair value of Hawthorne, such as controls related to revenue and expense growth rates, the selection of an appropriate discount rate and pricing multiples. |
• | We evaluated management’s ability to accurately forecast revenue and expense growth rates by comparing actual results to management’s historical forecasts. |
• | Due to the uncertain growth in the U.S. retail hydroponic market, we evaluated the reasonableness of management’s forecasts of revenue and expense growth rates by comparing the forecasts to (1) the historical results of Hawthorne, (2) internal communications to management and the board of directors, (3) external communications made by management to analysts and investors, and (4) industry reports containing analyses of the Company’s markets. |
• | We considered the impact of changes in the regulatory environment on management’s forecasts of revenue and expense growth rates. |
• | With the assistance of our fair value specialists, we evaluated the reasonableness of the discount rate, including testing the source information underlying the determination of the discount rate, testing the mathematical accuracy of the calculation, and developing a range of independent estimates and comparing those to the discount rate selected by management. |
• | With the assistance of our fair value specialists, we evaluated the reasonableness of the pricing multiples, including testing the source information underlying the determination of the pricing multiples, testing the mathematical accuracy of the calculation, and comparing the multiples selected by management to its guideline companies. |
/s/ DELOITTE & TOUCHE LLP | |
Columbus, Ohio | |
November 27, 2019 | |
We have served as the Company’s auditor since 2005. | |
60
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of
The Scotts Miracle-Gro Company
Marysville, Ohio
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of The Scotts Miracle-Gro Company and subsidiaries (the “Company”) as of September 30, 2019, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2019, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended September 30, 2019, of the Company and our report dated November 27, 2019, expressed an unqualified opinion on those financial statements and included an explanatory paragraph regarding the Company’s adoption of the new accounting guidance in ASU 2017-04 Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment and ASU 2014-09 Revenue from Contracts with Customers (Topic 606).
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Annual Report of Management on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ DELOITTE & TOUCHE LLP | |
Columbus, Ohio | |
November 27, 2019 | |
61
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Operations
(In millions, except per share data)
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
Net sales | $ | $ | $ | ||||||||
Cost of sales | |||||||||||
Cost of sales—impairment, restructuring and other | |||||||||||
Gross profit | |||||||||||
Operating expenses: | |||||||||||
Selling, general and administrative | |||||||||||
Impairment, restructuring and other | |||||||||||
Other (income) expense, net | ( | ) | ( | ) | |||||||
Income from operations | |||||||||||
Equity in (income) loss of unconsolidated affiliates | ( | ) | ( | ) | |||||||
Interest expense | |||||||||||
Other non-operating (income) expense, net | ( | ) | |||||||||
Income from continuing operations before income taxes | |||||||||||
Income tax expense (benefit) from continuing operations | ( | ) | |||||||||
Income from continuing operations | |||||||||||
Income (loss) from discontinued operations, net of tax | ( | ) | |||||||||
Net income | $ | $ | $ | ||||||||
Net (income) loss attributable to noncontrolling interest | ( | ) | |||||||||
Net income attributable to controlling interest | $ | $ | $ | ||||||||
Basic income (loss) per common share: | |||||||||||
Income from continuing operations | $ | $ | $ | ||||||||
Income (loss) from discontinued operations | ( | ) | |||||||||
Basic net income per common share | $ | $ | $ | ||||||||
Diluted income (loss) per common share: | |||||||||||
Income from continuing operations | $ | $ | $ | ||||||||
Income (loss) from discontinued operations | ( | ) | |||||||||
Diluted net income per common share | $ | $ | $ | ||||||||
See Notes to Consolidated Financial Statements.
62
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Comprehensive Income (Loss)
(In millions)
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
Net income | $ | $ | $ | ||||||||
Other comprehensive income (loss): | |||||||||||
Net foreign currency translation adjustment, including reclassifications to net income of $2.5, $11.7 and $18.5 for fiscal 2019, fiscal 2018 and fiscal 2017, respectively | ( | ) | |||||||||
Net unrealized gain (loss) on derivative instruments, net of tax of $(5.2), $3.3 and $3.1 for fiscal 2019, fiscal 2018 and fiscal 2017, respectively | ( | ) | |||||||||
Reclassification of net unrealized (gains) losses on derivative instruments to net income, net of tax of $(0.5), $(1.1) and $1.1 for fiscal 2019, fiscal 2018 and fiscal 2017, respectively | ( | ) | ( | ) | |||||||
Net unrealized gain (loss) in pension and other post-retirement benefits, net of tax of $(3.9), $2.4 and $6.0 for fiscal 2019, fiscal 2018 and fiscal 2017, respectively | ( | ) | |||||||||
Reclassification of net pension and other post-retirement benefit losses to net income, net of tax of $0.7, $0.4 and $2.3 for fiscal 2019, fiscal 2018 and fiscal 2017, respectively | |||||||||||
Total other comprehensive income (loss) | ( | ) | |||||||||
Comprehensive income | |||||||||||
Comprehensive (income) loss attributable to noncontrolling interest | ( | ) | |||||||||
Comprehensive income attributable to controlling interest | $ | $ | $ | ||||||||
See Notes to Consolidated Financial Statements.
63
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Cash Flows
(In millions)
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
OPERATING ACTIVITIES | |||||||||||
Net income | $ | $ | $ | ||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Impairment, restructuring and other | |||||||||||
Share-based compensation expense | |||||||||||
Depreciation | |||||||||||
Amortization | |||||||||||
Deferred taxes | ( | ) | ( | ) | ( | ) | |||||
(Gain) loss on long-lived assets | ( | ) | ( | ) | |||||||
(Gain) loss on sale of business / unconsolidated affiliate | ( | ) | ( | ) | |||||||
Equity in (income) loss and distributions from unconsolidated affiliates | ( | ) | |||||||||
Recognition of accumulated foreign currency translation loss | |||||||||||
Changes in assets and liabilities, net of acquired businesses: | |||||||||||
Accounts receivable | ( | ) | |||||||||
Inventories | ( | ) | |||||||||
Prepaid and other assets | ( | ) | ( | ) | |||||||
Accounts payable | ( | ) | |||||||||
Other current liabilities | |||||||||||
Restructuring and other | ( | ) | ( | ) | |||||||
Other non-current items | ( | ) | ( | ) | ( | ) | |||||
Other, net | ( | ) | |||||||||
Net cash provided by operating activities | |||||||||||
INVESTING ACTIVITIES | |||||||||||
Proceeds from sale of long-lived assets | |||||||||||
Post-closing working capital payment related to sale of International Business | ( | ) | |||||||||
Proceeds from sale of business, net of cash disposed of | |||||||||||
Investments in property, plant and equipment | ( | ) | ( | ) | ( | ) | |||||
Investments in loans receivable | ( | ) | ( | ) | |||||||
Proceeds from loans receivable | |||||||||||
Proceeds from sale of investment in unconsolidated affiliates | |||||||||||
Net distributions from unconsolidated affiliates | ( | ) | |||||||||
Investments in acquired businesses, net of cash acquired | ( | ) | ( | ) | ( | ) | |||||
Other investing, net | |||||||||||
Net cash provided by (used in) investing activities | ( | ) | |||||||||
FINANCING ACTIVITIES | |||||||||||
Borrowings under revolving and bank lines of credit and term loans | |||||||||||
Repayments under revolving and bank lines of credit and term loans | ( | ) | ( | ) | ( | ) | |||||
Proceeds from issuance of 5.250% Senior Notes | |||||||||||
Financing and issuance fees | ( | ) | ( | ) | ( | ) | |||||
Dividends paid | ( | ) | ( | ) | ( | ) | |||||
Distribution paid by AeroGrow to noncontrolling interest | ( | ) | |||||||||
Purchase of Common Shares | ( | ) | ( | ) | ( | ) | |||||
Payments on seller notes | ( | ) | ( | ) | ( | ) | |||||
Excess tax benefits from share-based payment arrangements | |||||||||||
Cash received from exercise of stock options | |||||||||||
Acquisition of noncontrolling interests | ( | ) | |||||||||
Net cash (used in) provided by financing activities | ( | ) | ( | ) | |||||||
Effect of exchange rate changes on cash | ( | ) | |||||||||
Net increase (decrease) in cash and cash equivalents | ( | ) | ( | ) | |||||||
Cash and cash equivalents at beginning of year excluding cash classified within assets held for sale | |||||||||||
Cash and cash equivalents at beginning of year classified within assets held for sale | |||||||||||
Cash and cash equivalents at beginning of year | |||||||||||
Cash and cash equivalents at end of year | $ | $ | $ | ||||||||
See Notes to Consolidated Financial Statements.
64
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Balance Sheets
(In millions, except stated value per share)
September 30, | |||||||
2019 | 2018 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | $ | |||||
Accounts receivable, less allowances of $4.2 in 2019 and $3.6 in 2018 | |||||||
Accounts receivable pledged | |||||||
Inventories | |||||||
Prepaid and other current assets | |||||||
Total current assets | |||||||
Investment in unconsolidated affiliates | |||||||
Property, plant and equipment, net | |||||||
Goodwill | |||||||
Intangible assets, net | |||||||
Other assets | |||||||
Total assets | $ | $ | |||||
LIABILITIES AND EQUITY | |||||||
Current liabilities: | |||||||
Current portion of debt | $ | $ | |||||
Accounts payable | |||||||
Other current liabilities | |||||||
Total current liabilities | |||||||
Long-term debt | |||||||
Distributions in excess of investment in unconsolidated affiliate | |||||||
Other liabilities | |||||||
Total liabilities | |||||||
Commitments and contingencies (Notes 18, 19 and 20) | |||||||
Equity: | |||||||
Common shares and capital in excess of $.01 stated value per share; shares outstanding of 55.8 in 2019 and 55.3 in 2018 | |||||||
Retained earnings | |||||||
Treasury shares, at cost; 12.4 shares in 2019 and 12.8 shares in 2018 | ( | ) | ( | ) | |||
Accumulated other comprehensive loss | ( | ) | ( | ) | |||
Total equity—controlling interest | |||||||
Noncontrolling interest | |||||||
Total equity | |||||||
Total liabilities and equity | $ | $ | |||||
See Notes to Consolidated Financial Statements.
65
THE SCOTTS MIRACLE-GRO COMPANY
Consolidated Statements of Shareholders’ Equity
(In millions, except per share data)
Common Shares | Capital in Excess of Stated Value | Retained Earnings | Treasury Shares | Accumulated Other Comprehensive Income (Loss) | Non-controlling Interest | ||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Total | Total | ||||||||||||||||||||||||||||||||
Balance at September 30, 2016 | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Dividends declared ($2.030 per share) | — | — | — | ( | ) | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||||||||||
Treasury share purchases | — | — | — | — | ( | ) | — | ( | ) | — | ( | ) | |||||||||||||||||||||||||
Treasury share issuances | — | — | ( | ) | — | ( | ) | — | — | ||||||||||||||||||||||||||||
Adjustment to noncontrolling interest due to ownership change | — | — | ( | ) | — | — | — | — | ( | ) | |||||||||||||||||||||||||||
Distribution declared by Aerogrow | — | — | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||||||||
Balance at September 30, 2017 | ( | ) | ( | ) | |||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Dividends declared ($2.140 per share) | — | — | — | ( | ) | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||||||||||
Treasury share purchases | — | — | — | — | ( | ) | — | ( | ) | — | ( | ) | |||||||||||||||||||||||||
Treasury share issuances | — | — | ( | ) | — | ( | ) | — | — | ||||||||||||||||||||||||||||
Acquisition of remaining noncontrolling interest in Gavita | — | — | ( | ) | — | — | — | — | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||
Balance at September 30, 2018 | ( | ) | ( | ) | |||||||||||||||||||||||||||||||||
Adoption of new accounting pronouncements (see Note 1) | — | — | — | — | — | ( | ) | — | |||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | ( | ) | |||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — | — | — | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
Share-based compensation | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Dividends declared ($2.230 per share) | — | — | — | ( | ) | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||||||||||
Treasury share purchases | — | — | — | — | ( | ) | — | ( | ) | — | ( | ) | |||||||||||||||||||||||||
Treasury share issuances | — | — | ( | ) | — | ( | ) | — | — | ||||||||||||||||||||||||||||
Balance at September 30, 2019 | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | $ | |||||||||||||||||||||||||
See Notes to Consolidated Financial Statements.
66
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
The Scotts Miracle-Gro Company (“Scotts Miracle-Gro” or “Parent”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor, urban and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia.
Organization and Basis of Presentation
The Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. AeroGrow International, Inc. (“AeroGrow”), in which the Company has a controlling interest, is consolidated, with the equity owned by other shareholders shown as noncontrolling interest in the Consolidated Balance Sheets, and the other shareholders’ portion of net earnings and other comprehensive income shown as net (income) loss or comprehensive (income) loss attributable to noncontrolling interest in the Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income (Loss), respectively. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.
Advertising
Research and Development
Environmental Costs
The Company recognizes environmental liabilities when conditions requiring remediation are probable and the amounts can be reasonably estimated. Expenditures which extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. Environmental liabilities are not discounted or reduced for possible recoveries from insurance carriers.
Share-Based Compensation Awards
The fair value of awards is expensed over the requisite service period which is typically the vesting period, generally three to five years , except in cases where employees are eligible for accelerated vesting based on having satisfied retirement requirements relating to age and years of service. Performance-based awards are expensed over the requisite service period based on achievement of performance criteria. The Company uses a binomial model to determine the fair value of its option grants. The Company
67
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
classifies share-based compensation expense within selling, general and administrative expenses to correspond with the same line item as cash compensation paid to employees.
Earnings per Common Share
Basic income (loss) per common share of Scotts Miracle-Gro (“Common Share”) is computed by dividing income attributable to controlling interest from continuing operations, income (loss) from discontinued operations or net income attributable to controlling interest by the weighted average number of Common Shares outstanding each period. Diluted income (loss) per Common Share is computed by dividing income attributable to controlling interest from continuing operations, income (loss) from discontinued operations or net income attributable to controlling interest by the weighted average number of Common Shares outstanding plus all dilutive potential Common Shares (stock options, performance shares, performance units, restricted stock and restricted stock units) outstanding each period.
Cash and Cash Equivalents
Cash and cash equivalents were held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments. The Company considers all highly liquid financial instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash deposits in banks which from time to time exceed the amount of deposit insurance available. Management periodically assesses the financial condition of the Company’s banks and believes that the risk of any potential credit loss is minimal.
Accounts Receivable and Allowances
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Allowances for doubtful accounts reflect the Company’s estimate of amounts in its existing accounts receivable that may not be collected due to customer claims or customer inability or unwillingness to pay. The allowance is determined based on a combination of factors, including the Company’s risk assessment regarding the credit worthiness of its customers, historical collection experience and length of time the receivables are past due. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.
Inventories
Loans Receivable
Loans receivable are carried at outstanding principal amount, and are recognized in the “Other assets” line in the Consolidated Balance Sheets. Loans receivable are impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement. If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the asset exceeds the present value of expected future cash flows. Interest income was $8.6 million, $10.0 million and $10.0 million for fiscal 2019, fiscal 2018 and fiscal 2017, respectively. Interest income is recorded on an accrual basis. The Company classified interest income in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations in fiscal 2019 and fiscal 2018 and in the “Other (income) expense, net” line in the Consolidated Statements of Operations in fiscal 2017.
At September 30, 2019, the carrying value and estimated fair value of loans receivable were $95.1 million and $105.4 million, respectively. At September 30, 2018, the carrying value and estimated fair value of loans receivable were $112.6 million and $128.2 million, respectively. The estimated fair value was determined using an income-based approach, which includes market participant expectations of cash flows over the remaining useful life discounted to present value using an appropriate discount
68
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
rate. The estimate requires subjective assumptions to be made, including those related to credit risk and discount rates. The fair value measurement is based on significant inputs unobservable in the market and thus represents a Level 3 measurement.
Long-Lived Assets
Property, plant and equipment are stated at cost. Interest capitalized in property, plant and equipment amounted to $0.5 million, $0.3 million and $0.1 million during fiscal 2019, fiscal 2018 and fiscal 2017, respectively. Expenditures for maintenance and repairs are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost of the asset and the related accumulated depreciation are removed from the accounts with the resulting gain or loss being reflected in income from operations.
Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows:
Land improvements | 10 – 25 years |
Buildings | 10 – 40 years |
Machinery and equipment | 3 – 15 years |
Furniture and fixtures | 6 – 10 years |
Software | 3 – 8 years |
Intangible assets subject to amortization include technology, such as patents, customer relationships, non-compete agreements and certain tradenames. These intangible assets are being amortized over their estimated useful economic lives, which typically range from 3 to 25 years. The Company’s fixed assets and intangible assets subject to amortization are required to be tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. If an evaluation of recoverability was required, the estimated undiscounted future cash flows associated with the asset group would be compared to the asset group carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.
The Company had non-cash investing activities of $22.1 million, $9.8 million and $16.1 million during fiscal 2019, fiscal 2018 and fiscal 2017, respectively, representing unpaid liabilities incurred during each fiscal year to acquire property, plant and equipment.
Statements of Cash Flows
Supplemental cash flow information was as follows:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Interest paid | $ | $ | $ | ||||||||
Property and equipment acquired under capital leases | |||||||||||
Income taxes paid | |||||||||||
During fiscal 2019, the Company paid a post-closing net working capital adjustment obligation of $6.6 million related to the fiscal 2018 acquisition of Sunlight Supply (as defined in “NOTE 8. ACQUISITIONS AND INVESTMENTS”), which was classified as an investing activity in the “Investments in acquired businesses, net of cash acquired” line in the Consolidated Statements of Cash Flows. During fiscal 2018, the Company paid contingent consideration of $3.0 million related to the fiscal 2016 acquisition of Gavita Holdings B.V., and its subsidiaries (collectively, “Gavita”) and $5.8 million related to the fiscal 2017 acquisition of Agrolux Holding B.V. (now known as Hawthorne Lighting B.V.), and its subsidiaries (collectively, “Agrolux”), which were classified as financing activities in the “Payments on seller notes” line in the Consolidated Statements of Cash Flows. During fiscal 2017, the Company paid contingent consideration of $6.7 million, $6.5 million and $15.5 million, respectively, related to the fiscal 2014 acquisition of Fafard & Brothers Ltd. (“Fafard”), the fiscal 2016 acquisition of a Canadian growing media operation and the fiscal 2017 acquisition of American Agritech, L.L.C., d/b/a Botanicare (“Botanicare”), which were classified as financing activities in the “Payments on seller notes” line in the Consolidated Statements of Cash Flows.
69
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The Company uses the “cumulative earnings” approach for determining cash flow presentation of distributions from unconsolidated affiliates. Distributions received are included in the Consolidated Statements of Cash Flows as operating activities, unless the cumulative distributions exceed the portion of the cumulative equity in the net earnings of the unconsolidated affiliate, in which case the excess distributions are deemed to be returns of the investment and are classified as investing activities in the Consolidated Statements of Cash Flows.
Internal Use Software
Goodwill and Indefinite-lived Intangible Assets
Goodwill and indefinite-lived intangible assets are not subject to amortization. Goodwill and indefinite-lived intangible assets are reviewed for impairment by applying a fair-value based test on an annual basis, as of the first day of the Company’s fiscal fourth quarter, or more frequently if circumstances indicate impairment may have occurred. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include reporting unit specific operating results as well as new events and circumstances impacting the operations or cash flows of the reporting units. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of its reporting units to their respective fair values. A reporting unit is defined as an operating segment or one level below an operating segment. The Company has identified seven reporting units. The Company determines the fair value of its reporting units using a combination of income-based and market-based approaches and incorporates assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows while the market-based approach utilizes market multiples. These approaches are dependent upon internally-developed forecasts that are based upon annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective reporting units and in the internally-developed forecasts. To further confirm fair value, the Company compares the aggregate fair value of the reporting units to the Company’s total market capitalization.
With respect to indefinite-lived intangible assets, the Company performs either a qualitative or quantitative evaluation for each of its indefinite-lived intangible assets. Factors considered in the qualitative test include indefinite-lived intangible asset specific operating results as well as new events and circumstances impacting the cash flows of the indefinite-lived intangible assets. For the quantitative test, the value of all indefinite-lived intangible assets is determined under the income-based approach utilizing discounted cash flows and incorporating assumptions the Company believes market participants would utilize. For tradenames, value was determined using a royalty savings methodology similar to that employed when the associated businesses were acquired but using updated estimates of sales, cash flow and profitability.
If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.
Insurance and Self-Insurance
The Company maintains insurance for certain risks, including workers’ compensation, general liability and vehicle liability, and is self-insured for employee-related health care benefits up to a specified level for individual claims. The Company accrues for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors and other relevant information. Costs are recognized in the period the claim is incurred, and accruals include an actuarially determined estimate of claims incurred but not yet reported.
Income Taxes
The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change.
70
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The Company establishes a liability for tax return positions in which there is uncertainty as to whether or not the position will ultimately be sustained. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled. The Company recognizes interest expense and penalties related to these unrecognized tax benefits within income tax expense. GAAP provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.
U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.
Translation of Foreign Currencies
Derivative Instruments
The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. A variety of financial instruments, including forward and swap contracts, are used to manage these exposures. These financial instruments are recognized at fair value in the Consolidated Balance Sheets, and all changes in fair value are recognized in net income or shareholders’ equity through accumulated other comprehensive income (loss). The Company’s objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow volatility associated with changes in the applicable rates and prices.
The Company has established policies and procedures that encompass risk-management philosophy and objectives, guidelines for derivative-instrument usage, counterparty credit approval, and the monitoring and reporting of derivative activity. The Company does not enter into derivative instruments for the purpose of speculation.
The Company formally designates and documents instruments at inception that qualify for hedge accounting of underlying exposures in accordance with GAAP. The Company formally assesses, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The Company designates certain commodity hedges as cash flow hedges of forecasted purchases of commodities and interest rate swap agreements as cash flow hedges of interest payments on variable rate borrowings.
RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
Revenue Recognition from Contracts with Customers
In May 2014, the Financial Accounting Standards Board (“FASB”) issued amended accounting guidance that replaces most existing revenue recognition guidance under GAAP. This guidance requires companies to recognize revenue in a manner that depicts the transfer of promised goods or services to customers in amounts that reflect the consideration to which a company expects to be entitled in exchange for those goods or services. The standard involves a five-step process that includes identifying the contract with the customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract and recognizing revenue when the entity satisfies the performance obligations. The new standard also results in enhanced disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. Subsequently, additional guidance was issued on several areas including guidance intended to improve the operability and understandability of the implementation of principal versus agent considerations and clarifications on the identification of performance obligations and implementation of guidance related to licensing.
71
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The Company adopted this guidance effective October 1, 2018 under the modified retrospective approach. The Company’s revenue primarily consists of product sales, which are recognized at a point in time when title transfers to customers and the Company has no further obligation to provide services related to such products. The Company’s timing of recognition of revenue is substantially unchanged under the amended guidance. The new accounting guidance required the Company to recognize earlier certain deferred revenue associated with a license agreement related to the sale of the International Business (as defined in “NOTE 3. DISCONTINUED OPERATIONS”), resulting in a cumulative adjustment to its fiscal 2019 opening balance of retained earnings of $9.1 million, other current liabilities of $1.4 million and other liabilities of $7.7 million. With the exception of this item, the adoption of the amended accounting guidance did not have a significant impact on the Company’s consolidated financial statements. The additional disclosures required by this guidance are presented within “NOTE 2. REVENUE RECOGNITION” and “NOTE 21. SEGMENT INFORMATION.”
Cash Flow Presentation
In August 2016, the FASB issued an accounting standard update that amends the guidance on the classification of certain cash receipts and payments in the statement of cash flows. The Company adopted this guidance on a retrospective basis effective October 1, 2018. The adoption of this guidance did not have a significant impact on the Company’s consolidated cash flows.
Business Combinations
In January 2017, the FASB issued an accounting standard update that clarifies the definition of a business to provide additional guidance to assist in evaluating whether transactions should be accounted for as an acquisition (or disposal) of either an asset or business. The Company adopted this guidance on a prospective basis effective October 1, 2018. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
Employee Benefit Plans
In March 2017, the FASB issued an accounting standard update that requires entities to (1) disaggregate the current-service-cost component from the other components of net benefit cost (the “other components”) and present the current-service-cost with other current compensation costs for related employees in the income statement, (2) present the other components elsewhere in the income statement and outside of income from operations if that subtotal is presented and (3) limit the amount of costs eligible for capitalization (e.g., as part of inventory or property, plant, and equipment) to only the service-cost component of net benefit cost. The provisions are required to be applied retrospectively for the presentation of cost components in the income statement and prospectively for the capitalization of cost components. The Company adopted this guidance effective October 1, 2018 and has classified non-service-cost components of net benefit cost/income in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
Income Taxes
On December 22, 2017, H.R.1 (the “Act,” formerly known as the “Tax Cuts and Jobs Act”) was signed into law. The Act provides for significant changes to the U.S. Internal Revenue Code of 1986, as amended (the “Code”). Among other items, the Act implemented a territorial tax system, imposed a one-time transition tax on deemed repatriated earnings of foreign subsidiaries, and reduced the federal corporate statutory tax rate to 21% effective January 1, 2018.
Additionally, the Securities and Exchange Commission (the “SEC”) released Staff Accounting Bulletin No. 118 (“SAB 118”) which provides guidance on accounting for the Act’s impact under Accounting Standards Codification (“ASC”) Topic 740, Income Taxes (“ASC 740”). The guidance in SAB 118 allowed companies to use provisional estimates to record the effects of the Act and also provided a measurement period (not to exceed one year from the date of enactment) to complete the accounting for the impacts of the Act. The Company completed its accounting for the impacts of the Act during the first quarter of fiscal 2019.
For discussion of the impacts of the Act that are material to the Company and required disclosures related to the Act pursuant to the guidance provided under SAB 118, refer to “NOTE 15. INCOME TAXES.”
Reporting Comprehensive Income
In February 2018, the FASB issued an accounting standard update that allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Act. The Company elected to adopt this guidance effective October 1, 2018, resulting in a reclassification of $13.8 million from accumulated other comprehensive income (loss) (“AOCI”) to retained earnings upon adoption.
72
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Share-Based Compensation
In June 2018, the FASB issued an accounting standard update that simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the amended accounting guidance, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The Company elected to adopt this guidance effective October 1, 2018. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows.
Goodwill
In January 2017, the FASB issued an accounting standard update which removes the requirement to compare the implied fair value of goodwill with its carrying amount as part of step 2 of the goodwill impairment test. Goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of the goodwill. The Company adopted this guidance on a prospective basis during the third quarter of fiscal 2018.
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
Leases
In February 2016, the FASB issued its final standard on lease accounting. This guidance requires lessees to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2019 and require a modified retrospective transition approach for leases that exist as of or are entered into after the beginning of either (i) the date of adoption or (ii) the earliest comparative period presented in the financial statements.
The Company adopted the new standard on October 1, 2019 and elected certain practical expedients, including the optional transition method that allows for the application of the new standard at its adoption date with no restatement of prior period amounts. As allowed under the new accounting standard, the Company elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The Company anticipates the adoption of this new standard will result in the recognition of right-of-use (“ROU”) assets of between approximately $120 million and $140 million and aggregate current and non-current liabilities of between approximately $125 million and $145 million on its Consolidated Balance Sheet with the difference largely due to deferred rent that will be reclassified to the ROU asset. The Company expects no material cumulative effect adjustment to its Consolidated Balance Sheet as of the date of adoption. Adoption of the new standard is not expected to have a material impact on the Company’s results of operations or cash flows.
Credit Losses
In June 2016, the FASB issued an accounting standard update related to the measurement of credit losses on financial instruments. The amended accounting guidance changes the impairment model for most financial assets to require measurement and recognition of expected credit losses for financial assets held. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2020. The Company is continuing to assess the impact of the amended guidance.
Cloud Computing Costs
In August 2018, the FASB issued an accounting standard update that aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2020. The Company is continuing to assess the impact of the amended guidance.
Employee Benefit Plans
In August 2018, the FASB issued an accounting standard update that removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. The provisions are effective for the Company’s financial statements no later than the fiscal year beginning October 1, 2020. The Company is continuing to assess the impact of the amended guidance.
73
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 2. REVENUE RECOGNITION
Nature of Goods and Services
The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto Company (“Monsanto”) for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. The Company also provides marketing, research and development and certain ancillary services to Bonnie Plants, Inc. (“Bonnie”). Refer to “NOTE 21. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 7. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements.
Identification and Satisfaction of Performance Obligations
Product sales are recognized at a point in time when control of products transfers to customers and the Company has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction, therefore revenue is primarily recorded on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer.
Under the terms of the Second Amended and Restated Exclusive Agency and Marketing Agreement (the “Restated Marketing Agreement”) as amended by the Third Amended and Restated Exclusive Agency and Marketing Agreement (the “Third Restated Agreement”), pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Restated Marketing Agreement and Third Restated Agreement also require the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Restated Marketing Agreement and Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross profit dollars or net income.
Under the terms of the Marketing, R&D and Ancillary Services Agreement (the “Services Agreement”) with Bonnie and its sole shareholder, Alabama Farmers Cooperative, Inc. (“AFC”), the Company provides marketing, research and development and certain ancillary services to Bonnie. In exchange for these services, Bonnie reimburses the Company for certain costs and provides a commission fee earned based on a percentage of the growth in earnings before interest, income taxes and amortization of Bonnie’s business of planting, growing, developing, manufacturing, distributing, marketing, and selling live plants, plant food, fertilizer and potting soil (the “Bonnie Business”). The commission earned under the Services Agreement is included in the “Net sales” line in the Consolidated Statements of Operations. Additionally, the Company records costs incurred under the Services Agreement for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross profit dollars or net income.
74
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Transactional Price and Promotional Allowances
Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto and Bonnie agreements is recognized over the program year as the services are being performed based upon the commission income formula in the agreements.
The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotion costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.
NOTE 3. DISCONTINUED OPERATIONS
International Business
Prior to August 31, 2017, the Company operated consumer lawn and garden businesses located in Australia, Austria, Belgium, Luxembourg, Czech Republic, France, Germany, Poland and the United Kingdom (the “International Business”). On April 29, 2017, the Company received a binding and irrevocable conditional offer (the “Offer”) from Exponent Private Equity LLP (“Exponent”) to purchase the International Business for approximately $250.0 million (subject to potential adjustment following closing in respect of the actual financial position at closing) and a deferred payment amount of up to $23.8 million. On July 5, 2017, the Company accepted the Offer and entered into the Share and Business Sale Agreement (the “Agreement”) contemplated by the Offer. Pursuant to the Agreement, Scotts-Sierra Investments LLC, an indirect wholly-owned subsidiary of the Company (“Sierra”), and certain of its direct and indirect subsidiaries, entered into separate stock or asset sale transactions with respect to the International Business. As a result, effective in its fourth quarter of fiscal 2017, the Company classified its results of operations for all periods presented to reflect the International Business as a discontinued operation and classified the assets and liabilities of the International Business as held for sale.
On August 31, 2017, the Company completed the sale of the International Business for cash proceeds of $150.6 million at closing, which was net of a closing statement adjustment for expected financial position at closing and net of seller financing provided by the Company in the form of a $29.7 million loan for seven years bearing interest at 5 % for the first three years, with annual 2.5 % increases thereafter. The transaction also included contingent consideration, a non-cash investing activity, with a maximum payout of $23.8 million and an initial fair value of $18.2 million, the payment of which will depend on the achievement of certain performance criteria by the International Business following the closing of the transaction through fiscal 2020. The seller financing loan and the contingent consideration receivable are recorded in the “Other assets” line in the Consolidated Balance Sheets. The cash proceeds from the sale were subject to post-closing adjustments related to the expected working capital adjustment obligation in respect of the actual closing date financial position of the International Business. The Company recorded a pre-tax gain on the sale of the International Business of $32.7 million, partially offset by the provision for income taxes of $12.0 million, during fiscal 2017. The fiscal 2017 pre-tax gain included a write-off of accumulated foreign currency translation loss adjustments of $18.5 million. During fiscal 2018, the Company recorded a decrease to the pre-tax gain of $0.7 million related to the resolution of post-closing working capital adjustments.
In connection with the transaction, the Company entered into certain ancillary agreements including a transition services agreement and a material supply agreement, which are not material, as well as a licensing agreement for the use of certain of the Company’s brand names with an initial fair value of $14.1 million. Deferred licensing revenues of $12.1 million were recorded on the Consolidated Balance Sheets as of September 30, 2018. Refer to “NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES” for further discussion of the impact of the amended revenue recognition accounting guidance that was adopted during the first quarter of fiscal 2019.
During fiscal 2018 and fiscal 2017, the Company recognized $1.8 million and $15.5 million, respectively, in transaction related costs associated with the sale of the International Business as well as termination benefits and facility closure costs of zero and $(0.4 ) million, respectively, in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations.
75
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Wild Bird Food
During fiscal 2014, the Company completed the sale of its U.S. and Canadian wild bird food business. As a result, effective in fiscal 2014, the Company classified its results of operations for all periods presented to reflect the wild bird food business as a discontinued operation. During fiscal 2019, the Company recognized a favorable adjustment of $22.5 million as a result of the final resolution of the previously disclosed settlement agreement related to the In re Morning Song Bird Food Litigation legal matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations. This matter relates to a class-action lawsuit filed in 2012 in connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008 by the Company’s previously sold wild bird food business. In addition, during fiscal 2019, the Company recognized insurance recoveries of $13.4 million related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations. During fiscal 2018, the Company recognized a pre-tax charge of $85.0 million for a probable loss related to this matter. At September 30, 2019 and 2018, zero and $85.0 million, respectively, was accrued for a probable loss related to this matter in the “Other current liabilities” line in the Consolidated Balance Sheets. Refer to “NOTE 20. CONTINGENCIES” for more information.
The following table summarizes the results of discontinued operations described above and reflected within discontinued operations in the Company’s consolidated financial statements for each of the periods presented:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Net sales | $ | $ | $ | ||||||||
Operating and exit costs | |||||||||||
Impairment, restructuring and other | ( | ) | |||||||||
Other (income) expense, net | |||||||||||
(Gain) loss on sale / contribution of business | ( | ) | |||||||||
Interest expense | |||||||||||
Income (loss) from discontinued operations before income taxes | ( | ) | |||||||||
Income tax expense (benefit) from discontinued operations | ( | ) | |||||||||
Income (loss) from discontinued operations, net of tax | $ | $ | ( | ) | $ | ||||||
76
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER
Activity described herein is classified within the “Cost of sales—impairment, restructuring and other,” “Impairment, restructuring and other” and “Income (loss) from discontinued operations, net of tax” lines in the Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Cost of sales—impairment, restructuring and other: | |||||||||||
Restructuring and other charges | $ | $ | $ | ||||||||
Property, plant and equipment impairments | |||||||||||
Operating expenses: | |||||||||||
Restructuring and other charges, net | |||||||||||
Goodwill and intangible asset impairments | |||||||||||
Impairment, restructuring and other charges from continuing operations | $ | $ | $ | ||||||||
Restructuring and other charges (recoveries) from discontinued operations | ( | ) | |||||||||
Total impairment, restructuring and other charges (recoveries) | $ | ( | ) | $ | $ | ||||||
The following table summarizes the activity related to liabilities associated with restructuring and other, excluding insurance reimbursement recoveries, for each of the periods presented:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Amounts accrued for restructuring and other at beginning of year | $ | $ | $ | ||||||||
Restructuring and other charges from continuing operations | |||||||||||
Restructuring and other charges (recoveries) from discontinued operations | ( | ) | |||||||||
Payments and other | ( | ) | ( | ) | ( | ) | |||||
Amounts accrued for restructuring and other at end of year | $ | $ | $ | ||||||||
Included in restructuring accruals, as of September 30, 2019, is $3.1 million that is classified as long-term. Payments against the long-term accruals will be incurred as the employees covered by the restructuring plan retire or through the passage of time. The remaining amounts accrued will continue to be paid out over the course of the next twelve months.
Project Catalyst
In connection with the acquisition of Sunlight Supply during the third quarter of fiscal 2018, the Company announced the launch of an initiative called Project Catalyst, which is a company-wide restructuring effort to reduce operating costs throughout the U.S. Consumer, Hawthorne and Other segments and drive synergies from acquisitions within the Hawthorne segment. During fiscal 2019, the Company incurred charges of $13.7 million related to Project Catalyst. The Company incurred charges of $1.1 million in its U.S. Consumer segment, $4.2 million in its Hawthorne segment and $0.6 million in its Other segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2019 related to employee termination benefits, facility closure costs and impairment of property, plant and equipment. The Company incurred charges of $0.5 million in its U.S. Consumer segment, $3.9 million in its Hawthorne segment, $0.6 million in its Other segment and $2.8 million at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2019 related to employee termination benefits and facility closure costs. Costs incurred to date since the inception of Project Catalyst are $25.9 million for the Hawthorne segment, $13.2 million for the U.S. Consumer segment, $1.2 million for the Other segment and $2.8 million for Corporate.
During fiscal 2018, the Company incurred charges of $29.4 million related to Project Catalyst. The Company incurred charges of $8.2 million in its U.S. Consumer segment and $12.4 million in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2018 related to employee termination benefits, facility closure costs and impairment of property, plant and equipment. The Company incurred charges of $3.4 million in its U.S. Consumer segment and $5.4 million in its Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2018 related to employee termination benefits.
77
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Project Focus
In the first quarter of fiscal 2016, the Company announced a series of initiatives called Project Focus designed to maximize the value of its non-core assets and focus on emerging categories of the lawn and garden industry in its core U.S. business. During fiscal 2018, the U.S. Consumer segment recognized adjustments of $0.1 million related to previously recognized termination benefits associated with Project Focus in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. During fiscal 2017, the Company recognized restructuring costs related to termination benefits and facility closure costs of $8.3 million in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, including $6.7 million for the U.S. Consumer segment, $0.9 million for the Hawthorne segment and $0.7 million for the Other segment. Costs incurred to date since the inception of the current Project Focus initiatives are $10.0 million for the U.S. Consumer segment, $0.9 million for the Hawthorne segment and $1.2 million for the Other segment.
On August 31, 2017, the Company completed the sale of the International Business. Refer to “NOTE 3. DISCONTINUED OPERATIONS” for more information. During fiscal 2018 and fiscal 2017, the Company recognized $1.8 million and $15.5 million, respectively, in transaction related costs associated with the sale of the International Business as well as termination benefits and facility closure costs of zero and $(0.4 ) million, respectively, in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations.
Other
During fiscal 2019, the Company recognized a favorable adjustment of $22.5 million as a result of the final resolution of the previously disclosed settlement agreement related to the In re Morning Song Bird Food Litigation legal matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations. In addition, during fiscal 2019, the Company recognized insurance recoveries of $13.4 million related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations. During fiscal 2018, the Company recognized a pre-tax charge of $85.0 million for a probable loss related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations. Refer to “NOTE 20. CONTINGENCIES” for more information.
During fiscal 2019, the Company recognized a favorable adjustment of $0.4 million related to the previously disclosed legal matter In re Scotts EZ Seed Litigation in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. During fiscal 2018, the Company recognized a charge of $11.7 million for a probable loss related to this matter in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. Refer to “NOTE 20. CONTINGENCIES” for more information.
During fiscal 2018, the Company recognized a non-cash impairment charge of $94.6 million related to a goodwill impairment in the Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations as a result of the Company’s annual fourth quarter quantitative goodwill impairment test. Refer to “NOTE 5. GOODWILL AND INTANGIBLE ASSETS, NET” for more information.
During fiscal 2018, the Company recognized a non-cash impairment charge of $17.5 million related to the settlement of a portion of certain previously acquired customer relationships due to the acquisition of Sunlight Supply in the “Impairment, restructuring and other” line in the Consolidated Statement of Operations. Refer to “NOTE 8. ACQUISITIONS AND INVESTMENTS” for more information.
During fiscal 2017, the Company recognized a recovery of $4.4 million related to the reduction of a contingent consideration liability associated with a historical acquisition and recorded a $1.0 million impairment charge on the write-off of a trademark asset due to operating performance and future growth expectations within the “Impairment, restructuring and other” line in the Consolidated Statements of Operations.
78
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 5. GOODWILL AND INTANGIBLE ASSETS, NET
The following table displays a rollforward of the carrying amount of goodwill by reportable segment:
U.S. Consumer | Hawthorne | Other | Total | ||||||||||||
(In millions) | |||||||||||||||
Goodwill | $ | $ | $ | $ | |||||||||||
Accumulated impairment losses | ( | ) | ( | ) | |||||||||||
Balance at September 30, 2017 | |||||||||||||||
Acquisitions, net of purchase price adjustments | |||||||||||||||
Foreign currency translation | ( | ) | ( | ) | ( | ) | |||||||||
Impairment | ( | ) | ( | ) | |||||||||||
Goodwill | $ | $ | $ | $ | |||||||||||
Accumulated impairment losses | ( | ) | ( | ) | ( | ) | |||||||||
Balance at September 30, 2018 | |||||||||||||||
Acquisitions, net of purchase price adjustments | |||||||||||||||
Foreign currency translation | ( | ) | ( | ) | ( | ) | |||||||||
Goodwill | $ | $ | $ | $ | |||||||||||
Accumulated impairment losses | ( | ) | ( | ) | ( | ) | |||||||||
Balance at September 30, 2019 | $ | $ | $ | $ | |||||||||||
The Company performed annual impairment testing as of the first day of its fourth fiscal quarter in fiscal 2019, 2018 and 2017 and, with the exception of the Hawthorne reporting unit in fiscal 2018, concluded that there were no impairments of goodwill as the estimated fair value of each reporting unit exceeded its carrying value. During the fourth quarter of fiscal 2018, the Company recognized a non-cash goodwill impairment charge of $94.6 million related to the Hawthorne reporting unit in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The impairment was primarily driven by a downturn in the U.S. retail hydroponic market. This impairment charge did not impact the Company’s liquidity, cash flows from operations or compliance with debt covenants. The fair value estimates utilize significant unobservable inputs and thus represent Level 3 nonrecurring fair value measurements.
79
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents intangible assets, net:
September 30, 2019 | September 30, 2018 | ||||||||||||||||||||||
Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||
(In millions) | |||||||||||||||||||||||
Finite-lived intangible assets: | |||||||||||||||||||||||
Tradenames | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | |||||||||||||
Customer accounts | ( | ) | ( | ) | |||||||||||||||||||
Technology | ( | ) | ( | ) | |||||||||||||||||||
Other | ( | ) | ( | ) | |||||||||||||||||||
Total finite-lived intangible assets, net | |||||||||||||||||||||||
Indefinite-lived intangible assets: | |||||||||||||||||||||||
Indefinite-lived tradenames | |||||||||||||||||||||||
Marketing Agreement Amendment | |||||||||||||||||||||||
Brand Extension Agreement | |||||||||||||||||||||||
Total indefinite-lived intangible assets | |||||||||||||||||||||||
Total intangible assets, net | $ | $ | |||||||||||||||||||||
During the fourth quarter of fiscal 2019, the Company entered into a Brand Extension Agreement Asset Purchase Agreement (the “BEA Purchase Agreement”) under which it sold to Monsanto specified assets related to the development, manufacture, production, advertising, marketing, promotion, distribution, importation, exportation, offer for sale and sale of specified Roundup® branded products sold outside the non-selective weedkiller category within the residential lawn and garden market. Refer to “NOTE 7. MARKETING AGREEMENT” for more information.
During the third quarter of fiscal 2018, the Company’s Hawthorne segment recognized a non-cash impairment charge of $17.5 million related to the settlement of a portion of certain previously acquired customer relationships due to the acquisition of Sunlight Supply.
Total amortization expense was $33.4 million, $30.0 million and $23.3 million for fiscal 2019, fiscal 2018 and fiscal 2017, respectively. Amortization expense is estimated to be as follows for the years ending September 30 (in millions):
2020 | $ | ||
2021 | |||
2022 | |||
2023 | |||
2024 | |||
80
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 6. DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS
The following is detail of certain financial statement accounts:
September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
INVENTORIES: | |||||||
Finished goods | $ | $ | |||||
Work-in-progress | |||||||
Raw materials | |||||||
$ | $ | ||||||
PREPAID AND OTHER CURRENT ASSETS: | |||||||
Receivable associated with brand extension asset sale | $ | $ | |||||
Other | |||||||
$ | $ | ||||||
September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
PROPERTY, PLANT AND EQUIPMENT, NET: | |||||||
Land and improvements | $ | $ | |||||
Buildings | |||||||
Machinery and equipment | |||||||
Furniture and fixtures | |||||||
Software | |||||||
Capital leases | |||||||
Aircraft | |||||||
Construction in progress | |||||||
Less: accumulated depreciation | ( | ) | ( | ) | |||
$ | $ | ||||||
OTHER ASSETS: | |||||||
Loans receivable | $ | $ | |||||
Accrued pension, postretirement and executive retirement assets | |||||||
Contingent consideration receivable | |||||||
Bonnie Option | |||||||
Unamortized debt issuance costs | |||||||
Other | |||||||
$ | $ | ||||||
81
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
OTHER CURRENT LIABILITIES: | |||||||
Accrued restructuring and other | $ | $ | |||||
Advertising and promotional accruals | |||||||
Payroll and other compensation accruals | |||||||
Accrued interest | |||||||
Accrued insurance and claims | |||||||
Accrued taxes | |||||||
Other | |||||||
$ | $ | ||||||
OTHER NON-CURRENT LIABILITIES: | |||||||
Accrued pension, postretirement and executive retirement liabilities | $ | $ | |||||
Deferred tax liabilities | |||||||
Deferred licensing revenue | |||||||
Other | |||||||
$ | $ | ||||||
September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
ACCUMULATED OTHER COMPREHENSIVE LOSS: | |||||||||||
Unrecognized gain (loss) on derivatives, net of tax of $2.8, $(2.9) and $(1.3), respectively | $ | ( | ) | $ | $ | ||||||
Pension and other postretirement liabilities, net of tax of $22.8, $31.4 and $33.4, respectively | ( | ) | ( | ) | ( | ) | |||||
Foreign currency translation adjustment | ( | ) | ( | ) | ( | ) | |||||
$ | ( | ) | $ | ( | ) | $ | ( | ) | |||
NOTE 7. MARKETING AGREEMENT
The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries. On May 15, 2015, the Company and Monsanto entered into an Amendment to the Original Marketing Agreement (the “Marketing Agreement Amendment”), a Lawn and Garden Brand Extension Agreement (the “Brand Extension Agreement”) and a Commercialization and Technology Agreement (the “Commercialization and Technology Agreement”). In consideration for these agreements, the Company paid $300.0 million to Monsanto and recorded this amount as intangible assets for which the related economic useful life is indefinite.
On August 31, 2017, in connection with and as a condition to the consummation of the Company’s sale of its International Business, the Company entered into the Second Amended and Restated Agency and Marketing Agreement (the “Restated Marketing Agreement”) and the Amended and Restated Lawn and Garden Brand Extension Agreement - Americas (the “Restated Brand Extension Agreement”) to reflect the Company’s transfer and assignment to the purchaser of such business of the Company’s rights and responsibilities under the Original Marketing Agreement and the Brand Extension Agreement relating to those countries subject to the sale. The Company included $32.6 million of the carrying amount of the intangible asset associated with the Marketing Agreement Amendment with the International Business disposal unit on the basis of the asset’s historical carrying amount and this amount was disposed of as part of the sale of the International Business.
The annual commission payable under the Restated Marketing Agreement is equal to (1) 50 % of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business in the markets covered by the Restated Marketing Agreement (“Program EBIT”) for program years 2017 and 2018 and (2) 50 % of Program EBIT in excess of $40.0 million for program year 2019. The Restated Marketing Agreement also requires the Company to make annual payments of $18.0 million to Monsanto as
82
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
a contribution against the overall expenses of its consumer Roundup® business. During fiscal 2019, Monsanto agreed to reimburse the Company for $20.0 million of additional expenses incurred by the Company for certain activities connected to the Restated Marketing Agreement, which was recognized in the “Net sales” line in the Consolidated Statements of Operations.
Effective August 1, 2019, the Company entered into the Third Restated Agreement which, among other things:
• | Increases the amount of the commission to which the Company is entitled for program year 2020 and thereafter from |
• | Provides that if the Program EBIT for any program year is not at least $ |
• | Expands the definition of Roundup® products for which the Company is providing services under the Third Restated Agreement to include BEA products (as defined in the Third Restated Agreement); |
• | Expands the Company’s termination rights by authorizing the Company to terminate the Third Restated Agreement (i) for any reason effective as of September 30, 2022 by delivery of notice of termination to Monsanto on January 15, 2021 (a “Convenience Termination”) or (ii) upon the insolvency or bankruptcy of Monsanto; |
• | Expands Monsanto’s termination rights by authorizing Monsanto to terminate the Third Restated Agreement in the event that Monsanto decides to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Termination”); |
• | Updates the termination fee structure to require Monsanto to pay a termination fee to the Company in an amount equal to (i) $ |
• | Permits each party to terminate the Third Restated Agreement if Program EBIT falls below $ |
In addition, in connection with the signing of the Third Restated Agreement, the Company also entered into (i) the BEA Purchase Agreement, (ii) a termination agreement regarding the Brand Extension Agreement and (iii) a termination agreement regarding the Commercialization and Technology Agreement. The BEA Purchase Agreement provides for the sale by the Company to Monsanto of specified assets related to, among other things, the development, manufacture, production, advertising, marketing, promotion, distribution, importation, exportation, offer for sale and sale of specified Roundup® branded products sold outside the non-selective weedkiller category within the residential lawn and garden market. The consideration to be paid by Monsanto is the sum of $112.0 million plus the value of finished goods inventory of $3.5 million. This consideration is payable to the Company on January 15, 2020 and has been recorded in the “Prepaid and other current assets” line in the Consolidated Balance Sheets. The carrying value of the assets sold, which included the brand extension agreement intangible asset with a carrying value of $111.7 million, approximated the consideration received, resulting in an insignificant gain on the sale.
The elements of the net commission and reimbursements earned under the Restated Marketing Agreement and Third Restated Agreement and included in “Net sales” are as follows:
Year Ended September 30 | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Gross commission | $ | $ | $ | ||||||||
Contribution expenses | ( | ) | ( | ) | ( | ) | |||||
Amortization of marketing fee | ( | ) | ( | ) | |||||||
Net commission | |||||||||||
Reimbursements associated with Roundup® marketing agreement | |||||||||||
Total net sales associated with Roundup® marketing agreement | $ | $ | $ | ||||||||
83
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 8. ACQUISITIONS AND INVESTMENTS
FISCAL 2018
Sunlight Supply
On June 4, 2018, the Company’s Hawthorne segment acquired substantially all of the assets and certain liabilities of Sunlight Supply, Inc., Sunlight Garden Supply, Inc., Sunlight Garden Supply, ULC, and IP Holdings, LLC, and all of the issued and outstanding equity interests of Columbia River Industrial Holdings, LLC (collectively “Sunlight Supply”), a Vancouver, Washington based leading developer, manufacturer, marketer and distributer of horticultural, organics, lighting, and hydroponics products. Prior to the transaction, Sunlight Supply served as a non-exclusive distributor of the Company. The purchase price of Sunlight Supply was $459.1 million, a portion of which was paid by the issuance of 0.3 million Common Shares, a non-cash investing and financing activity, with a fair value of $23.4 million based on the average share price at the time of payment. The purchase price included contingent consideration, a non-cash investing activity, with an initial fair value of $3.1 million and a maximum payout of $20.0 million, which was finalized during the third quarter of fiscal 2019 and resulted in no additional payment by the Company. The purchase price was also subject to a post-closing net working capital adjustment which was paid during the first quarter of fiscal 2019.
The valuation of the acquired assets included (i) $5.3 million of cash, prepaid and other current assets, (ii) $19.3 million of accounts receivable, (iii) $84.3 million of inventory, (iv) $64.4 million of fixed assets, (v) $11.7 million of accounts payable and other current liabilities, (vi) $151.1 million of finite-lived identifiable intangible assets, and (vii) $146.4 million of tax-deductible goodwill. Identifiable intangible assets included tradenames of $65.1 million, customer relationships of $84.1 million and non-competes of $1.9 million with useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. The contingent consideration related to the Sunlight Supply acquisition was required to be accounted for as a derivative instrument and was recorded at fair value in the “Other current liabilities” line in the Consolidated Balance Sheets, with changes in fair value recognized in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The estimated fair value of the contingent consideration was $0.9 million as of September 30, 2018 and the fair value measurement was classified in Level 3 of the fair value hierarchy.
The acquisition of Sunlight Supply also resulted in the settlement of a portion of certain previously acquired customer relationships, which resulted in a non-cash impairment charge of $17.5 million recognized in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during the third quarter of fiscal 2018 to reduce the carrying value of these previously acquired customer relationship intangible assets to an estimated fair value of $30.9 million. The estimated fair value was determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate, and has been included as part of goodwill. Additionally, the Company reduced the value of deferred tax liabilities associated with the write-off of these previously acquired customer relationship intangible assets by $7.3 million, which was recognized in the “Income tax expense (benefit) from continuing operations” line in the Consolidated Statement of Operations for fiscal 2018.
The following unaudited pro forma information presents the combined results of operations as if the acquisition of Sunlight Supply had occurred at the beginning of fiscal 2017. Sunlight Supply’s pre-acquisition results have been added to the Company’s historical results. The pro forma results contained in the table below include adjustments for (i) the elimination of intercompany sales, (ii) amortization of acquired intangibles, (iii) increased depreciation expense as a result of acquisition date fair value adjustments, (iv) increased cost of goods sold for fiscal 2017 and decreased cost of goods sold for fiscal 2018 related to the acquisition date inventory fair value adjustment, (v) increased interest expense related to the financing of the acquisition, (vi) removal of the non-cash impairment charge of $17.5 million during the third quarter of fiscal 2018 related to the settlement of a portion of certain previously acquired customer relationships due to the acquisition of Sunlight Supply, (vii) adjustments to tax expense based on condensed consolidated pro forma results, and (viii) the impact of additional Common Shares issued as a result of the acquisition. The pro forma information does not reflect the realization of any potential cost savings or other synergies from the acquisition as a result of restructuring activities and other cost savings initiatives. These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.
84
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Year Ended September 30 | |||||||
Unaudited Consolidated Pro Forma Results | 2018 | 2017 | |||||
(In millions, except for common share data) | |||||||
Proforma net sales | $ | $ | |||||
Proforma net income attributable to controlling interest | |||||||
Proforma diluted net income per common share | |||||||
Gavita
On May 26, 2016, the Company’s Hawthorne segment acquired majority control and a 75 % economic interest in Gavita. Gavita’s former ownership group initially retained a 25 % noncontrolling interest in Gavita consisting of ownership of 5 % of the outstanding shares of Gavita and a loan with interest payable based on distributions by Gavita. The loan was recorded at fair value in the “Long-term debt” line in the Consolidated Balance Sheets. During the fourth quarter of fiscal 2017, the Company recorded a charge of $13.4 million to write-up the fair value of the loan to the noncontrolling ownership group of Gavita to the agreed upon buyout value in the “Other non-operating (income) expense” line in the Consolidated Statements of Operations. On October 2, 2017, the Company’s Hawthorne segment acquired the remaining 25 % noncontrolling interest in Gavita, including Agrolux, for $69.2 million, plus payment of contingent consideration of $3.0 million. The carrying value of the 25 % noncontrolling interest consisted of long-term debt of $55.6 million and noncontrolling interest of $7.9 million. The difference between purchase price and carrying value of $5.7 million was recognized in the “Common shares and capital in excess of $0.01 stated value per share” line within “Total equity—controlling interest” in the Consolidated Balance Sheets.
Can-Filters
On October 11, 2017, the Company’s Hawthorne segment completed the acquisition of substantially all of the U.S. and Canadian assets of Can-Filters Group Inc. (“Can-Filters”) for $74.1 million. Based in British Columbia, Can-Filters is a wholesaler of ventilation products for indoor and hydroponic gardening and industrial market customers. The valuation of the acquired assets included (i) $1.5 million of cash, prepaid and other current assets, (ii) $7.7 million of inventory and accounts receivable, (iii) $4.4 million of fixed assets, (iv) $0.7 million of accounts payable and other current liabilities, (v) $39.7 million of finite-lived identifiable intangible assets, and (vi) $21.5 million of tax-deductible goodwill. Identifiable intangible assets included tradenames and customer relationships with useful lives of 25 years. The estimated fair value of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Net sales for Can-Filters included within the Hawthorne segment for fiscal 2018 were $10.7 million.
FISCAL 2017
Agrolux
On May 26, 2017, the Company’s majority-owned subsidiary Gavita completed the acquisition of Agrolux for $21.8 million. Based in the Netherlands, Agrolux is a worldwide supplier of horticultural lighting. The purchase price included contingent consideration, a non-cash investing activity, with a maximum payout and initial fair value of $5.2 million, which was paid during the third quarter of fiscal 2018. The valuation of the acquired assets included (i) $8.0 million of cash, prepaid and other current assets, (ii) $9.9 million of inventory and accounts receivable, (iii) $0.5 million of fixed assets, (iv) $8.6 million of accounts payable and other current liabilities, (v) $6.7 million of short-term debt, (vi) $16.1 million of finite-lived identifiable intangible assets, (vii) $6.6 million of non-deductible goodwill, and (viii) $4.0 million of deferred tax liabilities. Identifiable intangible assets included tradenames and customer relationships with useful lives ranging between 10 and 20 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Net sales for Agrolux included within the Hawthorne segment for fiscal 2018 and fiscal 2017 were $53.2 million and $16.4 million, respectively.
85
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Botanicare
On October 3, 2016, the Company’s Hawthorne segment completed the acquisition of Botanicare, an Arizona-based leading producer of plant nutrients, plant supplements and growing systems used for hydroponic gardening, for $92.6 million. The purchase price included contingent consideration, a non-cash investing activity, of $15.5 million, which was paid during the third quarter of fiscal 2017. The valuation of the acquired assets included (i) $1.2 million of cash, prepaid and other current assets, (ii) $8.4 million of inventory and accounts receivable, (iii) $1.4 million of fixed assets, (iv) $2.3 million of accounts payable and other current liabilities, (v) $53.0 million of finite-lived identifiable intangible assets, and (vi) $30.9 million of tax-deductible goodwill. Identifiable intangible assets included tradenames, customer relationships and non-compete arrangements with useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.
Other
On August 11, 2017, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of the exclusive manufacturer and formulator of branded Botanicare products for $32.0 million. The valuation of the acquired assets included (i) $0.3 million of inventory, (ii) $5.0 million of finite-lived identifiable intangible assets, and (iii) $26.7 million of tax-deductible goodwill. Identifiable intangible assets included manufacturing know-how and non-compete agreements with useful lives ranging between 5 and 10 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate.
During the first quarter of fiscal 2017, the Company’s U.S. Consumer segment completed two acquisitions of companies whose products support water positive landscapes and internet-enabled technology for an aggregate purchase price of $3.2 million. The valuation of the acquired assets for the transactions included finite-lived identifiable intangible assets and goodwill of $2.8 million. During the third quarter of fiscal 2017, the Company’s Hawthorne segment completed the acquisition of a company focused on the technology supporting hydroponic growing systems for an aggregate purchase price of $3.5 million, which included finite-lived identifiable intangible assets of $3.2 million.
NOTE 9. INVESTMENT IN UNCONSOLIDATED AFFILIATES
On April 13, 2016, pursuant to the terms of the Contribution and Distribution Agreement (the “Contribution Agreement”) between the Company and TruGreen Holding Corporation (“TruGreen Holdings”), the Company completed the contribution of the Scotts LawnService® business (the “SLS Business”) to Outdoor Home Services Holdings LLC, a lawn services joint venture between the Company and TruGreen Holding Corporation (the “TruGreen Joint Venture”), in exchange for a minority equity interest of approximately 30% in the TruGreen Joint Venture. The Company’s interest had an initial fair value of $294.0 million and was accounted for using the equity method of accounting. In connection with the closing of the transactions contemplated by the Contribution Agreement on April 13, 2016, the TruGreen Joint Venture obtained debt financing and made a distribution of $196.2 million to the Company and the Company invested $18.0 million in second lien term loan financing to the TruGreen Joint Venture. The Company was reimbursed $1.4 million and $40.2 million during fiscal 2018 and fiscal 2017, respectively, for expenses incurred pursuant to a short-term transition services agreement, payments on claims associated with insurance programs and an employee leasing agreement. During the fourth quarter of fiscal 2017, the Company received an $87.1 million distribution from the TruGreen Joint Venture in connection with its August 2017 debt refinancing. In the first quarter of fiscal 2018, the Company’s net investment and advances were reduced to a liability and subsequently the Company no longer recorded its proportionate share of the TruGreen Joint Venture earnings in the Consolidated Statements of Operations. The Company received cumulative distributions from the TruGreen Joint Venture in excess of its investment balance, which resulted in an amount recorded in the “Distributions in excess of investment in unconsolidated affiliate” line in the Consolidated Balance Sheets of $21.9 million at September 30, 2018. The Company does not have any contractual obligations to fund losses of the TruGreen Joint Venture.
On March 19, 2019, the Company entered into an agreement under which it sold all of its approximately 30% equity interest in the TruGreen Joint Venture to TruGreen Companies L.L.C., a subsidiary of TruGreen Holding Corporation. In connection with this transaction, the Company received cash proceeds of $234.2 million related to the sale of its equity interest in the TruGreen Joint Venture and $18.4 million related to the payoff of second lien term loan financing, which was previously recorded in the “Other assets” line in the Consolidated Balance Sheets. During fiscal 2019, the Company also received a distribution from the TruGreen Joint Venture intended to cover certain required tax payments of $3.5 million, which was classified as an investing activity in the Consolidated Statements of Cash Flows. During fiscal 2019, the Company recognized a pre-tax gain of $259.8 million related to this sale in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations. The Company made cash tax payments of $99.5 million as a result of the sale of the Company’s equity interest, of which $47.1
86
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
million was previously recorded as deferred tax liabilities and classified in the “Other liabilities” line in the Consolidated Balance Sheets at September 30, 2018.
NOTE 10. RETIREMENT PLANS
The Company sponsors a defined contribution 401(k) plan for substantially all U.S. associates. The Company matches 200 % of associates’ initial 3 % contribution and 50 % of their remaining contribution up to 6 %. The Company may make additional discretionary profit sharing matching contributions to eligible employees on their initial 3 % contribution. The Company recorded charges of $18.9 million, $15.3 million and $13.9 million under the plan in fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
The Company sponsors two defined benefit pension plans for certain U.S. associates and three defined benefit pension plans associated with the former businesses in the United Kingdom and Germany. Benefits under these plans have been frozen and closed to new associates since 1997 for the U.S. plans, 2010 for the United Kingdom plans and 2017 for the Germany plan. The benefits under the plans are based on years of service and compensation levels. The Company’s funding policy, consistent with statutory requirements and tax considerations, is based on actuarial computations using the Projected Unit Credit method.
The following tables present information about benefit obligations, plan assets, annual expense, assumptions and other information about the Company’s defined benefit pension plans. The defined benefit pension plans are valued using a September 30 measurement date.
U.S. Defined Benefit Pension Plans | International Defined Benefit Pension Plans | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
(In millions) | |||||||||||||||
Change in projected benefit obligation: | |||||||||||||||
Benefit obligation at beginning of year | $ | $ | $ | $ | |||||||||||
Interest cost | |||||||||||||||
Actuarial (gain) loss | ( | ) | ( | ) | |||||||||||
Benefits paid | ( | ) | ( | ) | ( | ) | ( | ) | |||||||
Other | — | — | — | ||||||||||||
Foreign currency translation | — | — | ( | ) | ( | ) | |||||||||
Projected benefit obligation at end of year | $ | $ | $ | $ | |||||||||||
Accumulated benefit obligation at end of year | $ | $ | $ | $ | |||||||||||
Change in plan assets: | |||||||||||||||
Fair value of plan assets at beginning of year | $ | $ | $ | $ | |||||||||||
Actual return on plan assets | |||||||||||||||
Employer contribution | |||||||||||||||
Benefits paid | ( | ) | ( | ) | ( | ) | ( | ) | |||||||
Foreign currency translation | — | — | ( | ) | ( | ) | |||||||||
Fair value of plan assets at end of year | $ | $ | $ | $ | |||||||||||
Overfunded (underfunded) status at end of year | $ | ( | ) | $ | ( | ) | $ | $ | |||||||
87
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
U.S. Defined Benefit Pension Plans | International Defined Benefit Pension Plans | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
(In millions) | |||||||||||||||
Information for pension plans with an accumulated benefit obligation in excess of plan assets: | |||||||||||||||
Projected benefit obligation | $ | $ | $ | $ | |||||||||||
Accumulated benefit obligation | |||||||||||||||
Fair value of plan assets | |||||||||||||||
Amounts recognized in the Consolidated Balance Sheets consist of: | |||||||||||||||
Noncurrent assets | $ | $ | $ | $ | |||||||||||
Current liabilities | ( | ) | ( | ) | ( | ) | ( | ) | |||||||
Noncurrent liabilities | ( | ) | ( | ) | ( | ) | ( | ) | |||||||
Total amount accrued | $ | ( | ) | $ | ( | ) | $ | $ | |||||||
Amounts recognized in accumulated other comprehensive loss consist of: | |||||||||||||||
Actuarial loss | $ | $ | $ | $ | |||||||||||
Prior service cost | — | — | |||||||||||||
Total amount recognized | $ | $ | $ | $ | |||||||||||
U.S. Defined Benefit Pension Plans | International Defined Benefit Pension Plans | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
(In millions, except percentage figures) | |||||||||||||||
Total change in other comprehensive loss attributable to: | |||||||||||||||
Pension benefit gain (loss) during the period | $ | ( | ) | $ | $ | ( | ) | $ | |||||||
Reclassification of pension benefit losses to net income | |||||||||||||||
Prior service cost recognized during the period | ( | ) | |||||||||||||
Foreign currency translation | |||||||||||||||
Total change in other comprehensive loss | $ | ( | ) | $ | $ | ( | ) | $ | |||||||
Amounts in accumulated other comprehensive loss expected to be recognized as components of net periodic benefit cost in fiscal 2020 are as follows: | |||||||||||||||
Actuarial loss | $ | $ | |||||||||||||
Prior service cost | |||||||||||||||
Amount to be amortized into net periodic benefit cost | $ | $ | |||||||||||||
Weighted average assumptions used in development of projected benefit obligation: | |||||||||||||||
Discount rate | % | % | % | % | |||||||||||
88
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
U.S. Defined Benefit Pension Plans | International Defined Benefit Pension Plans | ||||||||||||||||||||||
2019 | 2018 | 2017 | 2019 | 2018 | 2017 | ||||||||||||||||||
(In millions, except percentage figures) | |||||||||||||||||||||||
Components of net periodic benefit (income) cost: | |||||||||||||||||||||||
Service cost | $ | — | $ | — | $ | — | $ | — | $ | — | $ | ||||||||||||
Interest cost | |||||||||||||||||||||||
Expected return on plan assets | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Net amortization | |||||||||||||||||||||||
Net periodic benefit (income) cost | — | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||
Settlement | — | — | — | ||||||||||||||||||||
Total benefit (income) cost | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | |||||||||||
Weighted average assumptions used in development of net periodic benefit (income) cost: | |||||||||||||||||||||||
Weighted average discount rate - service cost | n/a | n/a | n/a | n/a | n/a | % | |||||||||||||||||
Weighted average discount rate - interest cost | % | % | % | % | % | % | |||||||||||||||||
Expected return on plan assets | % | % | % | % | % | % | |||||||||||||||||
Rate of compensation increase | n/a | n/a | n/a | n/a | n/a | % | |||||||||||||||||
Investment Strategy
Target allocation percentages among various asset classes are maintained based on an individual investment policy established for each of the various pension plans. Asset allocations are designed to achieve long-term objectives of return while mitigating against downside risk considering expected cash requirements necessary to fund benefit payments. However, the Company cannot predict future investment returns and therefore cannot determine whether future pension plan funding requirements could materially and adversely affect its financial condition, results of operations or cash flows.
Basis for Long-Term Rate of Return on Asset Assumptions
The Company’s expected long-term rate of return on asset assumptions are derived from studies conducted by third parties. The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings expected. While the studies give appropriate consideration to recent fund performance and historical returns, the assumptions primarily represent expectations about future rates of return over the long term.
89
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
U.S. Defined Benefit Pension Plans | International Defined Benefit Pension Plans | ||||||
(In millions, except percentage figures) | |||||||
Other information: | |||||||
Plan asset allocations: | |||||||
Target for September 30, 2020: | |||||||
Equity securities | % | % | |||||
Debt securities | % | % | |||||
Real estate securities | % | % | |||||
Cash and cash equivalents | % | % | |||||
September 30, 2019 | |||||||
Equity securities | % | % | |||||
Debt securities | % | % | |||||
Real estate securities | % | % | |||||
Cash and cash equivalents | % | % | |||||
September 30, 2018 | |||||||
Equity securities | % | % | |||||
Debt securities | % | % | |||||
Real estate securities | % | % | |||||
Cash and cash equivalents | % | % | |||||
Insurance contracts | % | % | |||||
Expected company contributions in fiscal 2020 | $ | $ | |||||
Expected future benefit payments: | |||||||
2020 | $ | $ | |||||
2021 | |||||||
2022 | |||||||
2023 | |||||||
2024 | |||||||
2025 – 2029 | |||||||
The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy (in millions):
U.S. Defined Benefit Pension Plans | International Defined Benefit Pension Plans | |||||||||||||||||
Fair Value Hierarchy Level | 2019 | 2018 | 2019 | 2018 | ||||||||||||||
Cash and cash equivalents | Level 1 | $ | $ | $ | $ | |||||||||||||
Mutual funds—real estate | Level 2 | |||||||||||||||||
Mutual funds—equities | Level 2 | |||||||||||||||||
Mutual funds—fixed income | Level 2 | |||||||||||||||||
Insurance contracts | Level 2 | |||||||||||||||||
Total | $ | $ | $ | $ | ||||||||||||||
90
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 11. ASSOCIATE MEDICAL BENEFITS
The Company provides comprehensive major medical benefits to its associates. The Company is self-insured for certain health benefits up to $0.7 million per occurrence per individual. The cost of such benefits is recognized as expense in the period the claim is incurred. This cost was $31.4 million, $31.2 million and $33.4 million in fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
The Company also provides comprehensive major medical benefits to certain retired associates and their dependents. Substantially all of the Company’s domestic associates who were hired before January 1, 1998 become eligible for these benefits if they retire at age 55 or older with more than ten years of service. The retiree medical plan requires certain minimum contributions from retired associates and includes provisions to limit the overall cost increases the Company is required to cover. The Company funds its portion of retiree medical benefits on a pay-as-you-go basis.
The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.
2019 | 2018 | ||||||
(In millions, except percentage figures) | |||||||
Change in Accumulated Plan Benefit Obligation (APBO): | |||||||
Benefit obligation at beginning of year | $ | $ | |||||
Service cost | |||||||
Interest cost | |||||||
Plan participants’ contributions | |||||||
Actuarial (gain) loss | ( | ) | |||||
Benefits paid | ( | ) | ( | ) | |||
Benefit obligation at end of year | $ | $ | |||||
Change in plan assets: | |||||||
Fair value of plan assets at beginning of year | $ | $ | |||||
Employer contribution | |||||||
Plan participants’ contributions | |||||||
Gross benefits paid | ( | ) | ( | ) | |||
Fair value of plan assets at end of year | $ | $ | |||||
Unfunded status at end of year | $ | ( | ) | $ | ( | ) | |
2019 | 2018 | ||||||
(In millions, except percentage figures) | |||||||
Amounts recognized in the Consolidated Balance Sheets consist of: | |||||||
Current liabilities | $ | ( | ) | $ | ( | ) | |
Noncurrent liabilities | ( | ) | ( | ) | |||
Total amount accrued | $ | ( | ) | $ | ( | ) | |
Amounts recognized in accumulated other comprehensive (income) loss consist of: | |||||||
Actuarial loss | $ | $ | |||||
Prior service credit | ( | ) | ( | ) | |||
Total amount recognized | $ | ( | ) | $ | ( | ) | |
Total change in other comprehensive (income) loss attributable to: | |||||||
Benefit loss (gain) during the period | $ | $ | ( | ) | |||
Reclassification of prior service credit and benefit loss to net income | |||||||
Total change in other comprehensive (income) loss | $ | $ | ( | ) | |||
Discount rate used in development of APBO | % | % | |||||
91
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Net periodic benefit (income) cost was $(0.1 ) million, $0.1 million and $0.3 million during fiscal 2019, fiscal 2018 and fiscal 2017, respectively. The estimated actuarial loss and prior service credit that will be amortized from accumulated loss into net periodic benefit cost over the next fiscal year is $0.2 million and $1.1 million, respectively.
For measurement as of September 30, 2019, management has assumed that health care costs will increase at an annual rate of 6.25 %, and thereafter decreasing to an ultimate trend rate of 4.75 % in 2026. A 100 basis point change in health cost trend rate assumptions would not have a material effect on service costs, interest costs or the APBO.
The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:
Gross Benefit Payments | Retiree Contributions | Net Company Payments | |||||||||
(In millions) | |||||||||||
2020 | $ | $ | ( | ) | $ | ||||||
2021 | ( | ) | |||||||||
2022 | ( | ) | |||||||||
2023 | ( | ) | |||||||||
2024 | ( | ) | |||||||||
2025 – 2029 | ( | ) | |||||||||
NOTE 12. DEBT
The components of debt are as follows:
September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
Credit Facilities: | |||||||
Revolving loans | $ | $ | |||||
Term loans | |||||||
Senior Notes – 5.250% | |||||||
Senior Notes – 6.000% | |||||||
Receivables facility | |||||||
Capital lease obligations | |||||||
Other | |||||||
Total debt | |||||||
Less current portions | |||||||
Less unamortized debt issuance costs | |||||||
Long-term debt | $ | $ | |||||
92
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The Company’s aggregate scheduled maturities of debt and capital lease obligations are as follows (in millions):
Capital Lease Obligations | Debt | Total | |||||||||
2020 | $ | $ | $ | ||||||||
2021 | |||||||||||
2022 | |||||||||||
2023 | |||||||||||
2024 | |||||||||||
Thereafter | |||||||||||
Total | |||||||||||
Interest | ( | ) | — | ( | ) | ||||||
Total debt | $ | $ | $ | ||||||||
Credit Facilities
On July 5, 2018, the Company entered into a fifth amended and restated credit agreement (the “Fifth A&R Credit Agreement”), providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2.3 billion, comprised of a revolving credit facility of $1.5 billion and a term loan in the original principal amount of $800.0 million (the “Fifth A&R Credit Facilities”).
At September 30, 2019, the Company had letters of credit outstanding in the aggregate principal amount of $26.7 million, and $1,326.2 million of borrowing availability under the Fifth A&R Credit Agreement. The weighted average interest rates on average borrowings under the Fifth A&R Credit Agreement and the former credit agreement were 4.6 %, 4.0 % and 3.9 % for fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
The Fifth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio on the last day of each quarter calculated as average total indebtedness, divided by the Company’s earnings before interest, taxes, depreciation and amortization (“EBITDA”), as adjusted pursuant to the terms of the Fifth A&R Credit Agreement (“Adjusted EBITDA”). The maximum leverage ratio is: (i) 5.00 for the third quarter of fiscal 2019 through the first quarter of fiscal 2020; (ii) 4.75 for the second quarter of fiscal 2020 through the fourth quarter of fiscal 2020; and (iii) 4.50 for the first quarter of fiscal 2021 and thereafter. The Company’s leverage ratio was 3.67 at September 30, 2019. The Fifth A&R Credit Agreement also contains an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters. The interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the Fifth A&R Credit Agreement, and excludes costs related to refinancings. The minimum interest coverage ratio was 3.00 for the twelve months ended September 30, 2019. The Company’s interest coverage ratio was 5.78 for the twelve months ended September 30, 2019.
The Fifth A&R Credit Agreement allows the Company to make unlimited restricted payments (as defined in the Fifth A&R Credit Agreement), including dividend payments and Common Share repurchases, as long as the leverage ratio resulting from the making of such restricted payments is 4.00 or less. Otherwise, the Company may make further restricted payments in an aggregate amount for each fiscal year not to exceed the amount set forth in the Fifth A&R Credit Agreement for such fiscal year ($200.0 million for fiscal 2019 and $225.0 million for fiscal 2020 and thereafter).
Senior Notes
On October 13, 2015, Scotts Miracle-Gro issued $400.0 million aggregate principal amount of 6.000 % Senior Notes due 2023 (the “6.000% Senior Notes”). On December 15, 2016, Scotts Miracle-Gro issued $250.0 million aggregate principal amount of 5.250 % Senior Notes due 2026 (the “5.250 % Senior Notes”). The 6.000 % and 5.250 % Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 6.000 % Senior Notes have interest payment dates of April 15 and October 15 of each year. The 5.250 % Senior Notes have interest payment dates of June 15 and December 15 of each year. Substantially all of Scotts Miracle-Gro’s domestic subsidiaries serve as guarantors of the 6.000 % and 5.250 % Senior Notes.
93
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
On October 22, 2019, Scotts Miracle-Gro issued $450.0 million aggregate principal amount of 4.500 % Senior Notes due 2029 (the “4.500 % Senior Notes”). The net proceeds of the offering were used to redeem all of our outstanding 6.000 % Senior Notes and for general corporate purposes. The 4.500 % Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.500 % Senior Notes have interest payment dates of April 15 and October 15 of each year, commencing April 15, 2020. Substantially all of Scotts Miracle-Gro’s domestic subsidiaries serve as guarantors of the 4.500 % Senior Notes.
On October 23, 2019, Scotts Miracle-Gro redeemed all of its outstanding 6.000 % Senior Notes for a redemption price of $412.5 million, comprised of $0.5 million of accrued and unpaid interest, $12.0 million of redemption premium, and $400.0 million for outstanding principal amount. The $12.0 million redemption premium will be recognized in the Company’s first quarter of fiscal 2020. As of September 30, 2019, the Company classified the $400.0 million of 6.000 % Senior Notes as long-term debt on the Consolidated Balance Sheet. Additionally, the Company had $3.1 million in unamortized bond issuance costs as of September 30, 2019, which will be written-off in the Company’s first quarter of fiscal 2020.
Receivables Facility
On April 7, 2017, the Company entered into a Master Repurchase Agreement (including the annexes thereto, the “Repurchase Agreement”) and a Master Framework Agreement, as amended annually (the “Framework Agreement” and, together with the Repurchase Agreement, the “Receivables Facility”). Under the Receivables Facility, the Company may sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers and simultaneously agree to repurchase the receivables on a weekly basis. The eligible accounts receivable consist of accounts receivable generated by sales to three specified customers. The Receivables Facility expires on August 21, 2020. The eligible amount of customer accounts receivables which may be sold under the Receivables Facility is $400.0 million and the commitment amount during the seasonal commitment period beginning on February 28, 2020 and ending on June 19, 2020 is $160.0 million.
The Company accounts for the sale of receivables under the Receivables Facility as short-term debt and continues to carry the receivables on its Consolidated Balance Sheets, primarily as a result of the Company’s requirement to repurchase receivables sold. As of September 30, 2019 and 2018, there were $76.0 million in borrowings on receivables pledged as collateral under the Receivables Facility, and the carrying value of the receivables pledged as collateral was $84.5 million. As of September 30, 2019 and 2018, there was $0.1 million and $0.4 million, respectively, of availability under the Receivables Facility.
Interest Rate Swap Agreements
The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $850.0 million and $800.0 million at September 30, 2019 and 2018, respectively. Interest payments made between the effective date and expiration date are hedged by the swap agreements, except as noted below.
The notional amount, effective date, expiration date and rate of each of these swap agreements outstanding at September 30, 2019 are shown in the table below:
Notional Amount (in millions) | Effective Date (a) | Expiration Date | Fixed Rate | ||||||
$ | (b) | 1/8/2018 | 6/8/2020 | % | |||||
6/20/2018 | 10/20/2020 | % | |||||||
(b) | 11/7/2018 | 6/7/2021 | % | ||||||
11/7/2018 | 7/7/2021 | % | |||||||
11/7/2018 | 10/7/2021 | % | |||||||
(a) | The effective date refers to the date on which interest payments were first hedged by the applicable swap agreement. |
(b) | Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time. |
The weighted average interest rates on the Company’s debt were 4.8 %, 4.3 % and 4.6 % for fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
94
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 13. EQUITY
Authorized and issued shares consisted of the following:
September 30, | |||
2019 | 2018 | ||
(In millions) | |||
Preferred shares, no par value: | |||
Authorized | |||
Issued | |||
Common shares, no par value, $.01 stated value per share: | |||
Authorized | |||
Issued | |||
In fiscal 1995, The Scotts Company merged with Stern’s Miracle-Gro Products, Inc. (“Miracle-Gro”). At September 30, 2019, the former shareholders of Miracle-Gro, including the Hagedorn Partnership, L.P., owned approximately 26 % of Scotts Miracle-Gro’s outstanding Common Shares on a fully diluted basis and, thus, have the ability to significantly influence the election of directors and other actions requiring the approval of Scotts Miracle-Gro’s shareholders.
Under the terms of the merger agreement with Miracle-Gro, the former shareholders of Miracle-Gro may not collectively acquire, directly or indirectly, beneficial ownership of Voting Stock (as that term is defined in the Miracle-Gro merger agreement) representing more than 49 % of the total voting power of the outstanding Voting Stock, except pursuant to a tender offer for 100 % of that total voting power, which tender offer is made at a price per share which is not less than the market price per share on the last trading day before the announcement of the tender offer and is conditioned upon the receipt of at least 50 % of the Voting Stock beneficially owned by shareholders of Scotts Miracle-Gro other than the former shareholders of Miracle-Gro and their affiliates and associates.
Accumulated Other Comprehensive Loss
During the second quarter of fiscal 2019, the Company recognized a charge of $2.5 million in the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations related to the write-off of accumulated foreign currency translation loss adjustments of a foreign subsidiary that was substantially liquidated. During the second quarter of fiscal 2018, the Company repatriated cash from a foreign subsidiary resulting in the liquidation of substantially all of the assets of the subsidiary and the write-off of accumulated foreign currency translation loss adjustments of $11.7 million within the “Other non-operating (income) expense, net” line in the Consolidated Statements of Operations.
Dividends
On August 6, 2018, Scotts Miracle-Gro announced that its Board of Directors approved an increase in the Company’s quarterly cash dividend from $0.53 to $0.55 per Common Share. On July 30, 2019, the Scotts Miracle-Gro Board of Directors approved an additional increase in the Company’s quarterly cash dividend from $0.55 to $0.58 per Common Share.
Share Repurchases
In August 2014, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $500.0 million of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 million increase to the share repurchase authorization ending on September 30, 2019. On August 2, 2019, the Scotts Miracle-Gro Board of Directors authorized an extension of the current share repurchase authorization through March 28, 2020. The amended authorization allows for repurchases of Common Shares of up to an aggregate amount of $1.0 billion through March 28, 2020. The authorization provides the Company with flexibility to purchase Common Shares from time to time in open market purchases or through privately negotiated transactions. All or part of the repurchases may be made under Rule 10b5-1 plans, which the Company may enter into from time to time and which enable the repurchases to occur on a more regular basis, or pursuant to accelerated share repurchases. The share repurchase authorization may be suspended or discontinued by the Board of Directors at any time, and there can be no guarantee as to the timing or amount of any repurchases. There were no share repurchases under the program during fiscal 2019. During fiscal 2018 and fiscal 2017, Scotts Miracle-Gro repurchased 3.5 million and 2.7 million Common Shares for $323.1 million and $245.8 million, respectively. From the inception of this share repurchase program in the fourth quarter of fiscal 2014 through September 30, 2019, Scotts Miracle-Gro repurchased approximately 8.3 million Common Shares for $714.6 million. The “Treasury share purchases” lines in the Consolidated Statements of Shareholders’ Equity includes cash paid to tax authorities to satisfy statutory income tax
95
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
withholding obligations related to share-based compensation of $2.7 million, $3.0 million and $9.2 million for fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
Acquisition of Sunlight Supply
On June 4, 2018, Scotts Miracle-Gro issued 0.3 million Common Shares, which represented a carrying value of $20.7 million, out of its treasury shares for payment of a portion of the purchase price for the acquisition of Sunlight Supply.
Gavita
On October 2, 2017, the Company’s Hawthorne segment acquired the remaining 25 % noncontrolling interest in Gavita, including Agrolux, for $69.2 million, plus payment of contingent consideration of $3.0 million. The carrying value of the 25 % noncontrolling interest consisted of long-term debt of $55.6 million and noncontrolling interest of $7.9 million. The difference between purchase price and carrying value of $5.7 million was recognized in the “Common shares and capital in excess of $0.01 stated value per share” line within “Total equity—controlling interest” in the Consolidated Balance Sheets.
Exercise of Outstanding AeroGrow Warrants
On November 29, 2016, the Company’s wholly-owned subsidiary SMG Growing Media, Inc. fully exercised its outstanding warrants to acquire additional shares of common stock of AeroGrow for an aggregate warrant exercise price of $47.8 million in exchange for the issuance of 21.6 million shares of common stock of AeroGrow, which increased the Company’s percentage ownership of AeroGrow’s outstanding shares of common stock (on a fully diluted basis) from 45 % to 80 %. The financial results of AeroGrow have been consolidated into the Company’s consolidated financial statements since the fourth quarter of fiscal 2014, when the Company obtained control of AeroGrow’s operations through increased involvement, influence and a working capital loan provided to AeroGrow. Following the exercise of the warrants, the Board of Directors of AeroGrow declared a $40.5 million distribution ($1.21 per share) payable on January 3, 2017 to shareholders of record on December 20, 2016. On January 3, 2017, AeroGrow paid a distribution of $8.1 million to its noncontrolling interest holders.
Share-Based Awards
Scotts Miracle-Gro grants share-based awards annually to officers and certain other employees of the Company and non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based awards. All of these share-based awards have been made under plans approved by the shareholders. Generally, employee share-based awards provide for three-year cliff vesting. Vesting for non-employee director awards is generally one year from the time of the award. Vesting of performance-based awards is dependent on service and achievement of specified performance targets. Share-based awards are forfeited if a holder terminates employment or service with the Company prior to the vesting date, except in cases where employees are eligible for accelerated vesting based on having satisfied retirement requirements relating to age and years of service. The Company estimates that 15 % to 20 % of its share-based awards will be forfeited based on an analysis of historical trends. This assumption is re-evaluated on an annual basis and adjusted as appropriate. Stock options have exercise prices equal to the market price of the underlying Common Shares on the date of grant with a term of 10 years. If available, Scotts Miracle-Gro will typically use treasury shares, or if not available, newly-issued Common Shares, in satisfaction of its share-based awards.
On January 30, 2017, the Company issued 0.5 million upfront performance-based award units, covering a five-year performance period, with an estimated fair value of $43.3 million on the date of grant to certain senior executives as part of its Project Focus initiative. These awards provide for a five-year vesting period based on achievement of specific performance goals aligned with the strategic objectives of the Company’s Project Focus initiatives. Based on the extent to which the targets are achieved, vested shares may range from 50 to 250 percent of the target award amount. The performance goals include a combination of five year cumulative operating cash flow less capital expenditures; five year average annual non-GAAP diluted EPS growth; and dividend yield. The Company assesses the probability of achievement of performance goals each period and records expense for the awards based on the probable achievement of such metrics. Performance-based award units accrue cash dividend equivalents that are payable upon vesting of the awards.
On October 30, 2017, the Company issued 0.2 million upfront performance-based award units (the “Hawthorne PFAs”), covering a four-year performance period, with an estimated fair value of $20.2 million on the date of grant to certain Hawthorne segment employees as part of its Project Focus initiative. The Hawthorne PFAs were to vest after approximately four years subject to the achievement of specific performance goals aligned with the strategic objectives of the Company’s Project Focus initiatives. Based on the extent to which the performance goals were achieved, vested shares were to range from 50 to 250 percent of the target award amount. The performance goals were based on cumulative Hawthorne non-GAAP adjusted earnings. The Hawthorne PFAs were to accrue cash dividend equivalents payable upon vesting of the awards. During the first quarter of fiscal 2019, in light
96
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
of Hawthorne’s acquisition of Sunlight Supply and the fiscal 2018 downturn in the Hawthorne business, the Company authorized the cancellation of the Hawthorne PFAs and the issuance of a one-time performance bonus grant for certain Hawthorne segment employees with targets based on specified levels of Hawthorne non-GAAP adjusted earnings, subject to participant consent. The Company issued 0.1 million one-time performance bonus award units to Hawthorne segment employees during fiscal 2019.
A maximum of 7.3 million Common Shares are available for issuance under share-based award plans. At September 30, 2019, approximately 3.0 million Common Shares were not subject to outstanding awards and were available to underlie the grant of new share-based awards. Common Shares held in treasury totaling 0.5 million, 0.4 million and 0.5 million were reissued in support of share-based compensation awards and employee purchases under the employee stock purchase plan during fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
The following is a summary of the share-based awards granted during each of the periods indicated:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
Employees | |||||||||||
Restricted stock units | |||||||||||
Performance units | |||||||||||
Board of Directors | |||||||||||
Deferred stock units | |||||||||||
Total share-based awards | |||||||||||
Aggregate fair value at grant dates (in millions) | $ | $ | $ | ||||||||
Total share-based compensation was as follows for each of the periods indicated:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Share-based compensation | $ | $ | $ | ||||||||
Tax benefit recognized | |||||||||||
The tax benefit realized from the tax deductions associated with the exercise of share-based awards and the vesting of restricted stock totaled $2.8 million for fiscal 2019.
Stock Options
Aggregate stock option activity was as follows:
No. of Options | Wtd. Avg. Exercise Price | |||||
Awards outstanding at September 30, 2018 | $ | |||||
Granted | ||||||
Exercised | ( | ) | ||||
Forfeited | ||||||
Awards outstanding at September 30, 2019 | ||||||
Exercisable | ||||||
97
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
At September 30, 2019, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was zero . The total intrinsic value of stock options exercised was $17.5 million, $17.2 million and $14.5 million during fiscal 2019, fiscal 2018 and fiscal 2017, respectively. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $21.4 million, $10.5 million and $11.0 million for fiscal 2019, fiscal 2018 and fiscal 2017, respectively. The following summarizes certain information pertaining to stock option awards outstanding and exercisable at September 30, 2019 (options in millions):
Awards Outstanding | Awards Exercisable | |||||||||||||||||
Range of Exercise Price | No. of Options | Wtd. Avg. Remaining Life | Wtd. Avg. Exercise Price | No. of Options | Wtd. Avg. Remaining Life | Wtd. Avg. Exercise Price | ||||||||||||
$45.32 – $49.19 | $ | $ | ||||||||||||||||
$63.43 – $68.68 | ||||||||||||||||||
$ | $ | |||||||||||||||||
The intrinsic values of the stock option awards outstanding and exercisable at September 30, 2019 were as follows (in millions):
2019 | |||
Outstanding | $ | ||
Exercisable | |||
The grant date fair value of stock option awards is estimated using a binomial model. Expected market price volatility is based on implied volatilities from traded options on Common Shares and historical volatility specific to the Common Shares. Historical data, including demographic factors impacting historical exercise behavior, is used to estimate stock option exercises and employee terminations within the valuation model. The risk-free rate for periods within the contractual life (normally ten years) of the stock option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of stock options is based on historical experience and expectations for grants outstanding. No stock options were granted in fiscal 2019, fiscal 2018 or fiscal 2017.
Restricted share-based awards
Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:
No. of Shares | Wtd. Avg. Grant Date Fair Value per Share | |||||
Awards outstanding at September 30, 2018 | $ | |||||
Granted | ||||||
Vested | ( | ) | ||||
Forfeited | ( | ) | ||||
Awards outstanding at September 30, 2019 | ||||||
At September 30, 2019, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was $10.2 million, which is expected to be recognized over a weighted-average period of 1.8 years. The total fair value of restricted stock units and deferred stock units vested was $6.3 million during fiscal 2019 and fiscal 2018 and $8.7 million during fiscal 2017.
98
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Performance-based awards
Performance-based award activity was as follows (based on target award amounts):
No. of Units | Wtd. Avg. Grant Date Fair Value per Unit | |||||
Awards outstanding at September 30, 2018 | $ | |||||
Granted | ||||||
Vested | ( | ) | ||||
Forfeited | ( | ) | ||||
Awards outstanding at September 30, 2019 | ||||||
At September 30, 2019, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based units not yet recognized was $26.6 million, which is expected to be recognized over a weighted-average period of 2.1 years. The total fair value of performance-based units vested was $3.9 million, $3.4 million and $8.8 million during fiscal 2019, fiscal 2018 and fiscal 2017, respectively.
NOTE 14. EARNINGS PER COMMON SHARE
The following table presents information necessary to calculate basic and diluted income per Common Share.
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions, except per share data) | |||||||||||
Income from continuing operations | $ | $ | $ | ||||||||
Net (income) loss attributable to noncontrolling interest | ( | ) | |||||||||
Income attributable to controlling interest from continuing operations | |||||||||||
Income (loss) from discontinued operations, net of tax | ( | ) | |||||||||
Net income attributable to controlling interest | $ | $ | $ | ||||||||
BASIC INCOME PER COMMON SHARE: | |||||||||||
Weighted-average Common Shares outstanding during the period | |||||||||||
Income from continuing operations | $ | $ | $ | ||||||||
Income (loss) from discontinued operations | ( | ) | |||||||||
Net income | $ | $ | $ | ||||||||
DILUTED INCOME PER COMMON SHARE: | |||||||||||
Weighted-average Common Shares outstanding during the period | |||||||||||
Dilutive potential Common Shares | |||||||||||
Weighted-average number of Common Shares outstanding and dilutive potential Common Shares | |||||||||||
Income from continuing operations | $ | $ | $ | ||||||||
Income (loss) from discontinued operations | ( | ) | |||||||||
Net income | $ | $ | $ | ||||||||
Stock options with exercise prices greater than the average market price of the underlying Common Shares are excluded from the computation of diluted income per Common Share because they are out-of-the-money and the effect of their inclusion would be anti-dilutive. There were no Common Shares covered by out-of-the-money options for the year ended September 30, 2019, 2018 or 2017.
99
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 15. INCOME TAXES
The provision (benefit) for income taxes allocated to continuing operations consisted of the following:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Current: | |||||||||||
Federal | $ | $ | $ | ||||||||
State | |||||||||||
Foreign | |||||||||||
Total Current | |||||||||||
Deferred: | |||||||||||
Federal | ( | ) | ( | ) | ( | ) | |||||
State | ( | ) | ( | ) | ( | ) | |||||
Foreign | ( | ) | ( | ) | ( | ) | |||||
Total Deferred | ( | ) | ( | ) | ( | ) | |||||
Income tax expense (benefit) from continuing operations | $ | $ | ( | ) | $ | ||||||
The domestic and foreign components of income from continuing operations before income taxes were as follows:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Domestic | $ | $ | $ | ||||||||
Foreign | ( | ) | |||||||||
Income from continuing operations before income taxes | $ | $ | $ | ||||||||
A reconciliation of the federal corporate income tax rate and the effective tax rate on income from continuing operations before income taxes is summarized below:
Year Ended September 30, | ||||||||
2019 | 2018 | 2017 | ||||||
Statutory income tax rate | % | % | % | |||||
Effect of foreign operations | ||||||||
State taxes, net of federal benefit | ||||||||
Domestic Production Activities Deduction permanent difference | ( | ) | ( | ) | ||||
Effect of other permanent differences | ( | ) | ( | ) | ||||
Research and Experimentation and other federal tax credits | ( | ) | ( | ) | ( | ) | ||
Effect of tax contingencies | ||||||||
Effect of tax reform | ( | ) | ||||||
Other | ( | ) | ( | ) | ||||
Effective income tax rate | % | ( | )% | % | ||||
On December 22, 2017, the Act was signed into law. The Act made broad and complex changes to the Code that affected the Company’s financial results in two primary ways.
First, effective January 1, 2018, the Act reduced the U.S. federal corporate statutory income tax rate from 35% to 21%. As the Company’s fiscal year end falls on September 30, the federal corporate statutory tax rate for fiscal 2018 was prorated to 24.5 %, with the statutory rate for fiscal 2019 and beyond at 21%. As a result of the lower tax rate, the Company remeasured its U.S. deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future and recognized a one-time $44.6 million net tax benefit adjustment reflecting the revaluation of its net deferred tax liability at the lower tax rate.
100
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Second, due to the move to a territorial tax system, the Act required companies to pay a mandatory one-time U.S. transition tax on deemed repatriation of certain undistributed earnings of foreign subsidiaries. The Company recorded a provisional U.S. transition tax of $21.2 million for the year ended September 30, 2018 based on $97.8 million of undistributed earnings of foreign subsidiaries. This expense was largely offset by $18.2 million of foreign tax credits, $0.5 million of which was carried forward from prior periods and offset by a full valuation allowance. The transitional impact was finalized during the fiscal year ended September 30, 2019, with no material change to tax expense.
In addition, the Act established new tax provisions that became effective for the Company beginning October 1, 2018, including (1) eliminating the U.S. manufacturing deduction; (2) establishing new limitations on deductible interest expense and certain executive compensation; (3) creating the base erosion anti-abuse tax (“BEAT”); (4) creating a new provision designed to tax global intangible low-tax income (“GILTI”); (5) establishing a deduction for foreign-derived intangible income (“FDII”); and (6) generally eliminating U.S. federal income taxes on dividends from foreign subsidiaries. The net effects of these provisions of the Act were immaterial to the Company’s tax provision for the year ended September 30, 2019.
Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the deferred income tax assets and liabilities were as follows:
September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
DEFERRED TAX ASSETS | |||||||
Inventories | $ | $ | |||||
Accrued liabilities | |||||||
Postretirement benefits | |||||||
Accounts receivable | |||||||
Federal NOL carryovers | |||||||
State NOL carryovers | |||||||
Foreign NOL carryovers | |||||||
Foreign tax credit carryovers | |||||||
Interest rate swaps | |||||||
Other | |||||||
Gross deferred tax assets | |||||||
Valuation allowance | ( | ) | ( | ) | |||
Total deferred tax assets | |||||||
DEFERRED TAX LIABILITIES | |||||||
Property, plant and equipment | ( | ) | ( | ) | |||
Intangible assets | ( | ) | ( | ) | |||
Outside basis difference in equity investments | ( | ) | |||||
Interest rate swaps | ( | ) | |||||
Other | ( | ) | ( | ) | |||
Total deferred tax liabilities | ( | ) | ( | ) | |||
Net deferred tax liability | $ | ( | ) | $ | ( | ) | |
GAAP requires that a valuation allowance be recorded against a deferred tax asset if it is more likely than not that the tax benefit associated with the asset will not be realized in the future. As shown in the table above, valuation allowances were recorded against $35.8 million and $33.6 million of deferred tax assets as of September 30, 2019 and 2018, respectively. Most of these valuation allowances relate to certain credits and net operating losses (“NOLs”), as explained further below.
Deferred tax assets related to foreign NOLs of certain controlled foreign corporations were $4.6 million as of September 30, 2019, the majority of which have indefinite carryforward periods. Due to a history of losses in many of these entities, a valuation allowance has been established against $4.0 million of these deferred tax assets. A valuation allowance has also been established against deferred tax assets related to other foreign items of $1.8 million.
101
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Foreign tax credits were $16.8 million and $16.4 million at September 30, 2019 and 2018, respectively. A full valuation allowance has been established against these foreign tax credits as the Company does not expect to utilize them prior to their expiration.
Certain federal NOLs are subject to limitation under IRC §382 from current and prior ownership changes. The Company determined that $10.5 million of these deferred tax assets will expire unutilized due to the closing of statutes of limitation and has established a valuation allowance accordingly. The Company estimates that $0.4 million of deferred tax assets will be available for utilization in tax years ending after September 30, 2019. These remaining NOLs will be utilized gradually through the tax year ending September 30, 2032.
Deferred tax assets related to state NOLs were $2.1 million as of September 30, 2019, with carryforward periods ranging from 5 to 20 years. Any losses not utilized within a specific state’s carryforward period will expire. A valuation allowance was recorded against $1.5 million of these deferred tax assets as of September 30, 2019 for state NOLs that the Company does not expect to realize within their respective carryforward periods. Tax benefits associated with state tax credits will also expire if not utilized and amounted to $1.7 million and $1.4 million at September 30, 2019 and 2018, respectively. A valuation allowance in the amount of $1.2 million has been established related to state credits the Company does not expect to utilize.
As of September 30, 2019, the Company maintains its assertions of indefinite reinvestment of the earnings of all material foreign subsidiaries with the exception of the cumulative earnings of Scotts Luxembourg Sarl, which are generally taxed on a current basis under “Subpart F” of the Code which prevents deferral of recognition of U.S. taxable income through the use of foreign entities.
The Company had $29.5 million, $13.9 million and $10.2 million of gross unrecognized tax benefits related to uncertain tax positions at September 30, 2019, 2018 and 2017, respectively. Of these amounts, $6.7 million, $4.8 million and $0.7 million of gross unrecognized tax benefits are related to discontinued operations at September 30, 2019, 2018 and 2017, respectively. Included in the September 30, 2019, 2018 and 2017 balances were $25.2 million, $12.6 million and $8.5 million, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.
A reconciliation of the unrecognized tax benefits is as follows:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Balance at beginning of year | $ | $ | $ | ||||||||
Additions for tax positions of the current year | |||||||||||
Additions for tax positions of prior years | |||||||||||
Reductions for tax positions of prior years | ( | ) | ( | ) | ( | ) | |||||
Settlements with tax authorities | ( | ) | ( | ) | |||||||
Expiration of statutes of limitation | ( | ) | ( | ) | ( | ) | |||||
Balance at end of year | $ | $ | $ | ||||||||
The Company continues to recognize accrued interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes. As of September 30, 2019, 2018 and 2017, the Company had $2.1 million, $1.5 million and $1.1 million, respectively, accrued for the payment of interest that, if recognized, would impact the effective tax rate. As of September 30, 2019, 2018 and 2017, the Company had $0.4 million, $0.4 million and $0.4 million, respectively, accrued for the payment of penalties.
The Scotts Miracle-Gro Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. There are currently no ongoing audits with respect to the U.S. federal or foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2016. The Company is currently under examination by certain U.S. state and local tax authorities covering various periods from fiscal years 2012 through 2018. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.
The Company currently anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although audit outcomes and the timing of audit payments are subject to significant uncertainty, the Company does not anticipate
102
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.
NOTE 16. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.
Exchange Rate Risk Management
The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. The notional amount of outstanding currency forward contracts was $120.0 million and $117.2 million at September 30, 2019 and 2018, respectively. Contracts outstanding at September 30, 2019 will mature over the next fiscal quarter.
Interest Rate Risk Management
The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. Since the interest rate swap agreements have been designated as hedging instruments, unrealized gains or losses resulting from adjusting these swaps to fair value are recorded as elements of AOCI within the Consolidated Balance Sheets.
The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. The swap agreements had a maximum total U.S. dollar equivalent notional amount of $850.0 million and $800.0 million at September 30, 2019 and 2018, respectively. Refer to “NOTE 12. DEBT” for the terms of the swap agreements outstanding at September 30, 2019. Included in the AOCI balance at September 30, 2019 was a loss of $4.2 million related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.
Commodity Price Risk Management
The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea, diesel and resin requirements. These financial instruments are carried at fair value within the Consolidated Balance Sheets. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCI. Realized gains or losses remain as a component of AOCI until the related inventory is sold. Upon sale of the underlying inventory, the gain or loss is reclassified to cost of sales. Changes in the fair value of derivatives that do not qualify for hedge accounting are recorded as an element of cost of sales. Included in the AOCI balance at September 30, 2019 was a loss of $0.1 million related to commodity hedges that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.
The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:
September 30, | ||||
2019 | 2018 | |||
Commodity | ||||
Urea | ||||
Resin | ||||
Diesel | ||||
Heating Oil | ||||
103
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Fair Values of Derivative Instruments
The fair values of the Company’s derivative instruments were as follows:
Assets / (Liabilities) | ||||||||||
2019 | 2018 | |||||||||
Derivatives Designated As Hedging Instruments | Balance Sheet Location | Fair Value | ||||||||
(In millions) | ||||||||||
Interest rate swap agreements | Prepaid and other current assets | $ | $ | |||||||
Other assets | ||||||||||
Other current liabilities | ( | ) | ||||||||
Other liabilities | ( | ) | ||||||||
Commodity hedging instruments | Prepaid and other current assets | |||||||||
Other current liabilities | ( | ) | ||||||||
Total derivatives designated as hedging instruments | $ | ( | ) | $ | ||||||
Derivatives Not Designated As Hedging Instruments | Balance Sheet Location | |||||||||
Currency forward contracts | Prepaid and other current assets | $ | $ | |||||||
Other current liabilities | ( | ) | ( | ) | ||||||
Commodity hedging instruments | Prepaid and other current assets | |||||||||
Other current liabilities | ( | ) | ||||||||
Total derivatives not designated as hedging instruments | ||||||||||
Total derivatives | $ | ( | ) | $ | ||||||
Amount Of Gain / (Loss) Recognized In AOCI | ||||||||
Derivatives In Cash Flow Hedging Relationships | 2019 | 2018 | ||||||
(In millions) | ||||||||
Interest rate swap agreements | $ | ( | ) | $ | ||||
Commodity hedging instruments | ( | ) | ||||||
Total | $ | ( | ) | $ | ||||
Reclassified From AOCI Into | Amount Of Gain / (Loss) | |||||||||
Derivatives In Cash Flow Hedging Relationships | Statement Of Operations | 2019 | 2018 | |||||||
(In millions) | ||||||||||
Interest rate swap agreements | Interest expense | $ | ( | ) | $ | |||||
Commodity hedging instruments | Cost of sales | |||||||||
Total | $ | $ | ||||||||
Recognized In | Amount Of Gain / (Loss) | |||||||||
Derivatives Not Designated As Hedging Instruments | Statement of Operations | 2019 | 2018 | |||||||
(In millions) | ||||||||||
Currency forward contracts | Other income / expense, net | $ | $ | |||||||
Commodity hedging instruments | Cost of sales | ( | ) | |||||||
Total | $ | $ | ||||||||
104
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 17. FAIR VALUE MEASUREMENTS
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
Level 1 — Quoted prices in active markets for identical assets or liabilities.
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
The following describes the valuation methodologies used for financial assets and liabilities measured or disclosed at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.
Cash Equivalents
Cash equivalents consist of highly liquid financial instruments with original maturities of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.
Derivatives
Derivatives consist of currency, interest rate and commodity derivative instruments. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Commodity contracts are measured using observable commodity exchange prices in active markets.
Other
Other assets include investment securities in non-qualified retirement plan assets and the Company’s option to increase its economic interest in Bonnie Plants, Inc. (the “Bonnie Option”). Other liabilities included the contingent consideration related to the acquisition of Sunlight Supply. Investment securities in non-qualified retirement plan assets are valued using observable market prices in active markets. The fair value of the Bonnie Option is determined using a simulation approach, whereby the total value of the loan receivable and optional exchange for additional equity is estimated considering a distribution of possible future cash flows discounted to present value using an appropriate discount rate.
Debt Instruments
Debt instruments are recorded at cost. The interest rate on borrowings under the Fifth A&R Credit Agreement fluctuates in accordance with the terms of the Fifth A&R Credit Agreement and thus the carrying value is a reasonable estimate of fair value. The fair values of the 5.250 % Senior Notes and 6.000 % Senior Notes were determined based on the trading of these Senior Notes in the open market. The difference between the carrying value and the fair value of the Senior Notes represents the premium or discount on that date. The interest rate on the short-term debt associated with accounts receivable pledged under the Receivables Facility fluctuates in accordance with the terms of the Receivables Facility and thus the carrying value is a reasonable estimate of fair value.
105
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table summarizes the fair value of Company’s assets and liabilities for which disclosure of fair value is required (in millions):
2019 | 2018 | |||||||||||||||||
Fair Value Hierarchy Level | Carrying Amount | Estimated Fair Value | Carrying Amount | Estimated Fair Value | ||||||||||||||
Assets | ||||||||||||||||||
Cash equivalents | Level 1 | $ | $ | $ | $ | |||||||||||||
Derivatives | ||||||||||||||||||
Interest rate swap agreements | Level 2 | |||||||||||||||||
Currency forward contracts | Level 2 | |||||||||||||||||
Commodity hedging instruments | Level 2 | |||||||||||||||||
Other | ||||||||||||||||||
Investment securities in non-qualified retirement plan assets | Level 1 | |||||||||||||||||
Bonnie Option | Level 3 | |||||||||||||||||
Liabilities | ||||||||||||||||||
Derivatives | ||||||||||||||||||
Interest rate swap agreements | Level 2 | $ | $ | $ | $ | |||||||||||||
Currency forward contracts | Level 2 | |||||||||||||||||
Commodity hedging instruments | Level 2 | |||||||||||||||||
Debt instruments | ||||||||||||||||||
Credit facilities – revolving loans | Level 2 | |||||||||||||||||
Credit facilities – term loans | Level 2 | |||||||||||||||||
Senior Notes – 5.250% | Level 1 | |||||||||||||||||
Senior Notes – 6.000% | Level 1 | |||||||||||||||||
Receivables facility | Level 2 | |||||||||||||||||
Other | ||||||||||||||||||
Debt | Level 2 | |||||||||||||||||
Contingent consideration | Level 3 | |||||||||||||||||
NOTE 18. OPERATING LEASES
The Company leases certain property and equipment from third parties under various non-cancelable operating lease agreements. Certain lease agreements contain renewal and purchase options. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. Future minimum lease payments for non-cancelable operating leases at September 30, 2019, were as follows (in millions):
2020 | $ | ||
2021 | |||
2022 | |||
2023 | |||
2024 | |||
Thereafter | |||
Total future minimum lease payments | $ | ||
The Company also leases certain vehicles (primarily cars and light trucks) under agreements that are cancelable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company
106
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of September 30, 2019, the Company’s residual value guarantee would have approximated $3.4 million.
Rent expense for fiscal 2019, fiscal 2018 and fiscal 2017 totaled $68.4 million, $62.5 million and $53.6 million, respectively.
NOTE 19. COMMITMENTS
The Company has the following unconditional purchase obligations due during each of the next five fiscal years that have not been recognized in the Consolidated Balance Sheet at September 30, 2019 (in millions):
2020 | $ | ||
2021 | |||
2022 | |||
2023 | |||
2024 | |||
Thereafter | |||
$ | |||
NOTE 20. CONTINGENCIES
Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows.
Regulatory Matters
At September 30, 2019, $3.9 million was accrued in the “Other liabilities” line in the Consolidated Balance Sheets for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.
Other
The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows.
In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company, along with its Chief Executive Officer, had been named as defendants in four actions filed on and after June 27, 2012, which were consolidated, and, on March 31, 2017, certified as a class action in the United States District Court for the Southern District of
107
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
California as In re Morning Song Bird Food Litigation, Lead Case No. 3:12-cv-01592-JAH-AGS. The plaintiffs alleged various statutory and common law claims associated with the Company’s sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such sales. The plaintiffs alleged, among other things, a class action on behalf of all persons and entities in the United States who purchased certain bird food products. The plaintiffs asserted: (i) hundreds of millions of dollars in monetary damages (actual, compensatory, consequential, and restitution); (ii) punitive and treble damages; (iii) injunctive and declaratory relief; (iv) pre-judgment and post-judgment interest; and (v) costs and attorneys’ fees. The Company and its Chief Executive Officer disputed the plaintiffs’ assertions and have vigorously defended the consolidated action. The parties reached an agreement to settle this matter, which the parties memorialized in a settlement agreement submitted to the Court for approval on December 7, 2018. On January 31, 2019, the Court preliminarily approved the settlement, and on June 11, 2019, the Court granted final approval of the settlement. The settlement became effective on July 12, 2019. During the second quarter of fiscal 2019, the Company paid $42.5 million to the settlement fund in accordance with the settlement agreement, and the final payment of $20.0 million was made during the fourth quarter of fiscal 2019. At September 30, 2019 and 2018, zero and $85.0 million, respectively, was accrued for a probable loss related to this matter in the “Other current liabilities” line in the Consolidated Balance Sheets. During fiscal 2019, the Company recognized a favorable adjustment of $22.5 million in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations as a result of the final resolution of the previously disclosed settlement agreement. In addition, during fiscal 2019, the Company recognized insurance recoveries of $13.4 million related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations.
The Company was named as a defendant in In re Scotts EZ Seed Litigation, Case No. 12-cv-4727 (VB), a New York and California class action lawsuit filed August 9, 2012 in the United States District Court for the Southern District of New York that asserted claims under false advertising and other legal theories based on a marketing statement on the Company’s EZ Seed grass seed product from 2009 to 2012. The plaintiffs sought, on behalf of themselves and purported class members, various forms of monetary and non-monetary relief, including statutory damages that they contend could amount to hundreds of millions of dollars. The Company defended the action vigorously, and disputed the plaintiffs’ claims and theories, including the recoverability of statutory damages. In 2017, the Court eliminated certain claims, narrowed the case in certain respects, and permitted the case to continue proceeding as a class action. On August 7, 2017, the Court requested briefs on the Company’s request for interlocutory review of issues relating to the recoverability of statutory damages in a class action by the United States Court of Appeals for the Second Circuit and, on August 31, 2017, approved that request. On January 8, 2018, however, the Second Circuit denied the interlocutory appeal request. The parties engaged in mediation on April 9, 2018 and agreed in principle to a preliminary settlement of the outstanding claims on April 10, 2018. The preliminary settlement required the Company to pay certain attorneys’ and administrative fees and provide certain payments to the class members. The preliminary settlement was approved by the court on December 19, 2018. This case is now settled and the Company made final payment of the claims made by class members during the second quarter of fiscal 2019. At September 30, 2019 and 2018, zero and $11.7 million, respectively, was accrued for a probable loss related to this matter in the “Other current liabilities” line in the Consolidated Balance Sheets. During fiscal 2019, the Company recognized a favorable adjustment of $0.4 million related to this matter in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations as a result of the final payment of the claims made by class members.
The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.
NOTE 21. SEGMENT INFORMATION
The Company divides its operations into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of the Company’s consumer lawn and garden business located in the geographic United States. Hawthorne consists of the Company’s indoor, urban and hydroponic gardening business. Other consists of the Company’s consumer lawn and garden business in geographies other than the U.S. and the Company’s product sales to commercial nurseries, greenhouses and other professional customers. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the business segments. This identification of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company.
The performance of each reportable segment is evaluated based on several factors, including income (loss) from continuing operations before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”). Senior management uses Segment Profit (Loss) to evaluate segment performance because the Company believes this measure is indicative of performance trends and the overall earnings potential of each segment.
108
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following tables present financial information for the Company’s reportable segments for the periods indicated:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Net sales: | |||||||||||
U.S. Consumer | $ | $ | $ | ||||||||
Hawthorne | |||||||||||
Other | |||||||||||
Consolidated | $ | $ | $ | ||||||||
Segment Profit (Loss): | |||||||||||
U.S. Consumer | $ | $ | $ | ||||||||
Hawthorne | ( | ) | |||||||||
Other | |||||||||||
Total Segment Profit | |||||||||||
Corporate | ( | ) | ( | ) | ( | ) | |||||
Intangible asset amortization | ( | ) | ( | ) | ( | ) | |||||
Impairment, restructuring and other | ( | ) | ( | ) | ( | ) | |||||
Equity in income (loss) of unconsolidated affiliates (a) | ( | ) | |||||||||
Interest expense | ( | ) | ( | ) | ( | ) | |||||
Other non-operating income (expense), net | ( | ) | ( | ) | |||||||
Income from continuing operations before income taxes | $ | $ | $ | ||||||||
Depreciation and amortization: | |||||||||||
U.S. Consumer | $ | $ | $ | ||||||||
Hawthorne | |||||||||||
Other | |||||||||||
Corporate | |||||||||||
$ | $ | $ | |||||||||
Capital expenditures: | |||||||||||
U.S. Consumer | $ | $ | $ | ||||||||
Hawthorne | |||||||||||
Other | |||||||||||
$ | $ | $ | |||||||||
(a) | Included within equity in income (loss) of unconsolidated affiliates for fiscal 2017 are charges of $ |
September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
Total assets: | |||||||
U.S. Consumer | $ | $ | |||||
Hawthorne | |||||||
Other | |||||||
Corporate | |||||||
Consolidated | $ | $ | |||||
109
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table presents net sales by product category for the periods indicated:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
US Consumer: | |||||||||||
Growing media | $ | $ | $ | ||||||||
Lawn care | |||||||||||
Controls | |||||||||||
Roundup® marketing agreement | |||||||||||
Other, primarily gardening and landscape | |||||||||||
Hawthorne: | |||||||||||
Indoor, urban and hydroponic gardening | |||||||||||
Other: | |||||||||||
Growing media | |||||||||||
Lawn care | |||||||||||
Other, primarily gardening and controls | |||||||||||
Total net sales | $ | $ | $ | ||||||||
The Company’s three largest customers accounted for the following percentages of net sales for the fiscal years ended September 30:
Percentage of Net Sales | ||||||||
2019 | 2018 | 2017 | ||||||
Home Depot | % | % | % | |||||
Lowe’s | % | % | % | |||||
Walmart | % | % | % | |||||
Accounts receivable for these three largest customers as a percentage of consolidated accounts receivable were 61 % and 57 % as of September 30, 2019 and 2018, respectively.
The following table presents net sales by geographic area for the periods indicated:
Year Ended September 30, | |||||||||||
2019 | 2018 | 2017 | |||||||||
(In millions) | |||||||||||
Net sales: | |||||||||||
United States | $ | $ | $ | ||||||||
International | |||||||||||
$ | $ | $ | |||||||||
Other than the United States, no other country accounted for more than 10% of the Company’s net sales for any period presented above.
The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area:
September 30, | |||||||
2019 | 2018 | ||||||
(In millions) | |||||||
Long-lived assets: | |||||||
United States | $ | $ | |||||
International | |||||||
$ | $ | ||||||
110
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 22. QUARTERLY CONSOLIDATED FINANCIAL INFORMATION (UNAUDITED)
The following is a summary of the unaudited quarterly results of operations:
First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Full Year | |||||||||||||||
(In millions, except per share data) | |||||||||||||||||||
FISCAL 2019 | |||||||||||||||||||
Net sales | $ | $ | $ | $ | $ | ||||||||||||||
Gross profit | |||||||||||||||||||
Income (loss) from continuing operations | ( | ) | ( | ) | |||||||||||||||
Income (loss) from discontinued operations, net of tax | ( | ) | ( | ) | |||||||||||||||
Net income (loss) | ( | ) | ( | ) | |||||||||||||||
Net income (loss) attributable to controlling interest | ( | ) | ( | ) | |||||||||||||||
Basic income (loss) per Common Share: | |||||||||||||||||||
Income (loss) from continuing operations | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Income (loss) from discontinued operations | ( | ) | ( | ) | |||||||||||||||
Basic net income (loss) per Common Share | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Common Shares used in basic EPS calculation | |||||||||||||||||||
Diluted income (loss) per Common Share: | |||||||||||||||||||
Income (loss) from continuing operations | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Income (loss) from discontinued operations | ( | ) | ( | ) | |||||||||||||||
Diluted net income (loss) per Common Share | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Common Shares and dilutive potential Common Shares used in diluted EPS calculation | |||||||||||||||||||
FISCAL 2018 | |||||||||||||||||||
Net sales | $ | $ | $ | $ | $ | ||||||||||||||
Gross profit | |||||||||||||||||||
Income (loss) from continuing operations | ( | ) | ( | ) | |||||||||||||||
Income (loss) from discontinued operations, net of tax | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||
Net income (loss) | ( | ) | ( | ) | |||||||||||||||
Net income (loss) attributable to controlling interest | ( | ) | ( | ) | |||||||||||||||
Basic income (loss) per Common Share: | |||||||||||||||||||
Income (loss) from continuing operations | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Income (loss) from discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||
Basic net income (loss) per Common Share | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Common Shares used in basic EPS calculation | |||||||||||||||||||
Diluted income (loss) per Common Share: | |||||||||||||||||||
Income (loss) from continuing operations | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Income (loss) from discontinued operations | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||
Diluted net income (loss) per Common Share | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
Common Shares and dilutive potential Common Shares used in diluted EPS calculation | |||||||||||||||||||
The sum of the quarters may not equal full year due to rounding.
111
THE SCOTTS MIRACLE-GRO COMPANY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Common share equivalents, such as share-based awards, are excluded from the diluted loss per Common Share calculation in periods where there is a loss from continuing operations because the effect of their inclusion would be anti-dilutive. The Company’s business is highly seasonal, with approximately 75 % of net sales occurring in the second and third fiscal quarters. Refer to “NOTE 3. DISCONTINUED OPERATIONS” and “NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER” for more information regarding significant impairment, restructuring and other charges / recoveries reflected in the quarterly financial information.
NOTE 23. FINANCIAL INFORMATION FOR SUBSIDIARY GUARANTORS AND NON-GUARANTORS
The 6.000 % and 5.250 % Senior Notes were issued on October 13, 2015 and December 15, 2016, respectively, and are guaranteed by certain of the Company’s domestic subsidiaries and, therefore, the Company reports consolidating financial information in accordance with SEC Regulation S-X Rule 3-10, Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered. The guarantees are “full and unconditional,” as those terms are used in Regulation S-X Rule 3-10, except that a subsidiary’s guarantee will be released in certain customary circumstances, such as (1) upon any sale or other disposition of all or substantially all of the assets of the subsidiary (including by way of merger or consolidation) to any person other than Scotts Miracle-Gro or any “restricted subsidiary” under the indentures governing the 6.000 % and 5.250 % Senior Notes; (2) if the subsidiary merges with and into Scotts Miracle-Gro, with Scotts Miracle-Gro surviving such merger; (3) if the subsidiary is designated an “unrestricted subsidiary” in accordance with the indentures governing the 6.000 % and 5.250 % Senior Notes or otherwise ceases to be a “restricted subsidiary” (including by way of liquidation or dissolution) in a transaction permitted by such indenture; (4) upon legal or covenant defeasance; (5) at the election of Scotts Miracle-Gro following the subsidiary’s release as a guarantor under the Fifth A&R Credit Agreement, except a release by or as a result of the repayment of the Fifth A&R Credit Agreement; or (6) if the subsidiary ceases to be a “restricted subsidiary” and the subsidiary is not otherwise required to provide a guarantee of the 6.000 % and 5.250 % Senior Notes pursuant to the indentures governing the 6.000 % and 5.250 % Senior Notes.
The following 100% directly or indirectly owned subsidiaries fully and unconditionally guarantee at September 30, 2019 the 6.000 % and 5.250 % Senior Notes on a joint and several basis: Hyponex Corporation; Miracle-Gro Lawn Products, Inc.; OMS Investments, Inc.; Rod McLellan Company; Sanford Scientific, Inc.; Scotts Temecula Operations, LLC; Scotts Manufacturing Company; Scotts Products Co.; Scotts Professional Products Co.; Scotts-Sierra Investments LLC; SMG Growing Media, Inc.; Swiss Farms Products, Inc.; SMGM LLC; The Scotts Company LLC; The Hawthorne Gardening Company; Hawthorne Hydroponics LLC; HGCI, Inc. and GenSource, Inc. (collectively, the “Guarantors”). Effective in the three-month period ending July 1, 2017, American Agritech, L.L.C. was merged into Hawthorne Hydroponics LLC, and has been classified as a Guarantor for all periods presented. Effective in the three-month period ending September 30, 2018, SMG ITO Holdings, Inc. was added as a Guarantor and has been classified as a Guarantor for all periods presented. Effective in the three month period ending March 30, 2019, Gutwein & Co., Inc. was dissolved and its subsidiary guarantee was released. Effective in the three month period ending June 29, 2019, SLS Holdings, Inc. and SMG ITO Holdings, Inc. were dissolved and their subsidiary guarantees were released.
112
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Operations
for the fiscal year ended September 30, 2019
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
Net sales | $ | $ | $ | $ | $ | ||||||||||||||
Cost of sales | |||||||||||||||||||
Cost of sales—impairment, restructuring and other | |||||||||||||||||||
Gross profit | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||
Selling, general and administrative | |||||||||||||||||||
Impairment, restructuring and other | |||||||||||||||||||
Other (income) expense, net | ( | ) | |||||||||||||||||
Income (loss) from operations | ( | ) | |||||||||||||||||
Equity (income) loss in subsidiaries | ( | ) | ( | ) | |||||||||||||||
Equity in (income) loss of unconsolidated affiliates | ( | ) | ( | ) | |||||||||||||||
Interest expense | ( | ) | |||||||||||||||||
Other non-operating (income) expense, net | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Income (loss) from continuing operations before income taxes | ( | ) | |||||||||||||||||
Income tax expense (benefit) from continuing operations | ( | ) | |||||||||||||||||
Income (loss) from continuing operations | ( | ) | |||||||||||||||||
Income (loss) from discontinued operations, net of tax | ( | ) | |||||||||||||||||
Net income (loss) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Net (income) loss attributable to noncontrolling interest | |||||||||||||||||||
Net income (loss) attributable to controlling interest | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
113
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Comprehensive Income (Loss)
for the fiscal year ended September 30, 2019
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
Net income (loss) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Net foreign currency translation adjustment | ( | ) | ( | ) | ( | ) | |||||||||||||
Net change in derivatives | ( | ) | ( | ) | ( | ) | |||||||||||||
Net change in pension and other post-retirement benefits | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Total other comprehensive income (loss) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Comprehensive income (loss) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Comprehensive (income) loss attributable to noncontrolling interest | |||||||||||||||||||
Comprehensive income (loss) attributable to controlling interest | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
114
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2019
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (a) | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||
INVESTING ACTIVITIES (a) | |||||||||||||||||||
Proceeds from sale of long-lived assets | |||||||||||||||||||
Investments in property, plant and equipment | ( | ) | ( | ) | ( | ) | |||||||||||||
Proceeds from loans receivable | |||||||||||||||||||
Proceeds from sale of investment in unconsolidated affiliates | |||||||||||||||||||
Investments in acquired businesses, net of cash acquired | ( | ) | ( | ) | |||||||||||||||
Return of investments from affiliates | ( | ) | |||||||||||||||||
Investing cash flows from (to) affiliates | ( | ) | ( | ) | ( | ) | |||||||||||||
Other investing, net | |||||||||||||||||||
Net cash provided by (used in) investing activities | ( | ) | ( | ) | |||||||||||||||
FINANCING ACTIVITIES | |||||||||||||||||||
Borrowings under revolving and bank lines of credit and term loans | |||||||||||||||||||
Repayments under revolving and bank lines of credit and term loans | ( | ) | ( | ) | ( | ) | |||||||||||||
Financing and issuance fees | ( | ) | ( | ) | |||||||||||||||
Dividends paid | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Purchase of Common Shares | ( | ) | ( | ) | |||||||||||||||
Payments on seller notes | ( | ) | ( | ) | |||||||||||||||
Cash received from exercise of stock options | |||||||||||||||||||
Financing cash flows from (to) affiliates | ( | ) | |||||||||||||||||
Net cash provided by (used in) financing activities | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Effect of exchange rate changes on cash | ( | ) | ( | ) | |||||||||||||||
Net increase (decrease) in cash and cash equivalents | ( | ) | ( | ) | ( | ) | |||||||||||||
Cash and cash equivalents at beginning of year | |||||||||||||||||||
Cash and cash equivalents at end of year | $ | $ | $ | $ | $ | ||||||||||||||
(a) |
115
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Balance Sheet
As of September 30, 2019
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
ASSETS | |||||||||||||||||||
Current assets: | |||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||||
Accounts receivable, net | |||||||||||||||||||
Accounts receivable pledged | |||||||||||||||||||
Inventories | |||||||||||||||||||
Prepaid and other current assets | |||||||||||||||||||
Total current assets | |||||||||||||||||||
Property, plant and equipment, net | |||||||||||||||||||
Goodwill | |||||||||||||||||||
Intangible assets, net | |||||||||||||||||||
Other assets | |||||||||||||||||||
Equity investment in subsidiaries | ( | ) | |||||||||||||||||
Intercompany assets | ( | ) | |||||||||||||||||
Total assets | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
LIABILITIES AND EQUITY | |||||||||||||||||||
Current liabilities: | |||||||||||||||||||
Current portion of debt | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Accounts payable | |||||||||||||||||||
Other current liabilities | |||||||||||||||||||
Total current liabilities | ( | ) | |||||||||||||||||
Long-term debt | ( | ) | |||||||||||||||||
Other liabilities | |||||||||||||||||||
Equity investment in subsidiaries | ( | ) | |||||||||||||||||
Intercompany liabilities | ( | ) | |||||||||||||||||
Total liabilities | ( | ) | |||||||||||||||||
Total equity—controlling interest | ( | ) | |||||||||||||||||
Noncontrolling interest | |||||||||||||||||||
Total equity | ( | ) | |||||||||||||||||
Total liabilities and equity | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
116
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Operations
for the fiscal year ended September 30, 2018
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
Net sales | $ | $ | $ | $ | $ | ||||||||||||||
Cost of sales | |||||||||||||||||||
Cost of sales—impairment, restructuring and other | |||||||||||||||||||
Gross profit | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||
Selling, general and administrative | |||||||||||||||||||
Impairment, restructuring and other | |||||||||||||||||||
Other (income) expense, net | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Income (loss) from operations | ( | ) | ( | ) | |||||||||||||||
Equity (income) loss in subsidiaries | ( | ) | |||||||||||||||||
Equity in (income) loss of unconsolidated affiliates | ( | ) | ( | ) | ( | ) | |||||||||||||
Interest expense | ( | ) | |||||||||||||||||
Other non-operating (income) expense, net | ( | ) | ( | ) | ( | ) | |||||||||||||
Income (loss) from continuing operations before income taxes | ( | ) | ( | ) | |||||||||||||||
Income tax expense (benefit) from continuing operations | ( | ) | ( | ) | |||||||||||||||
Income (loss) from continuing operations | ( | ) | ( | ) | |||||||||||||||
Income (loss) from discontinued operations, net of tax | ( | ) | ( | ) | |||||||||||||||
Net income (loss) | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||
Net (income) loss attributable to noncontrolling interest | |||||||||||||||||||
Net income (loss) attributable to controlling interest | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||
117
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Comprehensive Income (Loss)
for the fiscal year ended September 30, 2018
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
Net income (loss) | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Net foreign currency translation adjustment | ( | ) | |||||||||||||||||
Net change in derivatives | ( | ) | |||||||||||||||||
Net change in pension and other post-retirement benefits | ( | ) | |||||||||||||||||
Total other comprehensive income (loss) | ( | ) | |||||||||||||||||
Comprehensive income (loss) | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||
Comprehensive (income) loss attributable to noncontrolling interest | |||||||||||||||||||
Comprehensive income (loss) attributable to controlling interest | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||
118
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2018
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (a) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
INVESTING ACTIVITIES (a) | |||||||||||||||||||
Proceeds from sale of long-lived assets | |||||||||||||||||||
Post-closing working capital payment related to sale of International Business | ( | ) | ( | ) | |||||||||||||||
Investments in property, plant and equipment | ( | ) | ( | ) | ( | ) | |||||||||||||
Investments in loans receivable | ( | ) | ( | ) | ( | ) | |||||||||||||
Proceeds from loans receivable | |||||||||||||||||||
Net distributions from (investments in) unconsolidated affiliates | ( | ) | ( | ) | |||||||||||||||
Investments in acquired businesses, net of cash acquired | ( | ) | ( | ) | ( | ) | |||||||||||||
Return of investments from affiliates | ( | ) | |||||||||||||||||
Investing cash flows from (to) affiliates | ( | ) | ( | ) | ( | ) | |||||||||||||
Other investing, net | |||||||||||||||||||
Net cash provided by (used in) investing activities | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
FINANCING ACTIVITIES | |||||||||||||||||||
Borrowings under revolving and bank lines of credit and term loans | |||||||||||||||||||
Repayments under revolving and bank lines of credit and term loans | ( | ) | ( | ) | ( | ) | |||||||||||||
Financing and issuance fees | ( | ) | ( | ) | ( | ) | |||||||||||||
Dividends paid | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Purchase of Common Shares | ( | ) | ( | ) | |||||||||||||||
Payments on seller notes | ( | ) | ( | ) | ( | ) | |||||||||||||
Cash received from exercise of stock options | |||||||||||||||||||
Acquisition of noncontrolling interests | ( | ) | ( | ) | |||||||||||||||
Financing cash flows from (to) affiliates | ( | ) | |||||||||||||||||
Net cash provided by (used in) financing activities | ( | ) | |||||||||||||||||
Effect of exchange rate changes on cash | |||||||||||||||||||
Net increase (decrease) in cash and cash equivalents | ( | ) | ( | ) | ( | ) | |||||||||||||
Cash and cash equivalents at beginning of year | |||||||||||||||||||
Cash and cash equivalents at end of year | $ | $ | $ | $ | $ | ||||||||||||||
(a) | Cash received by the Parent from the Guarantors and Non-Guarantors in the form of dividends in the amount of $ |
119
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Balance Sheet
As of September 30, 2018
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
ASSETS | |||||||||||||||||||
Current assets: | |||||||||||||||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||||
Accounts receivable, net | |||||||||||||||||||
Accounts receivable pledged | |||||||||||||||||||
Inventories | |||||||||||||||||||
Prepaid and other current assets | |||||||||||||||||||
Total current assets | |||||||||||||||||||
Investment in unconsolidated affiliates | |||||||||||||||||||
Property, plant and equipment, net | |||||||||||||||||||
Goodwill | |||||||||||||||||||
Intangible assets, net | |||||||||||||||||||
Other assets | — | ||||||||||||||||||
Equity investment in subsidiaries | ( | ) | |||||||||||||||||
Intercompany assets | ( | ) | |||||||||||||||||
Total assets | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
LIABILITIES AND EQUITY | |||||||||||||||||||
Current liabilities: | |||||||||||||||||||
Current portion of debt | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Accounts payable | |||||||||||||||||||
Other current liabilities | |||||||||||||||||||
Total current liabilities | ( | ) | |||||||||||||||||
Long-term debt | ( | ) | |||||||||||||||||
Distributions in excess of investment in unconsolidated affiliate | |||||||||||||||||||
Other liabilities | |||||||||||||||||||
Equity investment in subsidiaries | ( | ) | |||||||||||||||||
Intercompany liabilities | — | ( | ) | — | |||||||||||||||
Total liabilities | ( | ) | |||||||||||||||||
Total equity—controlling interest | ( | ) | |||||||||||||||||
Noncontrolling interest | |||||||||||||||||||
Total equity | ( | ) | |||||||||||||||||
Total liabilities and equity | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
120
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Operations
for the fiscal year ended September 30, 2017
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
Net sales | $ | $ | $ | $ | $ | ||||||||||||||
Cost of sales | |||||||||||||||||||
Gross profit | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||
Selling, general and administrative | |||||||||||||||||||
Impairment, restructuring and other | |||||||||||||||||||
Other (income) expense, net | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Income (loss) from operations | ( | ) | |||||||||||||||||
Equity (income) loss in subsidiaries | ( | ) | ( | ) | — | — | |||||||||||||
Other non-operating (income) loss | ( | ) | ( | ) | — | ||||||||||||||
Equity in (income) loss of unconsolidated affiliates | |||||||||||||||||||
Interest expense | ( | ) | |||||||||||||||||
Other non-operating (income) expense, net | — | ||||||||||||||||||
Income (loss) from continuing operations before income taxes | ( | ) | |||||||||||||||||
Income tax expense (benefit) from continuing operations | ( | ) | |||||||||||||||||
Income (loss) from continuing operations | ( | ) | |||||||||||||||||
Income (loss) from discontinued operations, net of tax | ( | ) | |||||||||||||||||
Net income (loss) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Net (income) loss attributable to noncontrolling interest | ( | ) | ( | ) | |||||||||||||||
Net income (loss) attributable to controlling interest | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
121
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Comprehensive Income (Loss)
for the fiscal year ended September 30, 2017
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
Net income (loss) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||
Net foreign currency translation adjustment | ( | ) | |||||||||||||||||
Net change in derivatives | ( | ) | |||||||||||||||||
Net change in pension and other post-retirement benefits | ( | ) | |||||||||||||||||
Total other comprehensive income (loss) | ( | ) | |||||||||||||||||
Comprehensive income (loss) | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
Comprehensive (income) loss attributable to noncontrolling interest | ( | ) | ( | ) | |||||||||||||||
Comprehensive income (loss) attributable to controlling interest | $ | $ | $ | $ | ( | ) | $ | ||||||||||||
122
THE SCOTTS MIRACLE-GRO COMPANY
Condensed Consolidating Statement of Cash Flows
for the fiscal year ended September 30, 2017
(In millions)
Parent | Subsidiary Guarantors | Non- Guarantors | Eliminations/ Consolidations | Consolidated | |||||||||||||||
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (a) | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||
INVESTING ACTIVITIES (a) | |||||||||||||||||||
Proceeds from sale of long-lived assets | |||||||||||||||||||
Proceeds from sale of business, net of cash disposed of | |||||||||||||||||||
Investments in property, plant and equipment | ( | ) | ( | ) | ( | ) | |||||||||||||
Investments in loans receivable | ( | ) | ( | ) | |||||||||||||||
Net distributions from (investments in) unconsolidated affiliates | ( | ) | |||||||||||||||||
Investments in acquired businesses, net of cash acquired | ( | ) | ( | ) | ( | ) | |||||||||||||
Return of investments from affiliates | ( | ) | |||||||||||||||||
Investing cash flows from (to) affiliates | ( | ) | ( | ) | |||||||||||||||
Net cash provided by (used in) investing activities | ( | ) | ( | ) | |||||||||||||||
FINANCING ACTIVITIES | |||||||||||||||||||
Borrowings under revolving and bank lines of credit and term loans | |||||||||||||||||||
Repayments under revolving and bank lines of credit and term loans | ( | ) | ( | ) | ( | ) | |||||||||||||
Proceeds from issuance of 5.250% Senior Notes | |||||||||||||||||||
Financing and issuance fees | ( | ) | ( | ) | ( | ) | |||||||||||||
Dividends paid | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Distribution paid by AeroGrow to noncontrolling interest | ( | ) | ( | ) | |||||||||||||||
Purchase of Common Shares | ( | ) | ( | ) | |||||||||||||||
Payments on seller notes | ( | ) | ( | ) | ( | ) | |||||||||||||
Excess tax benefits from share-based payment arrangements | |||||||||||||||||||
Cash received from exercise of stock options | |||||||||||||||||||
Financing cash flows from (to) affiliates | ( | ) | |||||||||||||||||
Net cash provided by (used in) financing activities | ( | ) | ( | ) | ( | ) | |||||||||||||
Effect of exchange rate changes on cash | |||||||||||||||||||
Net increase (decrease) in cash and cash equivalents | |||||||||||||||||||
Cash and cash equivalents at beginning of year excluding cash classified within assets held for sale | |||||||||||||||||||
Cash and cash equivalents at beginning of year classified within assets held for sale | |||||||||||||||||||
Cash and cash equivalents at beginning of year | |||||||||||||||||||
Cash and cash equivalents at end of year | $ | $ | $ | $ | $ | ||||||||||||||
(a) |
123
Schedule II—Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2019
Column A | Column B | Column C | Column D | Column E | Column F | |||||||||||||||
Classification | Balance at Beginning of Period | Reserves Acquired | Additions Charged to Expense | Deductions Credited and Write-Offs | Balance at End of Period | |||||||||||||||
(In millions) | ||||||||||||||||||||
Valuation and qualifying accounts deducted from the assets to which they apply: | ||||||||||||||||||||
Allowance for doubtful accounts | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
Income tax valuation allowance | ( | ) | ||||||||||||||||||
Schedule II—Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2018
Column A | Column B | Column C | Column D | Column E | Column F | |||||||||||||||
Classification | Balance at Beginning of Period | Reserves Acquired | Additions Charged to Expense | Deductions Credited and Write-Offs | Balance at End of Period | |||||||||||||||
(In millions) | ||||||||||||||||||||
Valuation and qualifying accounts deducted from the assets to which they apply: | ||||||||||||||||||||
Allowance for doubtful accounts | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
Income tax valuation allowance | ( | ) | ||||||||||||||||||
Schedule II—Valuation and Qualifying Accounts
for the fiscal year ended September 30, 2017
Column A | Column B | Column C | Column D | Column E | Column F | |||||||||||||||
Classification | Balance at Beginning of Period | Reserves Acquired | Additions Charged to Expense | Deductions Credited and Write-Offs | Balance at End of Period | |||||||||||||||
(In millions) | ||||||||||||||||||||
Valuation and qualifying accounts deducted from the assets to which they apply: | ||||||||||||||||||||
Allowance for doubtful accounts | $ | $ | $ | $ | ( | ) | $ | |||||||||||||
Income tax valuation allowance | — | |||||||||||||||||||
124
The Scotts Miracle-Gro Company
Index to Exhibits
Incorporated by Reference | ||||||||||
Exhibit No. | Description | Form | Exhibit | Filing Date | Filed Herewith | |||||
3.1(a) | 8-K | 3.1 | March 24, 2005 | |||||||
3.1(b) | 8-K | 3.2 | March 24, 2005 | |||||||
3.2 | 8-K | 3.3 | March 24, 2005 | |||||||
4.1(a) | 8-K | 4.1 | December 16, 2016 | |||||||
4.1(b) | 10-Q | 10.4 | August 8, 2018 | |||||||
4.1(c) | 8-K | 4.2 | December 16, 2016 | |||||||
4.2(a) | 8-K | 4.1 | October 28, 2019 | |||||||
4.2(b) | 8-K | 4.2 | October 28, 2019 | |||||||
4.2(c) | 8-K | 4.3 | October 28, 2019 | |||||||
4.3 | X | |||||||||
4.4 | X | |||||||||
10.1(a) | 8-K | 10.1 | July 11, 2018 | |||||||
10.1(b) | 8-K | 10.2 | July 11, 2018 | |||||||
10.2(a)† | 8-K | 10.1 | January 24, 2013 | |||||||
10.2(b)(i)† | 10-Q | 10.4 | February 11, 2010 | |||||||
125
Incorporated by Reference | ||||||||||
Exhibit No. | Description | Form | Exhibit | Filing Date | Filed Herewith | |||||
10.2(b)(ii)† | 10-Q | 10.3 | February 8, 2012 | |||||||
10.2(b)(iii)† | 10-Q | 10.7 | May 7, 2015 | |||||||
10.3(a)† | 8-K | 10.1 | January 30, 2017 | |||||||
10.3(b)(i)† | 8-K | 10.2 | January 30, 2017 | |||||||
10.3(b)(ii)† | 8-K | 10.1 | January 30, 2019 | |||||||
10.3(c)† | 8-K | 10.3 | January 30, 2017 | |||||||
10.3(d)† | 8-K | 10.4 | January 30, 2017 | |||||||
10.3(e)† | 8-K | 10.5 | January 30, 2017 | |||||||
10.3(f)† | 10-K | 10.3(f) | November 29, 2018 | |||||||
10.3(g)† | 10-K | 10.3(g) | November 29, 2018 | |||||||
10.3(h)(i)† | 10-K | 10.3(h)(i) | November 29, 2018 | |||||||
10.3(h)(ii)† | 10-K | 10.3(h)(ii) | November 29, 2018 | |||||||
10.4(a)† | 8-K | 10.1 | February 5, 2014 | |||||||
10.4(b)† | 10-Q | 10.1 | August 10, 2006 | |||||||
10.5† | 10-Q | 10.2 | February 5, 2015 | |||||||
10.6(a)† | 8-K | 10.2 | December 17, 2013 | |||||||
126
Incorporated by Reference | ||||||||||
Exhibit No. | Description | Form | Exhibit | Filing Date | Filed Herewith | |||||
10.6(b)† | 8-K | 10.1 | December 17, 2013 | |||||||
10.7† | X | |||||||||
10.8† | 10-Q | 10.1 | May 8, 2019 | |||||||
10.9(a)† | 10-Q | 10.9 | May 10, 2017 | |||||||
10.9(b)† | 10-Q | 10.10 | May 10, 2017 | |||||||
10.10(a) | 8-K/A | 10.4 | May 20, 2015 | |||||||
10.10(b) | 8-K | 10.7 | July 31, 2019 | |||||||
10.11 | 8-K | 10.2 | July 31, 2019 | |||||||
10.12(a) | 10-K | 10.14(b) | November 28, 2017 | |||||||
10.12(b) | 8-K | 10.5 | July 31, 2019 | |||||||
10.12(c) | 8-K | 10.4 | July 31, 2019 | |||||||
10.13(a)(i) | 8-K | 10.1 | April 13, 2017 | |||||||
10.13(a)(ii) | 8-K | 10.1 | August 24, 2018 | |||||||
10.14(a)(i) | 8-K | 10.2 | April 13, 2017 | |||||||
10.14(a)(ii) | 8-K | 10.1 | August 31, 2017 | |||||||
10.14(a)(iii) | 8-K | 10.2 | August 24, 2018 | |||||||
10.14(a)(iv) | 8-K | 10.1 | August 20, 2019 | |||||||
10.15 | 10-Q | 10.4 | May 11, 2016 | |||||||
10.16 | 10-K | 10.20 | November 28, 2017 | |||||||
127
Incorporated by Reference | ||||||||||
Exhibit No. | Description | Form | Exhibit | Filing Date | Filed Herewith | |||||
10.17 | 10-Q | 10.1 | August 8, 2018 | |||||||
10.18† | 8-K | 10.3 | August 24, 2018 | |||||||
10.19 | 8-K | 10.1 | March 20, 2019 | |||||||
21 | X | |||||||||
23 | X | |||||||||
24 | X | |||||||||
31.1 | X | |||||||||
31.2 | X | |||||||||
32 | X | |||||||||
101.SCH | XBRL Taxonomy Extension Schema | X | ||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase | X | ||||||||
101.DEF | XBRL Taxonomy Extension Definition Linkbase | X | ||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase | X | ||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase | X | ||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | X | ||||||||
† | Management contract, compensatory plan or arrangement. |
128
Exhibit 4.3
November 27, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: | The Scotts Miracle-Gro Company – Annual Report on Form 10-K for the fiscal year ended September 30, 2019 |
Ladies and Gentlemen:
The Scotts Miracle-Gro Company, an Ohio corporation (“Scotts Miracle-Gro”), is today filing its Annual Report on Form 10-K for the fiscal year ended September 30, 2019 (the “Form 10-K”).
Neither Scotts Miracle-Gro nor any of its consolidated subsidiaries has outstanding any instrument or agreement with respect to its long-term debt, other than those filed or incorporated by reference as an exhibit to the Form 10-K, under which the total amount of long-term debt authorized exceeds ten percent (10%) of the total assets of Scotts Miracle-Gro and its subsidiaries on a consolidated basis. In accordance with the provisions of Item 601(b)(4)(iii) of SEC Regulation S-K, Scotts Miracle-Gro hereby agrees to furnish to the SEC, upon request, a copy of each such instrument or agreement defining the rights of holders of long-term debt of Scotts Miracle-Gro or the rights of holders of long-term debt of one of Scotts Miracle-Gro’s consolidated subsidiaries, in each case which is not being filed or incorporated by reference as an exhibit to the Form 10-K.
Very truly yours,
THE SCOTTS MIRACLE-GRO COMPANY
/s/ THOMAS RANDAL COLEMAN
Thomas Randal Coleman
Executive Vice President and Chief Financial Officer
14111 Scottslawn Road Marysville, OH 43041 937-644-0011
www.scotts.com
www.scotts.com
Exhibit 4.4
DESCRIPTION OF CAPITAL STOCK
As of September 30, 2019, The Scotts Miracle-Gro Company (“Scotts,” the “Company,” “we,” “us” or “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common shares, without par value (our “common shares”).
The following summary describes the material features of our common shares and our preferred shares, without par value (our “preferred shares”). This summary does not describe every aspect of our common shares or preferred shares and is subject to, and qualified in its entirety by reference to, all the provisions of our amended articles of incorporation and code of regulations, each of which is filed as an exhibit to this Annual Report on Form 10-K, and the applicable provisions of Ohio law.
Authorized Capital Stock
Under our amended articles of incorporation, we have the authority to issue up to an aggregate amount of 100,000,000 common shares and 195,000 preferred shares. As of September 30, 2019, there were 55,805,211 common shares issued and outstanding and no preferred shares issued and outstanding.
Common Shares
Holders of our common shares are entitled to:
• | one vote for each share held; |
• | receive dividends when and if declared by our board of directors from funds legally available therefor, subject to the rights of holders of our preferred shares, if any, and any restrictions contained in our long-term indebtedness; and |
• | share ratably in our net assets, legally available to our shareholders in the event of our liquidation, dissolution or winding up, after provision for distribution to the holders of any preferred shares and to the payment in full of all amounts required to be paid to creditors or provision for such payment. |
Holders of our common shares have no preemptive, subscription, redemption, conversion or cumulative voting rights. All of our outstanding common shares are fully paid and non-assessable. Our amended articles of incorporation contain no restrictions on the alienability of our common shares.
Our common shares are listed on the New York Stock Exchange (“NYSE”) under the symbol “SMG.”
Preferred Shares
Under our amended articles of incorporation, our board of directors is authorized to issue, without any further vote or action by our shareholders, subject to certain limitations prescribed by Ohio law and the rules and regulations of the NYSE, up to an aggregate of 195,000 preferred shares in one or more series. Our board of directors is also authorized to fix or change the rights, preferences and limitations of each series, including the division of such shares into series and the designation and authorized number of each series, dividend and distribution rights, liquidation rights, preferences and price, redemption rights and price, sinking fund requirements, voting rights, preemptive rights, conversion rights and restrictions on issuance of shares. Absent a determination by the board of directors to establish different voting rights, holders of preferred shares are entitled to one vote per share on matters to be voted upon by the holders of common shares and preferred shares voting together as a single class. Ohio law also entitles the holders of preferred shares to exercise a class vote on certain matters.
Our board of directors may authorize the issuance of preferred shares with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common shares. The issuance of preferred shares could have the effect of decreasing the market price of our common shares. The issuance of preferred shares also could have the effect of delaying, deterring or preventing a change in control of us without further action by our shareholders.
Anti-Takeover Effects of Amended Articles of Incorporation, Code of Regulations and Ohio Law
Certain provisions in our amended articles of incorporation and code of regulations and the Ohio Revised Code could discourage potential takeover attempts and make attempts by shareholders to change management more difficult. These provisions could adversely affect the market price of our shares. A description of these provisions is set forth below.
Classified Board of Directors
Our board of directors is divided into three classes, with three-year staggered terms. This classification system increases the difficulty of replacing a majority of the directors at any one time and may tend to discourage a third party from making a tender offer or otherwise attempting to gain control of us. It also may maintain the incumbency of our board of directors. Under the Ohio General Corporation Law, our shareholders may not remove any directors on our classified board of directors without cause.
Supermajority Voting Provisions
Under the Ohio General Corporation Law, in the case of most mergers, sales of all or substantially all the assets of a corporation and amendments to a corporation’s articles of incorporation, the affirmative vote of two-thirds of the voting power of the corporation is required unless the corporation’s articles of incorporation provide for a lower amount not less than a majority. Our amended articles of incorporation change the default voting requirement provided by the Ohio General Corporation Law to a majority of the voting power, except that the affirmative vote of two-thirds of our voting power is required with respect to any of the following:
• | proposed amendments to the supermajority voting provision in our amended articles of incorporation; |
• | an agreement of merger or consolidation providing for the proposed merger or consolidation of us with or into one or more other corporations and requiring shareholder approval; |
• | a proposed combination or majority share acquisition involving the issuance of our shares and requiring shareholder approval; |
• | a proposal to sell, exchange, transfer or otherwise dispose of all, or substantially all, of our assets, with or without goodwill; and |
• | a proposed dissolution of us. |
Limited Shareholder Action by Written Consent
The Ohio General Corporation Law requires that an action by written consent of the shareholders in lieu of a meeting be unanimous, except that the code of regulations may be amended by an action by written consent of holders of shares entitling them to exercise two-thirds of the voting power of the corporation or, if the articles of incorporation or code of regulations otherwise provide, such greater or lesser amount, but not less than a majority. This provision may have the effect of delaying, deferring or preventing a tender offer or takeover attempt that a shareholder might consider to be in its best interest.
Control Share Acquisition Act
The Ohio General Corporation Law provides that certain notice and informational filings, and special shareholder meeting and voting procedures, must occur prior to any person’s acquisition of an issuer’s shares that would entitle the acquirer to exercise or direct the voting power of the issuer in the election of directors within any of the following ranges:
• | one-fifth or more but less than one-third of such voting power; |
• | one-third or more but less than a majority of such voting power; and |
• | a majority or more of such voting power. |
This provision, which is known as the Control Share Acquisition Act, does not apply to a corporation if its articles of incorporation or code of regulations so provide. We have not opted out of the application of the Control Share Acquisition Act.
Merger Moratorium Statute
Chapter 1704 of the Ohio Revised Code, known as the Merger Moratorium Statute, prohibits specified business combinations and other transactions (including mergers, consolidations, asset sales, loans, disproportionate distributions of property and disproportionate issuances or transfers of shares or rights to acquire shares) between an Ohio corporation and an “Interested Shareholder” (as such term is defined in Section 1704.01 of the Ohio Revised Code) for a period of three years after a person becomes an Interested Shareholder, unless, prior to such date, the directors approved either the business combination or other transaction or approved the acquisition that caused the person to become an Interested Shareholder. Under the Merger Moratorium Statute, an Interested Shareholder generally includes any beneficial owner of shares of an Ohio corporation who, alone or with others, may exercise or direct the exercise of at least 10% of the voting power of the corporation in the election of directors.
Following the three-year moratorium period, the corporation may engage in the covered transaction with the Interested Shareholder only if:
• | the transaction receives the approval of the holders of shares entitling them to exercise at least two-thirds of the voting power of the corporation in the election of directors (or a different proportion specified in the corporation’s articles of incorporation), including at least a majority of the voting shares held by persons other than an Interested Shareholder; or |
• | the remaining shareholders receive an amount for their shares equal to the higher of the highest amount paid in the past by the Interested Shareholder for the corporation’s shares or the amount that would be due to the shareholders if the corporation were to dissolve. |
The Merger Moratorium Statute does not apply to a corporation if its articles of incorporation or code of regulations so provide. We have not opted out of the application of the Merger Moratorium Statute.
Exhibit 10.7
Summary of Compensation for Nonemployee Directors of
The Scotts Miracle-Gro Company
Effective as of January 27, 2017
_____________________________________
At the meeting of the Board of Directors (the “Board”) of The Scotts Miracle-Gro Company (the “Company”) held on January 27, 2017, the Board approved the recommendations of the Nominating and Governance Committee of the Board (the “Committee”) with respect to compensation for the calendar year for nonemployee members of the Board (“Nonemployee Directors”) and the Lead Independent Director of the Company. The compensation approved by the Board is described below.
Annual Cash Retainer; Reimbursement of Expenses
Each of the Nonemployee Directors will be paid an annual cash retainer in the amount of $100,000 and the Lead Independent Director will be paid an additional annual cash retainer in the amount of $15,000. The annual cash retainer(s) will be paid on a quarterly basis, in January, April, July and October; provided, that, the Nonemployee Directors have the option to elect, in advance, to receive up to 100% of their quarterly cash retainers in cash or fully-vested restricted stock units. Nonemployee Directors receive reimbursement of all reasonable travel and other expenses associated with attending Board and Board committee meetings.
Restricted Stock Units
Shortly following each of the Company’s annual meetings: (a) each Nonemployee Director will be granted restricted stock units having a value of $185,000, with no additional restricted stock units awarded for serving as Board committee chairs or members; and (b) the Lead Independent Director will be granted additional restricted stock units having a value of $35,000. The number of restricted stock units (and related dividend equivalents) granted to each Nonemployee Director will be calculated by dividing the aggregate value of restricted stock units to be granted to such Nonemployee Director by the closing price of the Company’s common shares on the grant date and rounding any resulting fractional restricted stock unit up to the next whole restricted stock unit.
The restricted stock units (and related dividend equivalents) will be granted under The Scotts Miracle-Gro Company Long-Term Incentive Plan (Effective as of January 27, 2017) (the “2017 Plan”). Each whole restricted stock unit represents the right to receive one full common share of the Company at the time and in the manner described in the Restricted Stock Unit Award Agreement for Nonemployee Directors (with Related Dividend Equivalents) evidencing the award. Each dividend equivalent represents the right to receive additional restricted stock units (rounded to the nearest whole restricted stock unit) in respect of dividends that are declared and paid during the period beginning on the grant date and ending on the settlement date with respect to the common shares of the Company represented by the related restricted stock units.
In general, the restricted stock units, including any restricted stock units received in respect of dividend equivalents on or prior to the vesting date, will generally become 100% vested on the date of the next annual meeting of the Company’s shareholders (the “Vesting Date”). Any restricted stock units received in respect of dividend equivalents following the vesting date will be 100% vested on the date they are credited to the Nonemployee Director. If a Nonemployee Director ceases to be a member o
f the Board as a result of their death or becoming totally disabled, then all of the Nonemployee Director’s restricted stock units (and related dividend equivalents) will become 100% vested as of the date the Nonemployee Director’s service on the Board terminates. If a Nonemployee Director ceases to be a member of the Board prior to the vesting date for any reason other than a change in control of the Company (except as provided above for death or disability), the Nonemployee Director’s restricted stock units (and related dividend equivalents) will be immediately forfeited.
Subject to the terms of the 2017 Plan, vested restricted stock units (and related dividend equivalents) will be settled in a lump sum as soon as administratively practicable, but no later than 90 days, following the earliest to occur of (a) termination, (b) death, (c) disability, or (d) the third anniversary of the grant date. Whole restricted stock units (and related dividend equivalents) will be settled in full common shares of the Company and any fractional restricted stock units will be settled in cash, determined based on the fair market value of a common share of the Company on the settlement date.
If there is a Change in Control (as defined in the 2017 Plan), each Nonemployee Director’s restricted stock units (and related dividend equivalents) will become 100% vested on the date of the Change in Control and will be settled as described above.
For more information about the restricted stock units (and related dividend equivalents) granted to the Nonemployee Directors, please refer to: (a) the form of Restricted Stock Unit Award Agreement for Nonemployee Directors (with Related Dividend Equivalents) that is included as an exhibit to the Company’s Annual Report on Form 10-K; (b) the form of Restricted Stock Unit Award Agreement for Nonemployee Directors Retainer Deferrals (with Related Dividend Equivalents) that is included as an exhibit to the Company’s Annual Report on Form 10-K; and (c) the 2017 Plan that is included as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed January 30, 2017.
Exhibit 21
DIRECT AND INDIRECT SUBSIDIARIES OF
THE SCOTTS MIRACLE-GRO COMPANY
Directly owned subsidiaries, as of September 30, 2019, are located at the left margin, each subsidiary tier thereunder is indented. Subsidiaries are listed under the names of their respective parent entities. Unless otherwise noted, the subsidiaries are wholly-owned.
NAME | JURISDICTION OF FORMATION | |
GenSource, Inc. | Ohio | |
OMS Investments, Inc. | Delaware | |
Scotts Temecula Operations, LLC | Delaware | |
Sanford Scientific, Inc. | New York | |
Scotts Global Services, Inc. | Ohio | |
Scotts Luxembourg SARL | Luxembourg | |
Scotts Manufacturing Company | Delaware | |
Miracle-Gro Lawn Products, Inc. | New York | |
Scotts Products Co. | Ohio | |
Scotts Servicios, S.A. de C.V.1 | Mexico | |
Scotts Professional Products Co. | Ohio | |
Scotts Servicios, S.A. de C.V.1 | Mexico | |
SMG Growing Media, Inc. | Ohio | |
AeroGrow International, Inc.2 | Nevada | |
Hyponex Corporation | Delaware | |
Rod McLellan Company | California | |
The Hawthorne Gardening Company | Delaware | |
Hawthorne Hydroponics LLC | Delaware | |
Hawthorne Gardening B.V. | Netherlands | |
Gavita International B.V. | Netherlands | |
Hawthorne Lighting B.V. | Netherlands | |
Agrolux Nederland B.V. | Netherlands | |
Hawthorne Canada Limited | Canada | |
HGCI, Inc. | Nevada | |
________________________ |
1 Scotts Professional Products Co. owns 50% and Scotts Products Co. owns 50%. 2 SMG Growing Media, Inc.’s ownership is 80.5%. |
SMGM LLC | Ohio | |
Scotts-Sierra Investments LLC | Delaware | |
Scotts Gardening Co., Ltd. | China | |
Scotts Canada Ltd. | Canada | |
Laketon Peat Moss Inc.3 | Canada | |
Scotts de Mexico SA de CV4 | Mexico | |
SMG Germany GmbH | Germany | |
Scotts Holdings Limited | United Kingdom | |
Levington Group Limited | United Kingdom | |
SMG Gardening (UK) Limited | United Kingdom | |
The Scotts Company (Manufacturing) Limited | United Kingdom | |
Humax Horticulture Limited | United Kingdom | |
O M Scott International Investments Limited | United Kingdom | |
Swiss Farms Products, Inc. | Delaware | |
The Scotts Company LLC | Ohio | |
The Scotts Miracle-Gro Foundation5 | Ohio | |
________________________ |
3 Scotts Canada Ltd.'s ownership is 50.0%. 4 The Scotts Company LLC owns 0.5% and Scotts-Sierra Investments LLC owns the remaining 99.5%. 5 The Scotts Miracle-Gro Foundation is a 501(c)(3) corporation. |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 033-47073, 333-72715, 333-124503, 333-131466, 333-147397, 333-153925, 333-154364, 333-186187, 333-215774, and 333-222840 on Form S-8 and Registration Statement No 333-228854 on Form S-3 of our reports dated November 27, 2019, relating to the consolidated financial statements and consolidated financial statement schedules of The Scotts Miracle-Gro Company and subsidiaries (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph regarding the Company’s adoption of the new accounting guidance in ASU 2017-04 Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment and ASU 2014-09 Revenue from Contracts with Customers (Topic 606)), and to the effectiveness of the Company's internal control over financial reporting, appearing in this Annual Report on Form 10-K of the Company for the fiscal year ended September 30, 2019.
/s/ DELOITTE & TOUCHE LLP
Columbus, Ohio
November 27, 2019
Exhibit 24
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ DAVID C. EVANS |
David C. Evans
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ BRIAN D. FINN |
Brian D. Finn
POWER OF ATTORNEY
The undersigned officer and director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ JAMES HAGEDORN |
James Hagedorn
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ ADAM HANFT |
Adam Hanft
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ STEPHEN L. JOHNSON |
Stephen L. Johnson
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ THOMAS N. KELLY JR. |
Thomas N. Kelly Jr.
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ KATHERINE HAGEDORN LITTLEFIELD |
Katherine Hagedorn Littlefield
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ NANCY G. MISTRETTA |
Nancy G. Mistretta
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ PETER E. SHUMLIN |
Peter E. Shumlin
POWER OF ATTORNEY
The undersigned director of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn, Thomas Randal Coleman and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as the undersigned could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ JOHN R. VINES |
John R. Vines
POWER OF ATTORNEY
The undersigned officer of The Scotts Miracle-Gro Company, an Ohio corporation (the “Corporation”), which anticipates filing with the Securities and Exchange Commission, Washington, D.C., under the provisions of the Securities Exchange Act of 1934, as amended, the Annual Report of the Corporation on Form 10-K for the fiscal year ended September 30, 2019, hereby constitutes and appoints James Hagedorn and Ivan C. Smith, and each of them, with full power of substitution and resubstitution, as attorney-in-fact and agent to sign for the undersigned, in any and all capacities, such Annual Report on Form 10‑K and any and all amendments thereto (“Annual Report on Form 10-K”), and any and all applications or documents to be filed with the Securities and Exchange Commission pertaining to such Annual Report on Form 10-K, each in such form as they or any one of them may approve, and to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, and grants unto each said attorney-in-fact and agent full power and authority to do and perform any and all acts and things whatsoever required and necessary to be done in the premises, as fully to all intents and purposes as he could do if personally present. The undersigned hereby ratifies and confirms all that each said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on November 27, 2019.
/s/ THOMAS RANDAL COLEMAN |
Thomas Randal Coleman
Exhibit 31.1
Rule 13a-14(a)/15d-14(a) Certifications
(Principal Executive Officer)
CERTIFICATIONS
I, James Hagedorn, certify that:
1. | I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the fiscal year ended September 30, 2019; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 27, 2019 | By: | /s/ JAMES HAGEDORN | ||
Printed Name: James Hagedorn | ||||
Title: Chief Executive Officer and Chairman of the Board | ||||
Exhibit 31.2
Rule 13a-14(a)/15d-14(a) Certifications
(Principal Financial Officer)
CERTIFICATIONS
I, Thomas Randal Coleman, certify that:
1. | I have reviewed this Annual Report on Form 10-K of The Scotts Miracle-Gro Company for the fiscal year ended September 30, 2019; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: November 27, 2019 | By: | /s/ THOMAS RANDAL COLEMAN | ||
Printed Name: Thomas Randal Coleman | ||||
Title: Executive Vice President and Chief Financial Officer | ||||
Exhibit 32
SECTION 1350 CERTIFICATIONS*
In connection with the Annual Report on Form 10-K of The Scotts Miracle-Gro Company (the “Company”) for the fiscal year ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned James Hagedorn, Chief Executive Officer and Chairman of the Board of the Company, and Thomas Randal Coleman, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:
1) | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
2) | The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company and its subsidiaries. |
/s/ JAMES HAGEDORN | /s/ THOMAS RANDAL COLEMAN | |||
Printed Name: James Hagedorn | Printed Name: Thomas Randal Coleman | |||
Title: Chief Executive Officer and Chairman of the Board | Title: Executive Vice President and Chief Financial Officer | |||
November 27, 2019 | November 27, 2019 | |||
* | THESE CERTIFICATIONS ARE BEING FURNISHED AS REQUIRED BY RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT OF 1934 (THE “EXCHANGE ACT”) AND SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE, AND SHALL NOT BE DEEMED “FILED” FOR PURPOSES OF SECTION 18 OF THE EXCHANGE ACT OR OTHERWISE SUBJECT TO THE LIABILITY OF THAT SECTION. THESE CERTIFICATIONS SHALL NOT BE DEEMED TO BE INCORPORATED BY REFERENCE INTO ANY FILING UNDER THE SECURITIES ACT OF 1933 OR THE EXCHANGE ACT, EXCEPT TO THE EXTENT THAT THE COMPANY SPECIFICALLY INCORPORATES THESE CERTIFICATIONS BY REFERENCE. |